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On being an ambassador for science to the world.
Class of 2018, you have the distinction of being the largest graduating class in the history of the Kenyon Neuroscience
Department/Program. Your dedication to excellence and hard work means that despite this phenomenal growth,
we, the faculty, have been able to both maintain and build on the high standards that we have set for you and
ourselves. As a result, we are confident that you received a superb education and looked forward to hearing of
your future achievements. In the last few years, we recognized that although you, our students, are well trained
to write for your scientific peers, we had, like many science training programs, neglected to push you to develop
your abilities to communicate science to the public. This skill is essential, especially in the current socio-political
atmosphere. More and more we see scientific ideas and facts marginalized in favor of financial and political
expedience. One needs only to look at the climate change “debate” to see a perfect example of this trend. We think
that the answer to this problem is a better educated public; that the average voter should have the opportunity
to have a clear understanding of current scientific issues and trends, even if they themselves are not scientists.
The burden of providing that education falls on us, members of the scientific community. We must find a way to
communicate to our fellow citizens the complexity, excitement, and wonder of science. Most importantly, we must
do so with respect, grace and humility. We must share out knowledge and discoveries with our fellow citizens by
inviting them into the scientific world though our engagement with the public. One way is to write about science
in everyday language for general consumption. That is what we asked you to do in your senior seminar and those
articles are presented here in Volume 2 of Scientific Kenyon: Neuroscience Edition. You chose topics that anyone
would be excited to read about; from head transplantation to synesthesia to animal linguistics and so many other
wonderful topics. We, the faculty, are inspired by the range of your interest as well as your knowledge and the
nuanced way in which you tell your stories. This is precisely the kind of public communication of science we had
in mind when we set you to this task. We hope that after you leave Kenyon, you will continue serve as ambassadors
for science in whatever way you see fit. Whatever path you take, we are confident that you will represent the
Neuroscience Department, Kenyon College, and yourselves with grace and distinction. We wish you well.
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Parasitic
Mind
Control

How a single celled parasite carried in the cat intestine may be
quietly tweaking our behavior
By Sophie Letcher
n November 30th, 2012,
Jonah Evans* fell from a
30-foot ledge in Rock Bridge Memorial State Park, landing in a
bed of leaves at the foot of a cave
called “Devil’s Icebox.” The Missouri native teen was hiking with
a friend when he got carried away
jumping from rock to rock along
the trail - ultimately leading to the
disastrous accidental slip. Jonah
was airlifted to the local hospital

O

*Names have been changed to protect
privacy
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and made a full recovery, but this
kind of behavior was not unusual.
Jonah is an extremely intelligent,
thoughtful, and kind hearted
person, but as his mother, Emily*, attested after the accident, he
tends to put himself in reckless
situations - jumping atop slippery rocks along a ledge perhaps
the most devastating example. As
mothers do in these situations,
Emily searched for some way that
she was at fault for Jonah’s fall.
Sitting around a table

of friends discussing the horrific accident (post recovery), Emily mulled over why Jonah could
be so reckless when he’s generally
such a clear-headed person. “I did
spend a lot of time around cats
when I was pregnant with Jonah maybe he contracted that parasite
that makes you crazy,” she halfjoked. The parasite Emily was referring to is called Toxoplasma gondii (T. gondii, for short), and it was
around this time that pop science
was picking up the idea that many
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Pregnant? Steer Clear of Litter Boxes
If you’ve ever heard of T. gondii or toxoplasmosis, it was probably in the context of cat litter and pregnancy. That’s
because if the parasite is acquired while pregnant, it can be transmitted to the fetus and cause some nasty side
effects in the child: eye defects and potential blindness, mental disabilities, low birth weight, jaundice, and in
rare instances, stillbirths.3,20 The CDC suggests taking precautions while expecting: avoiding changing cat litter,
avoiding stray cats, cooking meat thoroughly, keeping cats indoors, and feeding cats dry/commercial cat food and
not undercooked or raw meat. In the unfortunate event that a pregnant woman is infected (detectable through a
blood test), there are medications available but both the mother and the baby will have to be closely monitored.3
cats carry a mind-altering parasite
(T. gondii) that can infect humans
and manipulate them into illogical
risk taking behavior.1 Although
the idea seems like science fiction,
mounting evidence suggests that
Emily may have been onto something. While she isn’t at fault for
Jonah’s fall, infection with T. gondii
may very well change one’s behavior - uncharacteristic recklessness
being just the tip of the iceberg.
What is Toxoplasma gondii?
T. gondii has been on a list of major pathogenic parasites since the
1920s2 but until fairly recently,
knowledge of the effects of infection on humans halted after the
initial stage of infection. Acute
toxoplasmosis, infection with
rapidly dividing T. gondii, is usually asymptomatic in healthy humans, sometimes causing mild
flu symptoms such as swollen
lymph nodes, muscle aches, or
fatigue.3 However, when the immune system is unable to quell
the rapidly dividing invaders, as
is the case with the immunocompromised (such as people who are
HIV positive), infection can lead
to severe fever, nausea, confusion,
headaches, or seizures; potentially life-threatening situations.3

Acute toxoplasmosis is also a risk
factor if acquired while pregnant.
As the host’s immune system starts to halt rapid division
of T. gondii, the parasite switches
gears and barricades itself in intracellular cysts that are safe from
the host’s immune response. It
remains inside these cysts, slowly
dividing, throughout the host’s
lifetime.4 Parasite-filled cysts can
be found in all types of host tissue, but seem to have a higher
affinity for neural and muscular
tissue.4 Though this slowly dividing stage was initially thought to
be asymptomatic, evidence now
suggests that the parasite may be
quietly tweaking our behavior
and underlying some of the most
devastating neurological diseases.
T. gondii life cycle: from cats to
rats and back
To understand these parasite induced behavioral changes in humans, it is important to understand why T. gondii may have
evolved the ability to change host
behavior - and the parasite’s complex life cycle is at the root of it.
T. gondii can only reproduce inside the cat intestine - but because
sexual reproduction is slow and
costly, the parasite outsources it-

self to an intermediate host where
it can asexually reproduce. Dormant forms of the parasite leave
the cat through its feces and are
ingested by other mammals (the
intermediate hosts). During this
period of the life cycle, T. gondii
divides rapidly, proliferating for
as long as it can until ultimately
returning to the cat intestine to
sexually reproduce again and complete its life cycle. How does the
parasite find its way back to the
cat intestine? Although it is able
to infect any warm-blooded mammal, it makes the most sense for
T. gondii to infect mammals that
will be eaten by cats - and this is
where it gets interesting. When
T. gondii is ingested by rodents
(common cat prey), the parasite
manipulates the rodent’s behavior
in a way that makes them easier
prey for cats; Infected rodents experience “fatal feline attraction”5,6
where they lose their innate fear
of cats, spend more time in vulnerable positions,5 and are even
sexually attracted to cat urine.7
So what does this have to do with
humans? As mentioned before,
once T. gondii is shed from the
cat in its feces, any warm-blooded mammal is susceptible to infection - and it turns out that
humans can contract the parasite
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through many means, leading to
a 30-70% infection rate worldwide.8,9 The life cycle of T. gondii
is summarized in Figure 1, including possible routes of transmission
to humans. It seems as though
the behavioral manipulation
that T. gondii induces in rodents
to facilitate its life cycle may go
slightly haywire when the parasite
finds its way into human tissue.
From cats to...humans?
From T. gondii’s perspective, infection in humans is a dead end
- unless we have really powerful,
sadistic pet cats or find ourselves
in the presence of a hungry lion it
is unlikely that we will be eaten by
a cat and thus return T. gondii to
the cat intestine. Nonetheless, the
manipulative parasite still finds its
way into a large proportion of the
human population. Although cats
play a pivotal role in T. gondii’s life
cycle, most of the transmission to
humans happens through consuming undercooked contaminated
meat, contaminated water, or eating unwashed vegetables.3 A study
done in 2002 found that 38% of
British commercial meat was contaminated with T. gondii,8 and
countries such as France that prefer meat undercooked have a higher rate of infection.9 Unwashed

“Cut up steak” by Van Robin is licensed
under CC BY-SA 2.0.
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Figure 1 T. gondii life cycle. Adapted from “Toxoplasmosis Cycle” by
llovericexoxo, licensed under CC
BY-SA 4.0.

vegetables carry the parasite when
grown in dirt with cat feces containing T. gondii, and parasite-laden feces also find their way into water supplies.3 Lucky for cat lovers,
it seems as though domestic cats
have a very low chance of carrying
the parasite, negating the T. gondii-based “crazy cat lady” theory.1
Strange Behavioral Changes
The acute symptoms of T. gondii
infection are easily digestible - the
fact that single-celled organisms
such as viruses and bacteria can
bring us physical harm is accepted and understood. The behavioral changes, however, are far more

complex and as such much more
terrifying. As humans are “accidental hosts,” it seems as though the
behavioral changes are spin-offs of
the manipulation seen in rodents
to make them easier prey for cats.
One of the pioneer studies in uncovering behavioral
changes in humans with chronic
T. gondii infection was done by
a Czech scientist named Jaroslav
Flegr, who wanted to see if the
reckless behavior observed in infected rodents translates to humans. Indeed it seems to - Flegr
found that a potential combination of reckless behavior and decreased reaction time in infected
individuals lead to a greater like-
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lihood of getting in a car accident.
More specifically, infected individuals are 2.65 times more likely to
be in a risky crash, an odds ratio
that may contribute to up to one
million car crash-related deaths
per year.10 Crazy as it sounds, this
study has been replicated in other
countries and the theory holds in
context of further studies on T. gondii induced behavioral changes.11
Interestingly, many T. gondii-induced changes seem sex-specific, as summarized in the figure
to the right. One of the most fascinating differences is that while
men seem to retain the “fatal feline attraction” seen in infected rodents - perceiving the smell of cat
urine as more pleasant compared
with uninfected controls - infected women are the opposite, finding cat urine less appealing than
uninfected controls.12 Though
there hasn’t been an explanation
for this sex-specific difference in
odor perception yet, some of the
other differences may be explained
by the fact that T. gondii infection leads to increased testosterone (the male sex hormone) in
males but not in females. Many
scientists also speculate that differences occur simply because the
male and female brains are wired
differently, and thus may react to
the parasite-induced neurological changes in different ways.13
What does appear to be
conserved throughout infected
humans regardless of sex is the
correlation between seroprevalence (detection of immune response to T. gondii in the blood)
and various neurological disorders.
Numerous links have been made

Sex Differences in Behavioral Changes With Chronic Infection

Adapted from Flegr 2007, Flegr et al. 2003

Women
- Find cat urine odor less
appealing
- More aggressive
- Less impulsive sensa
tion seeking
- More rule-conscious &
outgoing
- More intelligent
- More trusting
- More image-conscious

Men
- Higher levels of
guilt-proneness
- Less cooperative
- Decreased reaction time
- Decreased
psychomotor
performance
- Higher prevalence of OCD,
Depression,
Schizophrenia

between infection and depression,
suicides, personality changes, bipolar disorder, OCD, and, most
prominently,
schizophrenia.13
Recent studies have also found
correlations between infection
and epilepsy14 and certain types
of cancers.15,16 Putting together
all the indirect ways T. gondii infection could kill you, the parasite may be one of the most successful undercover assassins that
most people have no idea exists!
How? Putting together
pieces of the puzzle
How can a single-celled organism
cause us to crash our car or even
drive people to schizophrenia or
suicide? Although there isn’t a single satisfying answer as to how T.
gondii is able to elicit such complex and specific alterations in the
minds of hosts, multiple lines of
evidence are beginning to chip

- Find cat urine
odor more appealing
- More impulsive
sensation seeking
- More distrustful
- Less intelligent
- More introverted/suspiscious
- Tend to disregard
rules

away at how the parasite changes
host behavior.
Immune response
One of the primary explanations
for T. gondii-induced behavioral
changes in humans is the indirect effect of the immune system
working to keep the parasite “dormant.” The constant production
of chemicals needed to keep infected tissues safe from total destruction by the parasite are also
involved in other essential processes. For example, the immune
response leads to breakdown of
a key precursor of serotonin, a
“feel good” neurotransmitter that
is often lacking in the brains of
those with depression.17 Constant activation of the immune
response also messes with the
glutamate pathway, a neurotransmitter involved with anxiety.17
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Parasite localization
Another plausible way that T.
gondii manipulates hosts is simply through residing in the right
areas of the brain. The brain is
an extremely complex organ, and
disrupting proper functioning of
a specific place may be enough
to elicit a specific behavior. Cysts
seem to preferentially form in areas of brain associated with emotions, fear, and odor processing
(olfactory bulbs, amygdala, and
nucleus accumbens).17 Further,
studies have indicated that rats
only have “fatal feline attraction”
and associated anxiety behaviors when the parasite is localized
to certain areas of the brain involved with higher cognitive processes.18 However, because most
physical and cognitive functions
of the host are left intact, it seems
unlikely that behavioral changes are solely due to T. gondii localization. It is more likely (and
perhaps more terrifying) that the
parasite manipulates specific cells
and neural circuits in just the right
way where behavior is altered but
physically the host is unchanged.
Neurotransmitter modulation
Neurotransmitters are the chemi-

cal messengers of the brain, running the show of emotions, actions, and everything in between.
One of the most studied and most
accepted neurological changes in
the brains of T. gondii infected animals - rodents and humans alike - is
the increase of host dopamine levels.19,20 Dopamine is a neurotransmitter involved in the reward
pathway and motor control,21 and
increased levels of dopamine relate
to many of the observed behavioral changes, from movement issues
to hyperactivity to schizophrenia. Although the mechanism by
which T. gondii changes host dopamine levels isn’t clear, genomic
analysis has revealed that the parasite may synthesize proteins that
are critical in the production of
dopamine.22 These studies imply
that T. gondii uses these proteins
to speed up dopamine production
inside infected brain tissue, facilitating the increased global dopamine levels that alter behavior.
T. gondii and Schizophrenia
Schizophrenia affects about 1% of
the population and is one of the
least understood mental illnesses, mystifying neuroscientists for
ages.23 Symptoms of schizophrenia

vary, but generally include hallucinations, disordered thoughts,
and losing touch with reality.23
Strangely enough, T. gondii infection is the greatest risk factor for
developing the disease, bypassing
genetic and environmental factors.24 Patients with schizophrenia
have a higher prevalence of T. gondii infection across a range of meta-analyses,25 and some rare cases
of acute toxoplasmosis have been
documented with symptoms that
are very similar to schizophrenia auditory hallucinations, thought
disorders, blunted affect, etc.24
These cases are especially prevalent
in infected immunocompromised
individuals, where T. gondii has
free reign of host tissues.24 Scientists speculate that infection may
switch on predispositions for developing schizophrenia - meaning
that T. gondii infection doesn’t directly cause schizophrenia, but if
genes, brain structure, or environmental conditions make one more
susceptible to the disease, T. gondii
may simply flip the switch that
effectively “turns on” the disease.
So how does T. gondii
flip this switch? A hallmark of a
schizophrenic brain and likely the
underlying cause of many behavioral deficits is an increase in neural concentrations of dopamine -

Manipulation Hypothesis
The activity of T. gondii seems to fit perfectly with the “manipulation hypothesis,” which holds that some parasites manipulate host behavior for their own evolutionary benefit - often helping the parasite pass through the
food chain when a parasite has a definitive host (where it can sexually reproduce) and intermediate hosts (where it
can reproduce asexually).10 Other parasites that follow the manipulation hypothesis can be found infecting a wide
range of organisms. For example, Malaria parasites (Plasmodium) lead mosquitoes to bite more humans per night.
Another fungal parasite, Ophiocordyceps unilateralis, selectively infects ants and leads them to clamp down on
leaves or twigs, remaining there while being consumed by the fungus - lending them the name “Zombie Ants”.11
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“Man Women’s Fragrant Flower Smell”
by eommina is licensed under Creative
Commons CC0.

and as discussed before, increasing
host dopamine levels also seems to
be T. gondii’s forte.20 Interestingly,
antipsychotic drugs used to treat
symptoms of schizophrenia that
target the dopamine system (haloperidol, valproic acid) also seem
to inhibit T. gondii replication and
ability to get into the brain, harboring the idea that antipsychotics
may be at least partially effective
as antiparasitics.26 Another interesting connection is that many
schizophrenic patients experience
deficiencies in their olfactory systems - if T. gondii is a causative
factor for schizophrenia, this could
be explained by the olfactory manipulation involved with “fatal
feline attraction.”12,27 Though the
connection between T. gondii and
schizophrenia is still fairly recent
and not well understood, it creates exciting opportunities for
the generation of novel therapeutics for one of the world’s most
devastating neurological diseases.
Like the smell of cat pee?
One of the most fascinating manipulations that occurs in rodents
and seems to be (at least partially)
conserved in humans is the selective change in the perception of cat
odor. The olfactory system is one
of the most intriguing and com-

plex sense systems - each “scent”
(chemical) has a specific wiring
and a specific receptor that tells the
brain what scent was picked up.
Webster and McConkey (2010)
speculate that T. gondii may specifically trip the wiring for the “cat
odor” pathway and make the host
no longer perceive cat odor. Thus,
if a cat is stalking an infected rodent, the rodent will not sense the
cat approaching and will make for
extremely easy prey. Alternatively,
the parasite may target the innate
pathway in the olfactory system the wiring that rodents are born
with that sends alarms to the fear
response pathway when predator
odors are sensed.17 Further, this
fear pathway may be rewired in a
way that ties it together with the
sexual arousal pathway - meaning
that when rodents sense something that they should fear (cat
odor), instead they feel sexually
aroused. Interestingly, this specific
rewiring of fear and sexual arousal also appears to be conserved
in humans. One study of 36,564
participants found that those infected with T. gondii (both men
and women) have increased attraction to sexual masochism and
BDSM-related practices.28 While
this behavioral manipulation does
not have to do with odor detection, it may be another example
of a human spin-off of rodent targeted T. gondii induced changes.
What does this mean for you? Is
there a cure?
Because the behavioral changes
associated with chronic T. gondii
infection are not well understood,

Humans as Superorganisms
Although there are more
single-celled organisms living
inside us than there are human
cells, these freeriders are seldom considered when thinking
about humans as a whole.28 But
what about the fundamental
biological idea that the entire
point of being an organism
(be it a single celled parasite,
bacterium, or human) is to
survive and reproduce in the
best possible way? Now think
about those billions of individual organisms, each with their
own evolutionary strategy - it’s
unlikely that they all line up, so
what gives?
Kramer and Bressan (2015)
bring up the idea of humans
as “superorganisms,” and that
when these “selfish entities”
(i.e. Brain microbes, components of the gut microbiome,
exogenous viruses, foreign
human cells, etc.) integrate into
the human body, the evolutionary strategies clash - possibly
explaining why humans do
things that do not promote
our fitness. Thus, our behavior
may be guided by both human
evolutionary strategies and microbial evolutionary strategies.29
Toxoplasma gondii may be just
one example of a “selfish entity”
that is part of our superorganism.
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there isn’t a specific cure for targeting chronic infection - and
as discussed, the encysted form
of the parasite that occurs with
chronic infection is extremely difficult to target and out of reach
from antibiotics or other typical
antiparasitic drugs. The most effective combat against infection
is prevention: fully washing vegetables before eating, ensuring
meat is fully cooked, and being
careful around outdoor/stray cats.
If you’re like me, learning all this information will immediately make you question if
we actually make any of our own
decisions, or are simply a puppet
of the parasites residing in our
brains. Even scarier, T. gondii is
just one of the millions of organisms we host in our bodies - where
do our thoughts and desires end
and microorganisms’ begin, and
how can we tell the difference
between the two? For now, we
may as well accept the fact that
we are not alone in our bodies and next time you do something
reckless, just blame the T. gondii!
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Synesthesia
Sometimes, you really do eat your words
By John Wilhelm

A

s far as State of the Union
speeches go, you have a few
clear favorites. In short, Harry
Truman’s 1946 address was cogent—he balanced partisan tensions and maintained a lighthearted, likable demeanor. Franklin
Delano Roosevelt’s 1941 address
on the immediate cusp of WWII
was no less impressive; you might
argue it formed the backbone of
modern liberalism. But nothing
compares to Abraham Lincoln’s
speech on December 1st, 1862.
When the country needed it most,
Lincoln stepped in to announce
the emancipation proclamation.
His writing was eloquent, his delivery was immaculate—or so say
the first-hand accounts. The most
impressive, though, beyond all of
Lincoln’s talents, was his ability to
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write a speech that tasted just like
a home-cooked thanksgiving dinner. He was great at keeping consistent taste throughout his speeches.
FDR, on the other hand, while his
verbiage wasn’t bad, he could never
keep his flavors cohesive. When he
discussed international relations,
you couldn’t help tasting overdressed salad, excess bleu cheese,
and flour. While Truman’s commentary on military management
was great by all accounts—it just
tasted like onions, onions, onions.
If nothing struck you
as odd halfway through that
last paragraph, then congratulations—you might be a lexical-gustatory synesthete! It is not
often that words carry a palpable
flavor, but this is nothing out of
the ordinary in lexical-gustatory

synesthesia—a condition where
written or spoken words elicit an
involuntary association with a specific taste.1 Of course, this is not
limited to food-related words; if
I said ‘delectable filet mignon,’ I
would not blame you for getting
a hint of tender steak—but any
lexical-gustatory synesthete could
feel the same way about the word
‘bunion.’ It is also worth noting
that, in reality, it would be quite
rare for an entire speech to taste
so cohesive to a lexical-gustatory synesthete. Often, words have
very distinct, disparate tastes; the
word ‘woman’ might taste like
potato chips, where something as
innocuous as the word ‘by’ could
taste like sewage gas.1 In that case,
a single one of FDR’s sentences
in a State of the Union address
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could jump from completely palatable words to absolutely repulsive ones in a matter of seconds;
but, in my defense, this makes for
a more confusing introduction.
Lexical-gustatory synesthesia is far from the only condition of its type. Broadly, synesthesia is a phenomenon in which two
neural pathways form a “long-distance relationship”—stimuli of
one perceptual pathway elicit a
response in another.1 There are
more than 60 documented types
of synesthesia.1 For example,
of a word or letter might provoke the feeling of a certain color (grapheme-color synesthesia),
as could hearing a specific music
note (tone-color synesthesia).
The associations in synesthesia
tend to be bidirectional, so for a
tone-color synesthete, musical
tones elicit colors and colors elicit
musical tones.3 Previously, synesthesia was thought to be an incredibly rare condition affecting less
than 1 in 2000, people, but it is
now known that roughly 4% of the
population has some type of synesthesia.4 Though they are grouped
under the same name, types of
synesthesia can look very different. For example, visualization of
time as a spatial construct around
the synesthete (Spatial Sequence
Synesthesia), and associating concrete personalities with letters and
numbers (Ordinal Linguistic Personification) are also considered
synesthesia.5,6 Types of synesthesia
also vary greatly in how common
they are, and how much scientists
understand about them. So, how
does synesthesia work? What is going on in the brains of synesthetes?

Lexical-gustatory synesthesia
As types of synesthesia go, lexical-gustatory is on the uncommon
side, affecting very few people—
less than 1% of the population.4
Lexical-gustatory synesthesia is so
scarce that there are next to no aggregate studies of individuals with
the condition; all of them take
the form of case studies—or longterm, in-depth analyses of a particular individual. While a case study
might not have the explanatory
power of a hundred-participant
meta-analysis, they provide a detailed picture of the individual in
question. The major risk of a case
study is generalizing the results beyond the appropriate context, so it
is important to be measured when
extrapolating from case studies.
At this point you might
be wondering how researchers
verify that a person has lexical-gustatory synesthesia in the first place.
It is hardly as simple as putting up a
“volunteers wanted” sign at your
local community
center. This is a
concern
when
studying any type
of synesthesia—
verifying that an
individual is indeed
a synesthete can be a
difficult task, since synesthesia is an internal, perceptual phenomenon. Nonetheless,
synesthesia researchers have developed many paradigms to this end,
which vary widely between types

of synesthesia. In the case of lexical-gustatory, researchers verify
an individual’s synesthesia by a
months-long ‘pop quiz’ model.7,8
They begin by establishing a list of
~100 word-taste associations with
the synesthete. Months later, they
quiz the synesthete on the same
associations without prompting—
the synesthetes are almost always
100% accurate, except in cases
of synonyms (e.g. the synesthete
might claim the word ‘table’ elicits the taste of ‘biscuits’ instead of
‘wafers’). Researchers have extended this paradigm by decades. In
one case, a lexical-gustatory synesthete had 100% consistent answers
27 years after the initial study.8
It is difficult to generalize the nature of lexical-gustatory
synesthesia from any individual

“Word cloud of
apple.” Pixabay, 23 June 2015, cdn.
pixabay.com/photo/2015/06/22/15/38/
tag-817712_960_720.jpg.
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case study, but most have a few
things in common. For instance,
lexical-gustatory synesthetes’ tastes
tend to be quite distinct, including texture and temperature sensations—e.g. a synesthete would
not just taste “beer,” they would
taste “bitter, flat beer.”7 Most
lexical-gustatory synesthetes also
have “tasteless” words, though the
amount of tasteless words varies
between synesthetes—one synesthete might “taste” every word in
a 100-word sample, but another
might only taste 44%.7 Additionally, the semantic meaning of the
word seems to influence taste associations for most synesthetes. Generally, food-words taste like the
food they describe (‘cabbage’ tastes
like cabbage), but this extends
to indirect semantic associations
(‘newspaper’ tasted like ‘chips’ to
a UK synesthete, where chips are
often eaten out of newspaper.8
The actual sound of the
word appears to influence taste
association, as well. For lexical-gustatory synesthetes, the taste
sensation provoked by real words
(‘beach’) can also be provoked by
similar-sounding
‘non-words,’
(‘keach’). Additionally, lexical-gustatory synesthetes seem to link
specific individual sounds to specific flavors.1 A case study of synesthete “JIW” demonstrated that
his synesthetic flavors were connected to specific phonemes (indivisible units of sound, like the /t/
in table). Of the 17 words which
elicited the taste of ‘cake,’ 10 of
them contained the /m/ phoneme.
This means that words containing
the sound /m/ (as in ‘mice’) were
highly associated with the taste of
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cake for JIW, significantly more so
than any other individual sound.
Other tastes were linked to sounds
in the same manner—for example, the taste of ‘yogurt’ was highly
linked to the sound /g/ (as in gosh)
and the taste of ‘egg’ was linked
to the sound /k/ (as in ‘key’).8
The reason for these associations
is unclear, but it is peculiar that
words containing /m/ taste like
cake, but the word “cake” does not
contain /m/—this holds true for
most lexical gustatory associations.
Because of the scarcity of
lexical-gustatory synesthetes, little
is known about the neural basis of
the condition. Of the few neuroimaging studies available, preliminary
evidence suggests that the “taste”
experienced by synesthetes has a
different neural basis than the taste
experienced by eating food. When
observing the neural activity of a
synesthete in response to taste-inducing words, researchers did not
see activity in the orbitofrontal
cortex or anterior cingulate cortex,
regions responsible for processing
“normal” taste.9 The researchers
did observe that displeasing synesthetic tastes induce activity in
the left anterior insular cortex—a
region associated with emotional
responses to sensory experiences, particularly smell and taste.9,10
This could indicate that while the
neural basis of synesthetic taste is
not the same as “normal” taste, the
disgust experienced upon hearing
the name Derek1 is just the same
as an individual tasting earwax.
1 “Derek Tastes of Earwax” (September
2004) is a BBC horizon documentary
about a lexical-gustatory synesthete apologies to all the Dereks out there.

Culture and upbringing
are two additional but poorly understood factors of lexical-gustatory synesthesia. Synesthete PS, a
native English and French speaker, experienced gustatory sensations in both languages, but not
in Spanish, which she picked up at
the age of 9.11 On one hand, this
could support the idea that synesthesia arises due to associations
formed in childhood. On the other hand, perhaps her lack of synesthesia was due to her level of fluency; after enough Spanish work,
“Otorrinolaringólogo” might start
to taste like pizza. Likewise, the exact stimuli required to elicit a gustatory response are ambiguous—
for instance, PS did not experience
taste when listening to an individual read words in quick succession,
but other synesthetes experience
taste from spoken words, written
words, and even ambient noise.
As fascinating as the condition is,
much remains to be discovered
about lexical-gustatory synesthesia.
Grapheme-color Synesthesia &
Ordinal Linguistic
Personification
“’One day,’ I said to my father, ‘I realized that to make an ‘R’ all I had
to do was first write a ‘P’ and then
draw a line down from its loop.
And I was so surprised that I could
turn a yellow letter into an orange
letter just by adding a line.’”39
Patricia Lynne Duffy, both a researcher and synesthete herself,
remembers discussing her synesthesia with her father at the age
of 16. Her father was completely
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baffled by Duffy’s account of her
synesthesia—and she was equally
baffled that he did not see letters
as colored. While it would be unlikely for a lexical-gustatory synesthete to spend decades of their
life without realizing they have
synesthesia, it isn’t uncommon
for grapheme-color synesthetes.1
Grapheme-color synesthetes associate graphemes (the smallest units
of written language, e.g. letters,
numbers, symbols) with a distinct
color, regardless of the physical
color of the grapheme.1 These
colors are quite specific to the
synesthete with the exception of
a few letters—across synesthetes,
“A” is often red, “B” is often blue,
and “C” is often yellow.12 Grapheme-color synesthesia affects 1%
of the population, making it one
of the most common types of the
condition.4 Like most versions of
visual synesthesia, grapheme-color
synesthetes can be broken down
into two categories: “projective”
and “associative.” When viewing a
grapheme, associative synesthetes
have a strong internal feeling of
a particular color, but projective
synesthetes see the color physically
represented on the grapheme. Associative synesthesia is much more
common than projective.13 Grapheme-color synesthesia frequently

“ABC-Kids.” Public Domain Pictures, www.publicdomainpictures.net/pictures/210000/velka/abc-kids.jpg.

co-occurs with a type of synesthesia called “ordinal linguistic personification” (OLP). To an OLP
synesthete, graphemes have distinct personalities, identities, and
motivations—for example, “3”
might be a concerned businesswoman working hard to support
her child’s education, while “5” is a
young, bright-eyed rock musician
and “Q” is a kindly grandmother.1
To verify that an individual has grapheme-color synesthesia, researchers employ an
altered version of the Stroop
task (depicted below) which
you can try now, for yourself.
For most individuals,
reading the color of the ink in the
incongruent condition (below the
black line) is harder than reading
the color of words in the match1) Read the words above the
black line
2) Read the words below the
black line
3) Read the colors of the ink
above the black line
4) Read the colors of the ink
below the black line

“Stroop Test 2.” Wikipedia, the Free Encyclopedia, 18 Nov. 2012, en.wikipedia.org/
wiki/File:Stroop_Test_2.jpg.

ing condition. This occurs because
of “semantic interference,” where
the semantic meaning of the word
makes naming the physical color more difficult.14 In an altered
Stroop task, synesthetic participants name the synesthetic color
of the individual graphemes in the
word.15 This is easier if the graphemes in the word match its semantic meaning (e.g. a synesthete who
sees “e” and “l” as blue reads the
grapheme colors of “blue”) and
harder if they are inconsistent (the
same synesthete reads the grapheme colors of “yellow”). For an
OLP synesthete, an altered Stroop
task consists of quickly stating the
gender of names, in rapid succession.6 A synesthete who considers
“J” a female letter is quicker to
identify “Jillian” as a female name
than “James” as a male name.
While the altered Stroop paradigm
serves to verify synesthesia, it can
also demonstrate its intensity. Recording the change in participants’
response time between normal
and altered Stroop tasks provides
a picture of how much synesthesia interferes with participants responses—a high level of interfer-
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ence indicates strong synesthesia.15
Owing to its commonality
and long history (descriptions of
grapheme-color synesthesia date as
far back as 1812) most neuroimaging research on synesthesia has
been carried out in grapheme-color synesthetes.16 Unfortunately,
meta-analyses show that the lion’s
share of neurophysiological studies have been inconclusive, inconsistent in methodology, or statistically erroneous.17 As a result, it
remains impossible to conclusively
define any neural correlate of synesthetic color. Despite this, there
is one peculiar result—research
has shown that the synesthetic
colors evoked by graphemes do
not change activation of the visual
cortex. One explanation for this
is that real and synesthetic colors
are processed differently altogether, similar to how the synesthetic
taste of lexical-gustatory synethetes differs from “normal” taste.
This could also be explained by
a difference in connectivity, e.g.
in a grapheme-color synesthete,
the regions responsible for color
processing have a stronger connection to word-processing areas than in a normal individual.1
Mirror-touch Synesthesia
“...[She] has a form of synaesthesia
in that she experiences touch from
purely visual input. She experiences
tactile stimulation on the part of
her body that mirrors the body part
she observes being touched. [She]
has spent the whole of her life experiencing touch when she observes
touch on others, unaware that the
vast majority of the population do
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not experience similar sensations.”20
On the list of “Top 10 Types of
Synesthesia That Make it Difficult To Watch An Action Movie,”
Mirror-touch synesthesia clocks
in at #1. Mirror-touch is a variant
of synesthesia in which watching
another person being touched—
tapped on the shoulder, poked in
the cheek, punched in the face—
elicits a similar tactile feeling for
the synesthete in the same area.
Unsurprisingly,
mirror-touch
synesthetes tend to score higher
than controls on tests of empathy.18 Researchers have tried to
elicit tactile sensations from mirror-touch synesthetes in various
ways, but it seems mirror-touch
synesthesia is highly specific to
observation of physical touch on
another human.19 Flashes of light
on an individual do not elicit tactile sensations, nor does observed
touch on an inanimate object.
The first formal study of a
mirror-touch synesthete occurred
in 2005; this makes it one of the
more recently characterized variants.20 Despite this, mirror-touch
is among the most common types
of synesthesia. A study of more
than 500 people at University College London revealed a prevalence
of 1.6%.19 Much like a Stroop task,
researchers verify mirror-touch
synesthesia by examining response
time on a test where two neural
pathways are concurrently activated: researchers have synesthetes report the location of touch on their
own face while observing touch to
another person’s face. Specifically
researchers look for “mirror-touch
errors” (e.g. a synesthete is poked

“Hand in Mirror.” Pxhere, 22 Mar.
2017, pxhere.com/en/photo/1229143.

in one cheek while watching
someone be poked in the other
cheek, and they report a sensation
in both cheeks) which are unique
to mirror-touch synesthetes.19
Now, imagine yourself as
a mirror-touch synesthete. You
are facing someone who is tapped
on their right shoulder—do you
feel the sensation on your right
shoulder, or your left shoulder? As
it turns out, either answer is correct. There are two categories of
mirror-touch synesthesia: “specular” and “anatomical.”19 Specular synesthetes feel a sensation
as though they are looking in a
mirror—a tap on someone’s left
shoulder elicits a feeling in their
right shoulder; while anatomical
synesthetes feel a sensation on the
observed side. The specular subtype is roughly four times more
common; researchers hypothesize
that this choice of mental frame
may be driven by individuals
viewing their own reflections.19,20
Unlike other types of
synesthesia, the neural basis of
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mirror-touch synesthesia may
lie in a recently discovered type
of neuron, a “mirror neuron.”
Completely independent of synesthesia, mirror neurons were first
discovered in Macaque monkeys,
when researchers noticed a peculiar pattern of neuronal firing.21
Mirror neurons are understood to
fire both when an observer watches an action being performed,
and when they perform the action themselves.22 It has been hypothesized that over-activation
or an abnormally high amount
of mirror neurons could account
for mirror-touch synesthesia.23
While appealing, this explanation
incorporates two poorly understood concepts, and mirror neurons are a topic of heated debate
in the neuroscience community.
A great deal of further research is
necessary to support a hypothesis linking these two phenomena.
Origins & Neural Basis of
Synesthesia
Beyond those that we have briefly discussed, dozens of synesthesia
variants exist. Other prominent
types include tone-color synesthesia, where music notes have
a specific color, day-color synesthesia, the most common type of
synesthesia (prevalence of 2.8%),
and auditory-tactile synesthesia,
where sounds result in a feeling of
touch on the body.1,4,24 The vast
and varying types of synesthesia
make it a difficult condition to
study. Currently, a major question
for researchers is whether or not
the varying types of synesthesia
are caused by similar mechanisms.

Broadly, proposed mechanisms of synesthesia all suggest
that synesthetes have atypical connectivity between brain regions
associated with their synesthesia.
Though this is the prevailing mentality in the literature, there has
yet to be conclusive evidence in
this regard. Despite claims of individual studies, a 2015 meta-analysis of neuroimaging literature
concluded that “most published
studies to date show, in fact, that
the brains of synesthetes are functionally and structurally similar to
the brains of non-synesthetes.”17
The origins of synesthesia
are not completely ambiguous,
though. There is a clear genetic component to the condition,
multiple studies have found that
roughly 40% of synesthetes have
another synesthete as a first-degree relative.25,26,27 Specific types of
synesthesia do not appear to be genetically linked. Having a relative
with grapheme-color synesthesia
makes you more likely to be a synesthete, but not a grapheme-color
synesthete; this could support the
idea of a shared neural basis between types of synesthesia.27 Of
course, it is also possible that the
familial synesthesia reflects a cultural influence, owing to a shared
upbringing, or even knowledge
of the existence of synesthesia.
Additionally, the evolutionary advantage conveyed by
synesthesia may indicate a genetic
basis. If synesthesia is an evolutionarily advantageous trait, then
it should be preferentially selected for, which could explain the
genetic origins of synesthesia. So,
what advantages are conveyed by

tasting words, hearing colors, and
seeing sounds? As it turns out,
quite a few. Multiple studies of
grapheme-color synesthetes indicate that they have superior color
discrimination than non-synesthetes.28,29 Tone-color synesthesia
often co-occurs with perfect pitch,
and the prevalence of synesthesia
among artists and musicians is at
least twice as high as in the normal population.4 But the benefits
of synesthesia aren’t limited to
creativity. From a very young age,
synesthetes tend to have superior
memories than non-synesthetes,
even if the topic has nothing to do
with their synesthesia.29,30 In particular, spatial-sequence synesthesia—where time is visualized as a
spatial construct, normally around
the synesthetes’ heads—has been
studied as the basis for remarkable
memories.31,32 Researchers at the
University of Edinburgh propose
that spatial-sequence synesthesia is linked to “hyperthymestic
syndrome”—an incredibly rare
condition where an individual
can recall every day of their life
in perfect, excruciating detail.31
Since many individuals with hyperthymestic syndrome are also
spatial-sequence synesthetes, it
may be that the extra memory cue
of spatial-sequence synesthetes’
mental maps allows them to remember far more about their lives.
Of course—if synesthesia
is governed strictly by genetics,
and conveys creative, artistic, and
memory benefits, we ought to
all be synesthetes by now, surely.
But it is unlikely that genetics are
the only component of synesthesia. Considering cases of identical
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twins where only one twin was a
synesthete, it is clear that synesthesia has a social component.28
In particular, the individual differences in synesthetes—the specific color of their letters, sounds,
tastes—seems to be greatly influenced by experiences early in life.33
For instance, many lexical-gustatory synesthetes’ taste associations
are foods which were commonplace in in their childhood.1 Colored alphabets from early childhood also seem to influence the
letter-color associations of many
synesthetes. In one intriguing case,
a grapheme color synesthete’s associations were traced back to a Fisher-Price™ magnetic alphabet set,
recovered from her parents attic.
Her associations almost perfectly
matched the color of the magnetic
letters, with the exception of the
letter “B,” which happened to be
missing from the set during her
childhood.34 Interestingly, when
the same individual moved to Russia at a young age and learned the
cyrillic alphabet, she developed
synesthetic associations based on
her prior associations in the latin
alphabet. Cyrillic characters which
closely resembled latin characters
took on the same color as their latin counterpart (“Б” and “b” were
both blue).34 This was the same for
characters with phonetic counterparts (“Ф” makes the same sound
as “F”, they were the same shade
of purple).35 The fact that old colors were mapped onto new graphemes—rather than new graphemes
inducing new colors—strongly
supports the idea that synesthesia reflects unique memories developed during early childhood.*
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“Fisher-Price Magnet Set.” Flickr, 20 Jul. 2015, https://www.flickr.com/photos/joybot/19150803152.

Much of the secrets of synesthesia have yet to be uncovered.
Though culture and upbringing
are important aspects of the condition, scientific understanding of
synesthesia across cultures is quite
limited. Despite years of effort,
structural and neuroimaging studies have not discovered a neural
basis for synesthesia. Nevertheless,
a great deal of progress has been
made in understanding the behavioral correlates and internal experience of synesthesia. The condition is absolutely intriguing, and
provides a unique opportunity to
study perception. Some researchers posit that the study of synesthesia will help to discover the neural
correlates of consciousness.37,38
Regardless, synesthesia research
will certainly continue to reveal
more about this unique condition.
Perhaps the researchers will arrive
at an earth-shattering conclusion
about consciousness; perhaps they
will shape cognitive neuroscience for years to come. Or maybe

they’ll end up eating their words.
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DEMENTIA
GONE VIRAL
How years of research linking Alzheimer’s
Disease and infections has been lost in
translation
By Mary Sawyer

The Diagnosis

T

he tangles in the brain begin
slowly, like vines in a jungle.
They feed, engorging themselves
as they expand and grow. They
bend back and forth, in and out,
becoming entangled like the roots
of a tree digging deeper and deeper into the ground. Soon the vines
become so entangled that they are
no longer individual vines clinging to one another, but rather a
single mass taking up the space
that used to exist. This space in
the brain once filled by cells called
neurons and glia has now fallen
victim to the grip of the tangles.
Typically masses of tangles are ob-
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served in brains infected with Alzheimer’s Disease, but it turns out
they play a role in the pathological development of bacteria and
virus induced dementia. These
tangles, also called neurofibrillary tangles (NFT), are composed
of tau proteins in an abnormal
state. Normally, tau proteins stabilize neuronal structures within
the brain.1 Thus, abnormal tau
proteins deteriorate networks of
neurons, which are typically created from neurons communicating
with one another via synapses.2
These synapses are at the end of
neurons and enable neuronal com-

munication through the release of
chemicals, ultimately allowing
neurons to “talk” and create a network. Through the work of Dr.
Alzheimer, we found another key
player in the destruction of neuronal networks, aside from NFTs.
In 1907 Dr. Alzheimer discovered NFTs during an autopsy of
the brain of his patient who had
progressive cognitive decline.
Confused by his clinical observations and unable to determine the
cause, he investigated his patient’s
brain further. In addition to the
observed NFTs within the cells,
he found clumps of proteins in
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regions of the brain where he had
expected to find cells and brain tissue.3 These “clumps” were actually
amyloid-beta plaques (Aβ). Existing concurrently, NFTs and Aβ
plaques deprive brain cells of the
oxygen and cortical space they need
to survive, forcing the cells into a
neurodegenerative state (Figure 1).
This pathology of AD manifests in
a loss of memory and cognitive
function, leading to heavy burdens
of this disease across thousands
of families all over the world.4
Over 100 years later, a
speculative AD diagnosis is made
according to the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition and the
National Institute of Neurological
Disorders and Stroke-Alzheimer
Disease and Related Disorders
working group.6 AD is a specific type of dementia for which an
official confirmation of the disease still requires an autopsy of
the brain after death. Five million
Americans are living with AD, and
at the current disease rate there
could be as many as 16 million
people affected by the year 2050
.7 Described as one of the “holy
grails of science”, AD research has
gained momentum as scientists
search for a cure. Most recently
AD made headlines because of
Bill Gates’ donation of 50 million
dollars in funding.8 Despite advances in research and technology,
a cure for AD remains an enigma.
Imagine a 90 year-old man
wandering the streets of a neighborhood in which he has lived for
over 30 years. Every few feet he
stops and looks around him with
a confused look on his face. Every-

thing is unfamiliar, even though
he has lived in the same place for
several years. This man suffers
from sporadic AD, also known
as late onset AD (LOAD).6 His
brain has lost a significant amount
of neurons, leaving gaping holes
where Aβ plaques now form. Neural networks have been destroyed
by the intracellular NFTs. The
disease started slowly, creeping
in on his memories, settling in
to stay. While many experience
the cognitive decline that comes
with age, there is a difference between the aging process and the
disease this old man suffers from.
Most notably, the pathology of
his brain is unique to those with
AD in that he has significant neuronal loss, as well as NFTs and
Aβ plaques present. Elderly individuals having trouble recalling
memories or thoughts may have
changes to their neuronal networks, including loss of synapses.9 Although this aging person
has synaptic loss, they do not have
significant neuronal death and
therefore, do not have dementia.
Dementia is an umbrella
term for diseases classified as a disturbance to cognition and memory in such a way that interferes
with daily activities suitable for
the age of the person presenting
symptoms.4 Thus, AD is a type
of dementia defined by the presence of NFTs and Aβ plaques;
AD is further split into two types:
LOAD and Early-Onset Dementia (EOD).6 LOAD, also called
sporadic AD, develops in individuals with no family history of
the disease. Typically genetics are
discussed relative to EOD, or fa-

milial AD; however, genetics may
also play a role in LOAD. Scientists found that mutations of the
Apolipoprotein E (ApoE) gene are
associated with LOAD. In healthy
individuals this gene codes for a
protein that performs many functions. One of these functions is to
clear Aβ from the space between
cells, ultimately preventing plaque
accumulation.10 Thus, with a mutation to this gene, some individuals may be more susceptible to
build up of Aβ plaque. One study
looked at the brains of 39 individuals with a confirmed AD diagnosis and 35 healthy individuals;
62% of AD-infected participants
had an ApoE mutation, compared to only 20% of the healthy
participants.11 This indicates that
genetics likely play a role in the
development of LOAD. Many of
us are familiar with the unique
emotional weight an individual
and their family must shoulder
upon a diagnosis of AD. However,
few of us understand how years of
research has connected this disease
to bacterial and viral infections.
There is a tendency to as-

Figure 1 Neurofibrillary tangles (NFTs)
and Aβ plaques affect intracellular space
(within the cell, or neuron) and extracellular space (between cells in the brain).5

21

SCIENTIFIC KENYON
Figure 2 A depiction of cold sores caused by HSV1 [15].

sume that each disease is special
– that each disease is diagnosed by
specific characteristics, leaving us
with a false sense of closure when
we can finally name our pain. This
is rarely the case. Dr. Alzheimer
said himself “how difficult it is
to define diseases with respect to
their clinical features”.12 For decades scientists have recognized
NFTs and Aβ plaques as characteristic of some chronic viral and bacterial infections. Certain pathogens can remain dormant in the
central nervous system for years,
and often a lifetime. These pathogens include herpes simplex virus
type 1 (HSV1), C. pneumoniae
(pneumonia), Borrelia burgdorferi
(Lyme disease), and other spirochetes (spirally shaped bacteria).6
Herpes and Alzheimer’s
The Center for Disease Control estimates that about 90% of
American adults are exposed to
the herpes simplex 1 virus (HSV1)
by the age of 60. This virus most
commonly manifests as cold sores
(Figure 2). The second form of the
herpes virus is the herpes simplex
2 virus (HSV2), which gets its rep22

utation from self-help books like
“how to live with herpes,” appearing in the form of genital sores.
About 1 in 6 people are estimated
to have genital herpes, according
to the CDC.13 Hearing the word
“herpes” makes many people run
for the hills. However, the reality
is that many of us have been exposed to herpes and it now quietly
resides in our CNS.2 HSV infection often lasts a lifetime and can
reactivate, producing cold sores.
Another more extreme form of
HSV1 is herpes encephalitis,
which is when the virus inhabits
the brain and induces dementia
with clinical features similar to
AD. Because of these similarities,
researchers have been hypothesizing a potential connection between
infections and AD for years.3
Researchers found that
AD-infected patients had less degeneration in brain regions containing more amounts of HSV1.14
This suggests that the presence of
the virus evoked some physiological response that was ultimately
protective. In contrast, Aβ was
found to prevent and reduce the
amount of HSV1 DNA replication. This would suggest that

more Aβ plaques reduces the viral infection, yet also spurs on the
neurodegenerative process as the
plaques accumulate.16 These results may mean that the presence
of HSV1 beneficially produces Aβ
and leads to greater preservation
of the brain. Seemingly contradictory results like these have left
scientists with inconclusive data.
Epidemiological studies advance
this discussion, further explaining the link between infection
and AD. In a study following 360
patients over 6 years researchers
found that those who were previously exposed to herpes were twice
as likely to develop AD compared
to those with no prior infection.17
Similarly, scientists followed an elderly population for 14 years, examining cognitive function every
few years. Baseline blood samples
showed who had been infected
with HSV prior to the 14-year investigation. They found that HSV
infection and the development of
AD were correlated, hinting that
early exposure to HSV may lead to
AD; however, it is also important
to remember the old saying that
correlation does not necessarily
equal causation.18 Though a causative relationship should be taken
with a grain of salt, another group
of researchers discovered that
HSV DNA is co-localized with
Aβ plaques in AD-infected brains,
further strengthening the association between infections and AD.19
Additionally, HSV1 and
AD have been linked genetically.
Mice with an ApoE genetic mutation had 13.7 times more HSV1
viral DNA present in their cells
compared to mice without a mu-
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tation.20 This genetic mutation,
as discussed before, is a risk factor
for AD. Thus, these data create an
interesting story illustrating how a
risk factor for developing AD could
also dictate the amount of virus
present in an individual. Despite
the interesting story being told by
years of research, no one has explored the clinical implications of
HSV and AD concurrency; could
anti-viral HSV treatment cure AD?
Pneumonia and Alzheimer’s
Pneumonia is a lung infection that
is currently the 6th leading cause
of death in America. While not
as common as herpes, community-acquired pneumonia (CAP),
or pneumonia acquired outside of
the hospital, still affects about 5.6
million Americans each year. C.
pneumoniae is a specific bacteria
that often causes CAP; however,
those infected with this bacteria
do not always develop symptoms
21
Multiple studies found that the
bacterium was present in most of
the AD-infected brains and in few
of the healthy brains, implicating
the bacteria as a risk factor for AD.
Researchers also found that the
bacterium was more prevalent in
areas of the brain most affected by
AD, such as the frontal, temporal,
and parietal cortex (Figure 3).3,23,24
Research linking C. pneumoni-

Figure 4 An image of a spirochete bacterium. Notice the spiral-shape, almost
like a corkscrew.26

ae to AD started in the 1990’s,
yet little has been done to develop this idea that the bacteria may
be causative. There is even research showing how the bacteria is able to spark cell death in
the brain. Despite these pivotal
findings, no research has been
done to determine if vaccines
can improve or prevent AD.

Figure 3 Research has shown that the
frontal (red), parietal (yellow), and temporal (purple) lobes are most susceptible
to AD and bacterial infection.

Spirochetes and
Alzheimer’s
The tick crawling on the floor
may seem harmless, but it
could be carrying bacteria called
Borrelia burgdorferi, most often referred to as Lyme disease.
Lyme disease infects approximately 300,000 Americans each
year, and this number continues
to grow.25 B. burgdorferi is a spirochete, meaning it is long and
spiral shaped (Figure 4). There are
many types of spirochetes – a form
of sexually transmitted disease that
causes dementia, one of which is
responsible for neurosyphilis.13
This bacterial-induced dementia
has similar pathological characteristics of AD, including a build-up
of spirochetes that are indistinguishable from AD plaques.6 Spirochetes have been detected more
frequently in AD-infected brains
than in healthy brains. The bacteria were also found in the same
areas as Aβ plaques in AD-infected brains, similar to findings
previously observed with HSV1
and C. pneumoniae.27 It seems
obvious that something is happening between AD and infections.
In addition, the number of
spirochetes in the brain increases

as the severity of dementia increases in individuals with an atrophic
form of general peresis – a disease
that leads to muscular weakness
from nerve damage. This was first
discovered in the 1920’s.3 The connection between the pathology of
infection-induced dementia and
AD pathology is apparent. It is
peculiar how such convincing data
and trends have been discussed
for decades without any progress
towards improving AD treatment.
Individuals with a higher infectious
burden have an increased risk of
cognitive decline. Elderly patients
exposed to multiple viruses were
2.5 times more likely to develop
cognitive impairments.28 A number of other epidemiological studies found that patients at risk of developing AD or with a confirmed
AD diagnosis were likely to have
been exposed to an infection at
some point in their life.14,18,25
AD is defined by standards set in the 1900’s and confirmation of diagnosis is still performed in the autopsy room. After
years of research, it seems crude
to diagnose AD based on clinical
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Figure 5 A beautiful yet daunting microscopic image of a virus.

features so similar to those present in infections. How can this
diagnosis be so confidently made
when symptoms across AD, herpes encephalitis, and neurosyphilis
are so similar? These diseases may
typically affect different populations, but that does not excuse
the potential confound during
diagnosis. A key piece to the puzzle connecting pathogens to AD
is the innate immune system.
The Innate Immune System
Living in a world full of viruses and bacteria, the human body
comes well equipped. Our bodies
are able to endure such trauma,
including microscopic trauma
that may go unnoticed. How do
our bodies endure? The innate
immune system protects both the
body and brain through activation
of various cells and proteins that
fight foreign pathogens. Scientists
are increasingly confident that Aβ
is part of the innate immune system. As mentioned previously, Aβ
prevention of HSV1 DNA replication suggests a protective role of
the protein.16 Shockingly, Aβ has
also been found to reduce bacterial growth and protect against
microbial infection.30,31 It turns
out that the protein that goes haywire in AD actually protects our
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brain from harmful pathogens.
If you recall, ApoE genetic mutations are risk factors for
AD. Interestingly, ApoE genetic
mutations similarly play a protective role. Children with heavier
burdens of diarrhea actually performed better on cognitive tests
if they had a genetic mutation of
ApoE.32 Thus, this risk factor for
AD can be protective depending
on the circumstances. While this
may seem surprising, the idea
that characteristics of a disease
may be protective is not novel.
For example, sickle cell anemia
protects people from malaria in
some parts of the world.33 In order to find a cure for AD, and the
“holy grail of science” we need to
consider all possibilities, including the idea that AD treatment
might include anti-viral treatment or vaccination (Figure 6).8
Over the range of pathogens aforementioned, one thing
remains a common denominator. After decades of research and
numerous published reviews of
research describing the poten-

Figure 6 “The grail may be closer than
meets the eye” by Mary Sawyer. Adapted
from “Cartoon scientist with magnifying
glass” by Boris Klissourski.

Figure 7 Image of the Swedish flag
overlaying the country of Sweden.35

tial role of infections in AD, few
strides have been made to clinically study these momentous scientific findings. Finally, the first study
will be conducted in Sweden using
herpes anti-viral treatment for AD
patients (Figure 7). Prior research
suggests that if Aβ accumulates
around the virus, then killing
the virus will also reduce the Aβ
plaques and potentially ameliorate
symptoms of AD.34 They started
enrolling participants in December 2016, but have not released
outcomes of their clinical trials. If
there is such a link between AD
and infections, why are we now
just trying anti-viral treatment to
cure AD? Why has it taken so long
to test this hypothesis given the
decades of research? Potentially,
it is the stigmatization of sexually transmitted infections that has
prevented a full scope of research.
Maybe we have become blind to
solutions that have stared us in the
face for years. With vaccinations
for C. pneumoniae and anti-viral treatment for HSV1, it seems
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to be an obvious next step to test
whether these could slow the progression of AD in people. In fact,
research published in 2011 even
showed how antiviral treatments
reduced the amount of Aβ plaques
and NFTs in cells.36 It seems that
Sweden is leading the rest of the
scientific community in this race
to find a cure. Hopefully, their
clinical trials will pique the curiosity of other scientists around the
world and advance the field of AD
research. As a captivated audience,
we must remember the role we
play – clinical trials are nonexistent
without willful participants. Not
only that, but a public engaged
with the sciences will encourage
funding for the most sought after research. While AD research
is currently caught in the public
eye, a link between the disease and
common infections is not exactly
what people want to hear. That being said, science is not about sharing pleasantries, it is about finding
the truth however hard that may
be to digest. For now I propose
a call to all scientists: it is time
to follow Sweden’s lead and take
this work to the clinical realm.
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Animal
Linguistics
how human language developed from
animal communication
By Fritz Josephsen

L

iving in the middle of a consciousness revolution, new insight comes from the strangest of
places. In the past few decades, geneticists, neuroscientists, psychologists, sociologists, economists
and others have made huge progress towards understanding the inner workings of the human mind.
The pieces of information presented now give us a better grasp of
human character, emotion, social
bonding, and human communication. In many ways, the gap left
void by theology and widened by
philosophy is being filled by brain
science.
To give us a sense of this consciousness revolution let’s consider
human language. The leading au-

thority on language development,
MIT scientist Noam Chomsky,
hypothesized that a specific aptitude for language is encoded in the
human brain at birth. According
to Chomsky, this so called ‘language organ’ is responsible for the
human brain’s capacity to understand complex communication.
Possessing the language organ is to
be equipped with a type of universal grammar, a set of rules that is
shared by all languages.
A distinction between
communication and language
must be established. Communication encompasses all exchange
of information that is verbal and
non-verbal. Facial expressions,
body gestures, visual art, mimicry,

and even odor signals are methods of communication. Language,
however, is a tool invented by humans in order to communicate
more effectively. Chomsky and
other psycholinguists have studied
the properties of human languages
to gain an understanding of specific characteristics of human intelligence. This effort by linguists is an
attempt to learn something about
human nature. Now, looking towards animal communication, the
very foundations of human language can be assessed. Aside from
humans, many animals have relied
upon communication systems to
form complex social bonds, and
thereby create intricate societies. Studying communication by
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animals reveals the workings of
ering this foundation of language?
simpler brains, which has the poThe first hint of an early
tential to teach us about our own
human tongue may not lie in an
brains.
ancient African tomb, but in anFor ages, language has
other living animal. Perhaps that
been described as a talent unique
animal is swimming in the oceans.
to human beings. This ability to
Maybe it’s flying in the air. Clearly,
transmit encoded thoughts from
forms of animal communication
one individual mind to anothfall short of language, but their
er is perhaps the basis for all hufeats of socialization warrant attenman advancement. Human beings
tion by the larger scientific comsharing ideas has led to a larger,
munity. These beasts of the wild
species-wide awakening. Sharing
have communication systems adideas caused an enlightenment
vanced enough to both utter and
that gives us an
perceive specific
advantage over
sounds. Some
“The
first
hint
of
an
early
other creatures
species can even
human
tongue
might
not
and has givlearn new units
en birth to the lie in an ancient African of sound then
modern day. But
combine these
tomb, but in another
how are we so
sounds to create
living
animal.”
adept at sharing
new meaning!
thought? Where
		
did this “language organ” come
Vocal learning is a remarkable abilfrom? Can archaeological research
ity that is rare amongst the animal
elucidate an understanding of lankingdom. Most communicative
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animals have a sound’s meaning
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“Cetaceans” by Chris huh is licensed by CC BY-SA 3.0.
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These alarm calls indicate specific
predators, such as leopards, eagles,
or snakes, to be in the area. These
alarm calls are learned just after
birth and are never relearned or
replaced throughout life.1
While vervet monkeys represent
vocal learning animals that acquire
knowledge of vocal calls during
a single period of life, other animals learn and relearn vocal signals throughout their lifespan.
Cetaceans are a clade of 89 extant
species of aquatic mammals that
are experts at learning signals.2
This clade includes: porpoises, dolphins, and whales. Baleen
whales have been found to learn
songs after birth and learn new
songs seasonally. Toothed whales
use learned auditory signals to
maintain their social relationships
which change daily for hunting
purposes. Likewise, bottlenose
dolphins’ use learned sounds referentially to determine individuals
within a pod.
One incredible aspect to
bottlenose dolphin communication is their signature whistle. In a
pod of dolphins, each dolphin will
call out a distinctive whistle representing an individual dolphin’s
name.2,3 In the deep murky waters
of the ocean, wild free-ranging
bottlenose dolphins will call their
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signature whistle to alert others in
the pod of their location. Dolphins
familiar with the caller will repeat
that signature whistle, as if echoing another’s name. If a dolphin
hears it’s own signature whistle it
is very likely to respond. Whereas, if a dolphin hears the whistle
of a familiar dolphin it is slightly
less likely to respond. Dolphins
will never respond to unheard
whistles.2,3 This name-calling behavior is the foundation for every
dolphin pod’s unique hierarchical
structure.
Still, dolphin communication is not limited to name-calling.
Dolphins frequently emit their
whistles and clicks to communicate with one another, but they
also are able to use echolocation
to communicate. Echolocation
enables all cetaceans to send out
sound waves, which allow them
to identify location, shape, and
size of distant objects in the water.
This biological sonar allows cetaceans to orient themselves, detect
their prey, and coordinate hunting tactics. In fact, echolocation
allows dolphins to hear and produce some of the highest frequency sounds of all mammals. In perspective, humans have a hearing
range from about 20 Hz to 20kHz,

whereas dolphins have a hearing
way, the human researchers were
range that exceeds 150kHz.4 This
integrated into the pod, and even
intense range of sound detection
assigned names by the dolphins.
has led many scientists to specuThere are many theories
late that dolphin communication
regarding how cetaceans develis more advanced than previously
oped complex communication
thought. Some have even argued
systems. Morphological studies
the possibility of dolphins having
have compared dolphin brain
a language system of their own,
cryoarchitecture to that of other
a language system which humans
highly social aquatic and terrestrial
would be unable to detect.
species. These studies have shown
A recent study popularthat cetaceans posses the largest
ized by the Ted Talk, “Could we
brain in absolute size related to
speak the language of dolphins?”,
body mass.5 There have been sevlooked into the question of doleral confounding theories presentphin’s having the capacity for laned to explain their brain developguage. Performed in collaboration
ment as being distinct from other
between leading researcher of cetamammals. Many of these theories
cean intelligence Denise Herzing,
assert that readapting to an aquatic
and computer scientists at Georgia
environment has influenced their
Tech, a device was created to bridge
brain development; however, the
the gap between human language
scientific community now largely
and dolphin communication. The
refutes these theories. After whole
device called CHAT (Cetacean
and sectional morphological analHearing and Telemetry) contains
yses the structural complexity of
a microphone able to detect the
their brains has been linked with
entire acoustic range of dolphins.
sociality and cognition. In parFurthermore, with the touch of a
ticular, the high density of Von
button, this device can repeat any
Economo neurons, characterized
signature whistle recorded in the
as having extended axons for fast
wild.4 Using this device, free-divneural information transfer, has
ing researchers
been
credited
were able to
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communicate
involved with
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and
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This finding is notable, as a quality
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of human brain communication
with the dolphins, such as passareas are a particularly high densiing a scarf from one individual to
ty of Von Economo neurons.6 The
another. Shockingly, the animals
high density of these neurons is a
began to reference the researchers
quality of human brain language
with signature whistles! In this
centers that is shared by the ceta-
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cean brain.
However, dolphins are
not the only animal to display
complex social behavior, nor are
they the only animal to have the
ability to communicate using ultrasonic frequencies. Indeed, bats
are equipped with this same biosonar and can produce and detect
up to 250kHz soundwaves. Evolutionary scientists believe these two
animals convergently evolved,7 or
independently developed these
traits. That means these two animal groups having the ability to
produce, detect, and interpret ultrasonic waves does not give evidence of a similar lineage between
these two animal groups.
		Bat vocalizations
have been shown to be even more
complex than dolphin whistles,8
and for good reason. While bottlenose dolphin pods may merge to
form superpods with over 1,000
individuals, a bat colony can contain up to a million bats! Remarkably, bats make up a quarter of
all mammalian species on Earth.
These highly social animals need
to communicate amongst their
colonies to cooperate on migration patterns.
To compare bat vocalizations with human language, first,
human sentences must be broken
down into discrete parts. In a single sentence, a human can: distinguish another person’s voice,
understand meaning from words
spoken, and understand a speaker’s intention by tone of voice.
Human speech parallels bat vocalizations on a number of levels.
A single Egyptian fruit bat vocalization has been shown to include
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information about: the identity of
the emitter, context of the call, behavioral response to the call, and
even the addressee of the call.8
In morphological studies comparing the brain sections
of bats, shrews, mice, rats, and
humans, the organization of calbindin-cholinergic cells shows a
marked difference in bat and human brain than that of the rodent
brain.9 In bat and human brains,
cholinergic innervation avoided
calbindin patches, this showed
intermittent entorhinal theta activity, whereas rodent brains entorhinal theta activity features
cholinergic innervation within
calbindin patches.9 A common
factor between bats and humans
caused selective pressure for this
conservation of cholinergic stellate and pyramidal cells avoidance
of calbindin patches. This means
that bat brains have developed
more complex brain structures
than their more related cousin
species in order to allow for more
advanced social behavior. Still, in
comparing cell distribution patterns, bat brains are not as advanced as human brains. Between
human and bat medial as well as
caudal entorhinal cortices, relative

neuron numbers of these calbindin patches was not constant.10
How have bat brains become more advanced than closely
related rodent species? A species’
brain morphology is almost entirely dependent upon that species’ genetics. Even the amount of
a gene expressed during an individual animal’s development can
alter that animal’s brain structure.
New research is ending the idea
that the origins of language are
lost in time. Linguists can no longer ignore the archaeological clues
emerging from genetics.
Almost two full decades
ago the gene related to a developing brain’s communication center
was identified. The FoxP2 gene
has been recognized as the gene
involved with development of
speech and language areas of the
brain.3,11,12 This gene displays extreme conservation in sequence
across all bird species having very
low rates of substitution. In fact,
all animals show high conservancy of this gene. Between zebrafish
and humans, the FoxP2 gene has
been shown to be 98% similar.11,12
This gives evidence suggesting its
huge involvement in animal development. Avian species have shown
location dependent and seasonal
dependent expression of this gene.
Meaning, whether the songbird is
in its mating season, FoxP2 will be
more or less expressed. Differential
expression of FoxP2 in avian vocal learners is associated with vocal
plasticity.3
While, as one might expect, dolphins and bats do not
have special versions of this gene,
they do however, express higher
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levels of FoxP2 genes during fetal
development than comparative
animals. During brain development, dolphins and bats have similar FoxP2 relative expression patterns as humans.11
Dolphins and Bats are two
examples of animals that have developed complex communicative
behaviors. These behaviors have
become essential parts of these
animals’ lifestyles. We now understand the behavioral, morphological, and genetic conditions that
animals must meet in order to
possess a capability for complex
communication.
These two animals live in
social groups and depend upon
these groups for their longevity.
Dolphin and bat brains feature
large centers that are used for communication. Perhaps given another few thousand years for these
animals to develop, a definitive
language will be created. Indeed,
the only key element of language
these animals seem to be without
is what linguists call “recursion,”
or the mind’s ability to create a
phrase based off another into the
syntax of an elaborate sentence. It
is believed that early humans attained this ability from the use of
another brain system, such as the

system animals use for navigation.
For a long time biologists
and linguists have purposefully
inhabited different worlds, because linguists take little interest
in evolution, which is the fundamental theory of biology. Any
hypotheses put forward regarding
the evolution of language, therefore, is promptly contested. How-

“New research is ending the idea that the
origins of language are
lost in time. Linguists
can no longer ignore
the archaeological clues
emerging from genetics.”
ever, since the FoxP2 gene breakthrough shook science nearly two
decades ago, a solid hypothesis regarding the origin of language has
been put forward.
The evolutionary theory
of the origin of complex human
language follows the gradualism
model of evolution, meaning that
language developed gradually over
time, without rapid bursts on the
evolutionary time scale. The “sexual selection information-sharing
hypothesis” states that vocal learn-

ing causes more selective mating preferences.13 These selective
mating preferences, in turn, cause
the next generation of offspring
to produce equally or more complex vocalizations. This hypothesis
hinges upon information-sharing
from one generation to the next
occurring during the language acquisition period.13,14 The human
language acquisition period peaks
at around six years of age with the
window of opportunity to naturally pick up on a language declining
after this age. This hypothesis was
imagined after better understanding the foundations of language,
that is, after understanding other
forms of animal communication.
The age-old mystery,
“Where did human language
originate?” is being solved. With
new insight from genetics, and an
understanding supported by observing animal forms of communication, human language can be
traced back to the time before our
globalized world’s effective communication. Back to a time before
the consciousness revolution, before written, or even, spoken history was recorded.
Only after making sense
of animal communication can we
imagine the pre-neolithic world:

“Bats, flying, sunset” by Ann Froschauer is licensed under PIXNIO Public Domain.
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early hominids communicating
abstract thoughts vocally, but not
yet speaking a set language. Entire generations of early hominids
lived within a community and
underwent vocal learning during
their language acquisition periods.
With each generation, an expansion arose in the community’s vocal repertoire. Within-group communication became easier while
between-group communication
became more difficult. Hence, sexual selection favored information
sharing.
This pre-neolithic world
is analogous to the pre-globalized
world, which had many distinct
languages, limiting genetic information transfer. This theory states
that for much of human history,
kin selection has been determined
by an individual’s ability to communicate with one another, which
was determined from birth. Finally, amongst these early hominid
groups, different vocal repertoires
further increased and diverged.
Communication better represented complete thoughts until,
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tremendously, it happened. Language was born.
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News on Nootropics:

Is META
COGNIT
I
O
N
right for y
ou?
By Diana Aboubakare

A

nimals exhibit cognition –
humans exhibit specialized
cognition.1 What makes us so special? One might theorize that the
human brain is constructed differently: do structural differences
separate us from other animals?
Human brains possess a prefrontal cortex whereas other animals
lack a brain area that resembles the
prefrontal cortex.2 Could it be our
big brains? While this argument
works for some animal model
comparisons, humans do not own
the title of having the largest brain.
The biggest known brain belongs
to sperm whales. In fact, the average human brain mass pales in
comparison to the brain mass of
other animals. Given this, some
have theorized that perhaps it is
our brain to body mass that makes

us unique, the graphic also mentions this idea. A more concrete
argument actually ties all of these
ideas together. Although neuron
counts vary between individuals,
we on average possess an astonishing number of neurons compared to other mammalian brains.
The brain of an African Bush Elephant weighs two times more than
the human brain but the human
brain has a whopping 16.3 billion
neurons while the brain of the elephant has 5.59 billion neurons.3
The neural networks exhibited in
human brains make our cognitive
abilities reach beyond all other animals and give us a unique complexity. Having such complex neural networks allows us to change
our preferences and gives us the
capability of processing massive

amounts of information which we
can further use for other applications.4 In fact, we use our cognitive abilities without even realizing
it: memory, attention, executive
tasks, perception, language, and
psychomotor functioning are all
processes that require higher cognitive areas.4 While there are clinical reasons for seeking out cognitive enhancers, individuals with
an average capacity of cognitive
performance experience societal
pressures and exaggerated standards that cause us to strive for
an altered, enhanced potential.
If you went onto your
smartphone, tablet, or computer and searched “how to improve
cognition”, approximately 28
million results are generated. You
might find articles that suggest ex-
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ercising, playing games and downloading apps that stimulate your
brain, or engaging in other intellectual activities. There are movies
that sensationalize being better
and smarter than we currently are.
They display catchphrases like:
“The average person uses 10% of
their brain capacity. Imagine what
she could do with 100%.” and
“Everything is possible when you
open your mind.” (Both of which
are not factual, more on this later.
But give yourself 10 brain points
if you can guess those movies.) We
are constantly searching for ways
to enhance our cognitive abilities.
Of the 28 million results, there
appear to be a few repeating buzzwords. One buzzword commonly
used amongst cognitive enhancement enthusiasts is nootropic: supplements that enhance cognition.4
The claim behind nootropics is
that they boost memory, focus,

Low Grade Cognitive
Optimizers
Tea
Caffeine
Energy Drinks
and motivation. However, cognitive optimizers come in many
other forms – some of which you
may already consume; for the purpose of this article, these different
forms will be categorized as highgrade cognitive optimizers and
low-grade cognitive optimizers.
Low-Grade Cognitive
Optimizers
Tea. The Tea Association of the
USA shared a statistic stating that
Americans consumed more than
3.8 billion gallons of tea in 2016;
over 158 million Americans are
consuming nootropics daily with-

High Grade Cognitive
Optimizers
Racetams
AlphaBrain ®
Modafinil
out realizing it!5 The dorsolateral
prefrontal cortex, an area within
the executive control center of the
brain, has been studied in regards
to activation caused by green tea
extract. This area is believed to be
involved in working memory and
cognitive processing.6 A neuroimaging study was completed while
participants performed a working
memory task after they were given 250 or 500 ml of a milk based
whey drink either with or without
the addition of green tea extract.
It was found that activation of
the dorsolateral prefrontal cortex increased when participants
consumed the concoctions with
green tea.7 This means that green
tea extract has a modulatory effect on the dorsolateral prefrontal cortex, facilitating memory.
Caffeine

By Knowing
Neurons - Knowingneurons.
com, CC BY
4.0, https://
commons.
wikimedia.org/w/
index.php?curid=54983232
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Many people believe that caffeine
helps get their day going, and for
some, it is an essential staple in
their daily routine. It is actually the
world’s most widely consumed psychoactive drug. Generally believed

“Coffee Break” by Alexandra is licensed
under CC0.
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to improve performance on simple
tasks, consumers use caffeine to
aid them in improving focus and
alertness. This logic is not unwarranted. In fact, research claims that
caffeine improves performance
on simple and complex attention
tasks that require executive control
networks suggesting that caffeine
does affect alertness by antagonizing adenosine receptors meaning
that caffeine works against the depressive effect of adenosine when
it binds to its receptor.8,9 Therefore, caffeine works as an attention
enhancer. However, there is also
evidence that causes one to refer
to the phrase “too much of a good
thing”. Caffeine in higher concentrations has been shown to have
anxiogenic affects: consuming too
much caffeine leads to feelings of
anxiety caused by a reduction of
oxygenated hemoglobin in the
prefrontal cortex.10 This being
said, there appears to be a way to
combat this and actually amplify the positive effects of caffeine.
Caffeine + Tea
To fully realize the potential of
caffeine, researchers suggest combining caffeine and tea to create
a synergistic affect. Tea is an anxiolytic, an anxiety inhibitor. Because of this characteristic of tea,
the anxiogenic effect of caffeine
is attenuated when taken in conjunction with tea. L-theanine, a
compound found in tea products,
combats the anxiety produced by
caffeine and actually helped to
improve reaction time during an
attention-switching task.11 This
makes sense given the implication that caffeine increases at-

Energy Drinks- Monster, Red Bull, and
Rockstar, CC BY 4.0, https://www.flickr.
com/photos/aukirk/8170825503

tention and alertness. With this
study, it was not the result of reaction times that was crucial, but
the accuracy expressed by the
participants during the task. Participants that were administered
l-theanine with caffeine experienced greater accuracy while those
that were given the tea alone had
lower accuracy during the tasks.11
Energy Drinks
Within the last 14 years, the worth
of the global energy drink market has risen from $3.8 billion to
$27.5 billion.12 They are trendy
and typically come in fun looking
cans. What could go wrong? The
three most popular energy drinks
consist of five (Red Bull), twenty-three (Monster), and twenty-two (Rockstar) ingredients, respectively. Not many consumers
are aware of the effects of these
ingredients. Shared ingredients
amongst popular brands are: l-theanine, glucose, ginseng, guarana,
tyrosine, gingko, theophylline,
flavanols, creatine, l-tryptophan,
St. John’s wort, and yohimbine.
While an individual can look at
the nutrition facts on a can and
recognize some of these ingredients, consumers blindly intake

energy drinks because of promised affects. Interestingly, of the
12 ingredients listed, research suggests that three of them: St. John’s
wort, yohimbine, and l-tryptophan are detrimental to mood and
performance.13 And this is just
what has been researched, fortunately, the remaining nine were
observed to be relatively beneficial to mood and performance.13
High-Grade Cognitive
Optimizers
History. This category of cognition
enhancers was initially used for
clinically treating cognitive deficits
such as those seen in patients with
Alzheimer’s, schizophrenia, stroke,
and ADHD.4 Pharmacological
enhancers, or synthetic stimulants,
were designed to improve the
brain functioning of individuals
that suffer from diminished brain
functioning. The advancements
made in cognitive enhancers for
the purpose of treating cognitive
deficits has led to the creation of
supplements and other synthetic
stimulants for improving cognition despite an observable lack

“Cerveau & Cognition” by Lorena
Biret is licensed by CC BY-SA 2.0.
35

SCIENTIFIC KENYON

of deficits. Nootropics of this nature are colloquially referred to as
“smart drugs” and are typically taken by young and healthy patients.
Piracetam. A stimulant belonging
to the class of synthetic stimulants
known as Racetams, Piracetams
are said to enhance neuronal
function by increasing membrane
fluidity in the brain.14 Studies
of this drug date back to 1960;
these studies investigated the use
of Piracetam as a counteractive
measure to memory dysfunction
in depressed patients and as a
prophylaxis against delirium.15,16
Clinical studies of this drug were
done in children with dyslexia and
elderly individuals. Age plays a
strong role in overall cognitive decline. However, elderly individuals
that underwent a regular dosing
regimen of Piracetam also experienced positive affects reported
as “greatly improved” brain functioning. A possible explanation
for this is that dysfunctional mitochondria (mitochondria: which
we all know is the powerhouse of
the cell and creates energy) treated with Piracetam experienced a
nearly complete recovery in membrane potential. In other words,
Piracetam elicits an improvement
in the brain functioning of elderly individuals because of its ability
to stabilize and protect mitochondria.17 In a more specific application, children with dyslexia also
received Piracetam treatment. The
children were administered two
reading tests, the Gray Oral Reading Test and the Gilmore Oral
Reading Test. On these tests, they
exhibited an improvement in their
nonverbal skills, demonstrating
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heightened reading and comprehension abilities after 12 weeks
of treatment.18 While affects were
only seen after 12 weeks of treatment for children with dyslexia,
one study reported that “normal”
adults treated with Piracetam
showed a significant increase in
verbal learning after just 14 days.19
Modafinil. Although Piracetam indicated similar efficacy in
both young and old individuals,
Modafinil (commercially known
as Provigil) demonstrates a higher
efficacy in younger, healthy patients. This drug is similar in its
profile to methylphenidate, more
commonly known as Ritalin. The
“beauty” of Modafinil is that it
works like an amphetamine but
without the side effects.20 Participants that were administered
Modafinil reported feelings of being more alert, attentive, and energetic, demonstrating that the drug
exhibits a positive effect on neuropsychological task performance.20
The effects of Modafinil on wakefulness are so strong that one
study gave sleep-deprived doctors
the drug and tested their performance.21 The doctors were given
a placebo or 200mg of Modafinil
and then subjected to neuropsychological tests and a Minimally
Invasive Surgical Trainer Virtual
Reality Machine (MISTVRM)
that tested psychomotor performance. The researchers found that
despite being sleep-deprived, the
doctors that were given Modafinil worked more efficiently when
solving memory and planning
problems, exercised less impulsive
decision making, and were better
at redirecting their attention.21

AlphaBrain. Web. https://www.onnit.
com/academy/alpha-brain-nootropic-shows-statistical-significance-in-groundbreaking-clinical-trial/

The MISTVRM showed that their
psychomotor performance was
unaffected. Another occupation
that requires strict attention to
detail and wakefulness is pilots.
On Modafinil, pilots remained
awake for 40 hour periods while
maintaining full mental capacity
during simulated flight performances. The results of this study
demonstrated that after 25 hours
without sleep, the performance of
the pilots significantly improved
on a 100mg dose of the drug
with sustained brain activity.22
AlphaBrain®. Sixty-three individuals were orally administered
AlphaBrain® to investigate the
efficacy of this supplement. The
experiment was designed so that
volunteers were treatment naïve
(it was not revealed that they were
being given the supplement or a
placebo). After six weeks of taking
AlphaBrain®, the volunteers returned and took neuropsychological tests; their results were compared to the results of the initial
testing. The participants showed
markedly improved performance
in tasks that required delayed verbal recall and executive functioning.23 AlphaBrain® works through
the mechanism of increasing ace-
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tylcholine in the brain by provide
raw choline through alpha GPC
as well as provide acetylcholinesterase inhibitors (these inhibit the
degradation of acetylcholine).24
What do users think?
Many users who have experimented with synthetic nootropics
have shared their testimonies.
Piracetam. One user, an 18-yearold male weighing 196 pounds,
shared that he took 2.4g/day.25 He
reported that the best effects he experienced were: long term memory improvement, linguistic ability,
memory recall in a conversation,
and logic improvement. The user
also reports that “slight details
of sound and sight are noticed
more.” The only side effect he experienced was decreased focus.
Modafinil. This individual identified himself as an “enthusiastic amateur” experimenting with Modafinil.26 Highlights of his usage:
“The biggest effect is that it obliterates the need for sleep … For me, it
brings a sharp and clear awakeness
similar to a non-caffeine user having a large coffee, except the effect is
larger and there is no jitteriness or
agitation.”
He also shared negative aspects of
the drug:
“I really lose track of time, and have
to set alarms. I will look around
and it will be 5AM, and 8PM
was not that long ago” and “I have
had bad experiences when taking
Modafinil in a particularly bad

mood. If I was ruminating…taking
Modafinil made me get deeper into
the rut and accomplish nothing.”
Another Modafinil user says he
discovered the drug through an
underground entrepreneur’s forum and was so convinced that he
purchased it online immediately
after.27 He writes how his focus
on Modafinil was “[…] breathtaking. It is like being on a train,
going through a tunnel. There
is no way to go but forward and
there are no distractions.” He further shares that he often goes until
5pm without eating while on the
drug. The testimonial concludes
with his experience post-Modafinil: “there are no nasty side effects, there is just back to normal.”
This testimony for Modafinil
comes from a college student.38
The user created two simple lists,
a pros list and a cons list. His pros:
1) “you can concentrate for hours
and get [a] lot of work done, and
remember it all afterwards”, 2) “it
helps you wake up early”, and 3)
“quite subtle: this is not an overwhelming experience”.
His cons:
1) “makes you unsociable”, 2) “you

can become too focused” and so you
must “be careful when crossing the
road”, 3) “your mood tends to swing
a little bit up and down while you
are on it”, and 4) “lots of trips to
the loo”.
AlphaBrain®. One user shared a
review of after being on the supplement for a month. [29] He
shares his experience as being “remarkable” and that the drug had
a positive effect on his disposition.
A highlight of his review: “turned
my daily activities from an almost
catatonic and quite semi-depressive state into much the opposite”.
One user did not share such a glowing review.30 They shared that they
used an entire bottle of the supplement “….and nothing. [I] did not
feel even the slightest bit different”.
So What?
Per the U.S. Food and Drug Administration, Piracetam has not
been approved for medical use
nor is it permitted to be sold as
a dietary supplement.31 Modafinil is a Schedule IV Controlled
Substance; according to the Drug
Enforcement
Administration,
Schedule IV drugs have a low potential for abuse and a low risk of
dependence.32 The current med-

The popularity of Modafinil
has skyrocketed for recreational use, even being cited
by CNN as “perfection in a
pill”.
“Perfection in a Pill”. Web. Youtube Screengrab. https://i.ytimg.com/vi/ZaZp6XfqYf8/hqdefault.jpg
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ical application for Modafinil is
treating patients with multiple
sclerosis. Modafinil can easily be
found online for purchase even
though Schedule IV drugs require
prescriptions. The popularity of
Modafinil has skyrocketed for
recreational use, even being cited
by CNN as “perfection in a pill”.
Natural nootropics belong to the
low-grade cognitive optimizers
while the high-grade cognitive optimizers are synthetics. The availability of these synthetic supplements is concerning. AlphaBrain®
boasts clinical trial results; other
supplements are not regulated
and can be sold without any verification or certification. General consumers can go online and
purchase anything. Some online
vendors make claims of being certified and state that their product
improves athletic performance as
well as the classic cognitive improvement claims of nootropics.
Many consumers believe the labels displayed on the bottles (or
in some cases, bags). You may
think “what is the harm?” when
it comes to self-prescribing and
purchasing synthetic stimulants,
but they as the user testimonies
suggest, there are pros and cons.
Conclusion
While these supplements should
be taken at your own risk, there
appears to be more to gain from
experimenting with high-grade
cognitive optimizers than fear the
risks involved. Because the risk of
dependence is low for these substances, the question is less of a
“why not?” but more of a “why?”.
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If one is already performing at a
level that is above being deemed
deficient, then for what purpose
does an individual need to take
cognitive enhancing supplements?
Humans already possess highly
complex neural networks that give
us a specialized cognitive system.
In a sense, it almost seems as if you
are cheating yourself of a character-building experience necessary
for bettering society. If we truly used only 10% of our brains,
perhaps I might understand conceding to these high-grade cognitive optimizers. The only reason
one might identify with this and
take this myth as truth is because
we see our own shortcomings
and think “I could be so much
better…if only I could use all of
my brain.” In fact, neuroimaging
studies have demonstrated that
brain areas are continuously active
over a 24-hour period.33 In conclusion, I would like to add one
last personal anecdote. In completing research on this topic, I
found myself wanting to experience the effects of these cognitive
optimizers (Modafinil, right?!) but
had I not written this organically,
I would have cheated myself out of
the opportunity of learning that I
can put together 2,832 words (up
until this point) into a relatively
cohesive article on a plane from
California to Ohio. Without any
cognitive optimizers. So yes, although my cognition does experience occasional lapses, I accept
my shortcomings and I feel more
accomplished in writing this article than I might have if I had used
a high-grade cognitive optimizer.
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The Curious Question of
Social Synchronization
By Jennifer Cabiya

H

ave you ever clapped in
time with an audience at a
concert or sporting event?
Have you ever fallen into step with
your friend on your way to class
the way marching bands do? Then
you’ve experienced a phenomenon known in the neuroscientific
field as “social synchronization.”
This term refers to the experience
of matching your actions to a
tempo set by another person, distinguishing it from regular “synchronization,” which is when you
follow a beat from a non-person
stimulus, like when you dance to
a song. While it seems simple, the
science behind this universal skill
is steeped in complicated interactions within the brain as well as
a history of conflicting models to
explain it. This article will explain
the most widely accepted cognitive
model of synchronization, discuss
the practical implications for social
synchronization, and as introduce
you to a field of study where social
synchronization is used commonly: two-person neuroscience.
As you can see in the picture to the , social synchronization
is needed to keep parades looking
organized. It can also be implicated in any other organized movement such as dance routines, playing patty-cake with a child, and of
course synchronized swimming.
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The current cognitive model
If you’ve ever heard of a pacemaker, the surgically implanted device
that helps hearts beat regularly,
you already know the importance
of keeping time in the body. Other uses for timekeeping includes
circadian rhythms, which help
you wake up and sleep on a regular schedule. These are examples
of endogenous, meaning within the body, timekeeping. Early
research on synchronization assumed that each cell, including
the neurons in the brain, had an
endogenous timekeeper and that
whichever collection of neurons
had an especially robust ability to
keep time, with whatever cellular

mechanism that might turn out to
be, would be responsible for estimating when the body should respond to a stimulus. However this
avenue of research, as many often
do, yielded to a more complicated
notion: that there was a specialized
collection of neurons that handled coordination (Wing, 2002).
Now, you may have heard of the
cerebellum as the part of the brain
that, when exposed to intoxicating
amounts of alcohol, makes you
clumsy. There, specifically in the
right lateral cerebellar cortex, is
where the two-level timing model
takes place.
The two-level timing model, developed by Alan Wing and A.
B. Kristofferson, is a mathematical

Photo taken by Louis Bricese. Retrieved from
United States Air Force Photo Gallery.
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Figure 2 Wing-Kristofferson two-level timing model. Timekeeper intervals (C) are subject to motor implementation delays (M) in defining interresponse intervals (I). Average
I is equal to the average C. However, variation in I reflects both C and M. In particular,
variation in M results in negatively correlated I (tendency for short and long intervaals
to alternate), as suggested by the dashed lines (Wing 2002).

explanation for how the brain synchronizes. The two levels within
the model are the “timekeeper interval” and the “motor implementation delay,” which refer to the
external signal to which you are
trying to synchronize and the time
at which you perform the synchronizing action (such as a clap
or tap of the finger) respectively.
Before you are synchronized with
a tempo, be it from a metronome
or someone else’s cue, there is a
temporal discrepancy between the
signal and your response. The goal
of synchronization is to reduce
this discrepancy to zero. In order
to do that, the right lateral cerebellar cortex must a) measure the
length of time between signals (the
timekeeper interval), b) measure
the length of time between your
responses (the motor implementation delay), and c) determine the
difference between the two. When
this is resolved by averaging multiple signals and responses, the cerebellum sends signals to the motor
cortex in the parietal lobe to adjust
your motor responses. Essentially,
the right lateral cerebellar cortex

is responsible for telling you when
to clap, based on how off-beat you
already are.
Biological correlates for synchronization
The right lateral cerebellar cortex
does not act alone in the process
of social synchronization. It must
interact with the oculomotor system, involving inputs from the
visual cortices in the occipital
lobe and outputs to the motor
cortices in the parietal lobe. Similarly, if the timekeeping stimu-

lus is auditory, then connections
with the auditory cortices in the
temporal lobe are also used. Interestingly, there is evidence of a
structural connection via white
matter (i.e. myelinated axons of
neurons, which send signals across
the brain) between the right lateral
cerebral cortex and the left inferior
frontal gyrus (IFG) (Hodge et al.,
2010). This second area is better
known as Broca’s area, discovered
by French physician Paul Broca in
1861, and is commonly known to
be involved in producing speech.
However, some interesting newer
research also implicates the area in
the interpretation of social actions
(Nishitani et al., 2005). Therefore,
social synchronization may rely on
the left inferior frontal gyrus to interpret signals from other people as
appropriate for synchronization.
Let’s apply this to a practical example of social synchronization. Imagine that you are sitting
at a table when your friend begins
tapping out a tune on the table,
and the rest of your friends begin
to sing along. Your visual system
(the oculo- part of the oculomotor
system) sends information in real

Image is in the public domain, retrieved from Wikimedia Commons.
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time to the inferior frontal gyrus
and the right lateral cerebellar cortex at the same time. When the left
IFG recognizes the tapping as musical, and not, say, a very emphatic
addition to your friend’s rant, then
the right lateral cerebellar cortex
can start synchronizing your hands
as they begin to tap on the table as
well. Your motor system (the -motor part of the oculomotor system)
plans out how your arm and wrist
and hand will move together in
one smooth motion, but it is your
cerebellum that tells you when to
do it.
The left IFG is also known
to have a high amount of mirror
neurons, which help us to mimic other people’s behavior. It is
tempting to assume that social
synchronization relies on the activation of the mirror neuron system, but in synchronization paradigms where voluntary movement
is limited, motor neurons do not
activate (Yun et al., 2012). They
only activate during purposeful
motor activity. Synchronization
can happen on a very small scale
with nonpurposive movements, so
mirror neurons may help to un-

derstand complex motions, but
may not be necessary for the synchronization process specifically.
The right lateral cerebellar
cortex also handles hand-eye coordination, which, for example,
helps you to catch an incoming
football at just the right moment.
Some research has shown that the
ideal disparity between a signal
(such as the sight of an oncoming
football) and the performance of
a behavioral response is 75 milliseconds (Miall & Reckess, 2002).
When this temporal lag between
the expectation of feedback and
the actual sensory experience is
unexpectedly long, the right lateral
cerebellar cortex shows increased
activation (Blakemore, 2001).
The existence of a preference, or
even an expectation, that must
be compensated with extra activation when unfulfilled provides
strong support for the localization
of synchronization to the right lateral cerebellar cortex. By performing experiments that artificially
manipulate the sensorimotor lag,
synchronization can be studied as
the right lateral cerebellar cortex
actively regulates motor behavior.
Retrieved from epilepsyu.com/blog/report-identifies-public-health-actionsepilepsy/
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Practical Uses for Social Synchronization
Aside from the myriad of anecdotal opportunities to exercise your
knowledge of the neurological
underpinnings of social synchronization, research on interpersonal
effectiveness has shown that social
synchronization correlates with
better teamwork and likeability
(Yun et al., 2012). Not only do
those who practice social synchronization later synchronize more
quickly and more accurately (Yun
et al., 2012), they also perform
better on cooperative tasks with
improved joint attention, which
helps to problem-solve more efficiently (Szymanski et al., 2017).
The chameleon effect is an
interpersonal phenomenon wherein people in dyads or a group will
mimic each other’s posture and
small movements. According to
Chartrand (1999), this behavior
is an automatic process, much like
synchronization. It is reasonable
to hypothesize that the chameleon
effect relies on the activation of
the mirror neuron system in the
left IFG which informs the synchronizing process that lies within
the cerebellum in order to keep up
with micro-expressions during a
social interaction. Chartrand goes
on to describe the perception-behavior link, which states that your
perceptions of others’ behavior
will influence your own. This resembles the fundamental effect of
social synchronization: another’s
cues guide your own motor activity, and the interaction between the
two facilitate rapport. A well-fa-
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cilitated rapport is useful in professional settings, but sometimes
difficult to promote naturally. Because social synchronization can
be practiced and improved, however, even a little effort could help
you to literally get on the same
wavelength as your co-workers.
Two-Person Neuroscience
Neuroscience has long been focused on the singular, individual
brain. While some of the most
compelling questions neuroscience asks are fundamentally interpersonal in nature, data collection
is limited by both mechanical and
financial cost. For example, an
fMRI machine can only fit one
person in it to measure brain activity at a time, and its maintenance
costs are often prohibitively expensive for many research groups.
A technique called hyperscanning
is an innovative solution to this dilemma because it allows for two or
more research participants to have
data collected at the same time.
Hyperscanning involves collecting
electroencephalography
(EEG)
recordings through electrode caps
(see image below) from two participants simultaneously while
their data is time-locked (Liu &
Pelowski, 2014). This allows researchers to measure interpersonal
interactions directly, rather than
make assumptions based on data
taken sequentially. By locking two
participants’ data in time, phase
synchronization can be measured.
Phase synchronization is
when two people’s EEG recordings, which are visually represented by waveforms, match up

so that the crests and valleys of
the waves occur at the same point
in time (Liu & Pelowski, 2014).
When phase synchronization occurs at the same node of an EEG
cap, researchers can assume that
the activity in the corresponding
brain area (such as the left IFG)
is similar across the two participants (Liu & Pelowski 2014). This
means that the micro-expressions
and spontaneous motor behaviors
are not just due to random muscle contractions, but are the result
of neurological processing derived
from face-to-face interaction. The
importance of this distinction is
immense: synchronization can be
described as having a dedicated
neurological basis. If this is true,
then it might be able to be studied in model animals or applied to
more integrative theories than if it
were considered emergent at rates
resembling chance. Data, models,
and theories about synchronization could have the potential to
explain how language and music are developed prenatally and
during critical learning years. Because phase synchrony is a marker
of social synchronization in general, which is in turn a correlate of
efficient interpersonal efficiency,
the applications of hyperscanning
can potentially be very direct in
answering questions about the social behaviors of humans.
One promising model for
synchronization in general, though
not necessarily social synchronization, are birds like the cockatoo,
who can be observed dancing to
music with a strong beat (Patel et
al., 2009). By studying their synchronization processes and occa-

sionally their brains, posthumously, neuroscientists could come to
conclusions that are difficult to
make while studying the human
brain, which is more complex.
In fact, areas like the cerebellum
cannot be accurately measured
by EEG, as it is more folded than
the cerebrum, which makes the
electrical signals picked up by the
EEG more scattered in direction.
If the cerebellum is to be studied
in humans, one of the more effective approaches is to use magnetoencephalography (MEG) which is
similar to EEG but better able to
detect signals from this convoluted
area of the brain (Baillet, 2017).
Conclusions
Social synchronization may not
be the most immediately critical
area of study, but understanding
how it works leads to not only
satisfied curiosity, but contributes
to a body of knowledge that can
solve tomorrow’s problems. As
two-person neuroscience develops
using measures of social synchronization, new questions are asked
and new perspectives are taken
on a field that is itself constantly
emerging. By answering the frivolous questions, we approach the
answers to more fundamental explorations on the field: how do we
connect with one another?
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a closer look at
Eating Disorders
By Kelsey Trulik
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My story begins at age 4…
I spent my entire childhood surrounded by weight stigma…
My eating disorder was unicorn
in shape…
As a man and a person of color, I
never had the space to be vulnerable…
My story with this battle begins
with a lifelong fight against anxiety and depression…
It has nothing to do with food…
I have more memories of my
eating disorder than I do of my
siblings and family and school…
It takes on a life of its own…
It just is…1

E

very person battling or having battled an eating disorder has a story to tell, and every
story is so different. These individuals had the courage to speak out
and share their experiences with
battling an eating disorder and the
tough road to recovery. However,
for many individuals, it’s not as
easy. While 3-5% of the population openly acknowledges their
disorder with eating, many individuals go through life’s motions

“Depression, Voices, Self-criticism” by
John Hain is licensed by CC0.
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A Few Definitions 3

Anorexia Nervosa (AN): Body weight that is less than 85% of normal
weight for height and age, intense fear of fatness, disturbed appearance
of one’s body weight and shape. Affects 0.5-3% of the world population
Bulimia Nervosa (BN): Recurrent episodes of binge eating, compensatory behaviors (purging, exercising, and fasting) Affects 1-3% of the
world population
Binge-Eating Disorder (BED): Regular binge eating episodes, absence of
compensatory behaviors
Affects 2-4% of the world population
without ever letting anyone know
about the internal battle they face.2
An eating disorder is not
a something you can turn on and
off. It’s a lifelong fight, affecting
many. It does not have a specific appearance, but rather affects
people regardless of race, gender,
and age. It removes the feeling of
self-worth, respect, and love for its
victims. It is common belief that
familial practices, peer influence,
hurtful words such as “chubby”
and “fat,” media, and constantly
shifting societal pressures to physically “fit in” promote the development of eating disorders, but the
root may go beyond this.
In a society where fashion
magazine models are a size zero,
movements like “pro-ana” and
“thinspiration” exist, Photoshop
and various other forms of digital technology manipulate “ideal”
body imagery, smartphone applications track calories consumed
and burned, and social media
platforms consume the time and
thoughts of children and young
adults, the incidence of eating disorders has greatly increased. We

are constantly bombarded by societal definitions of “beauty” and
the “ideal” body through various
public routes such as television,
magazines, billboards, and other
sources of media. And if one does
not fit these physical standards, society, especially one’s peers chastise
them. As a result, media is often
considered the root cause of eating
disorders, but eating disorders are
more complex than what media
contributes to them. Yes, social
and environmental factors influence the development of eating
disorders, but the true complexities lie in the combination of so-

“Individuals developed eating
disorders when our culture
developed a standard of beauty that they couldn’t obtain by
being helathy When unnatural
thinness became attractive, indiviudals did unnatrual things
to be thin.”
cial, psychological, and biological
factors.
Culture has shifted perceptions
of the body significantly over the
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past few decades. These cultural
shifts are reflected through various
forms of media, which have introduced a new “ideal” body image
for both men and women. Female
beauty is defined as being thin and
lean, and male beauty is defined as
being muscular and strong.4 What
the public sees in media are “ideals” that are unattainable, and often unhealthy. In fact, recent studies reveal that 70% of models are
under a healthy weight.4
Western media imagery is
seen everywhere these days, and
children and young adults are
heavily influenced by it. The power of Western media imagery is
often difficult to see, especially for
people who grow up with it; however, the negative effects can clearly be seen later on in life in various
aspects such as the development
of eating disorders. Many young
adults diagnosed with or recovering from an eating disorder reported initially changing their eating
habits and the ways they viewed
their bodies in order to look like
Alarming Facts (as of 2016)2
• At least one person dies
every 62 minutes as a direct
result of an eating disorder.
•

Eating disorders have the
highest mortality rate of
any mental illness.

•

At least 30 million people
suffer from an eating disorder in the US alone.

•

6% of transgender college
students report having an
eating disorder.

a certain person—a character from
their favorite TV show or a model on the cover of Vogue or Men’s
Health magazine.4 The negative
effects of Western media imagery
can further be explored by Becker
and his team.

“Cover Version” by Brett Jordan is
licensed by CC BY 2.0.

The Power of Western Media
Imagery:
In 1995, a group of researchers
(Becker and his team) traveled
to small, remote province in Fiji.
While the television had been invented 68 years prior to this year,
this Fijian community had yet to
be exposed to Western media imagery via television before. And
similarly to the lack of televisions,
the prevalence of eating disorders
in this area was rare to none.5
Becker and his team journeyed
to this province at a critical time,
as television was just being introduced into this community. The
researchers took time to interview
and survey the attitudes and behaviors of female adolescents in
this province. Their results confirmed what they had expected
from a traditional, Fijian community: robust women were glorified
and a hearty diet was encouraged.5
A desire to reshape one’s body
through exercise and diet was actually discouraged. Three years
after the emergence of television,
Becker and his team returned to
this province. They reported a
major shift in female adolescent’s
attitudes about their traditional,
cultural diets and appearances.5 In
fact, the prevalence of weight loss
significantly increased, and there
was a greater focus on body image

three years following the introduction of Western media imagery.5
Above all, these Fijian adolescents reflected that peer pressure
and changing societal body ideals
played a large role in this shift in
diet, behavior, and attitude.5 Media and imagery is a very powerful
tool that has become standard in
our society, but the negative effects
of it, as seen in this Fijian province, are undeniable.
Social Media is Everywhere:
		
Society regularly discusses how
problematic social media can be;
yet most of us still spend hours on
our computers or smart phones

“Fiji, Flag, Fingerprint” by Kurious is
licensed by CC0.
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scrolling through new Instagram
or Facebook posts throughout
the day. In fact, the average person spends six to seven hours a
day viewing some sort of media.4
While social media is a wonderful
way to stay informed and spread
vital information, it is also the
perfect platform to compare ourselves to others. Numerous studies
show the extent to which social
media influences eating disorders.
Increased time spent on social media has been shown to increase
disordered eating behaviors such
as engaging in appearance-based
behaviors like comparing one’s
photos to their friends, or untagging oneself from “unflattering”
photos.6 But who are we comparing ourselves to? People post
pictures on social media to show
the best and skinniest versions of
himself or herself, not the reality
of what we all see or face. It shows
fake perfection, not reality. Yet, it
is this peer competition that feeds
into our insecurities.7 Constant
changes in technology and the
introduction and further advancement of social media has increased
the risk of developing and eating
disorder through the use of a constant space for people to compare
themselves to others.

48

With a rise in media comes
a rise in perceptions and blame.
Pop culture sometimes suggests,
or does not refute the pre-existing
attitude, that eating disorders are
a personal choice only influenced
by media—that individuals with
eating disorders are mentally weak
and not strong enough to overcome their negative attitudes and
behaviors towards eating and body
image. These societal attitudes
foster stigma and discrimination
against individuals with eating disorders and create an environment
in which individuals are afraid to
get help out of fear of being attacked for their internal battle. As
a result, many suffer in silence for
years until it is too late.
While media does influence the risk of developing an eating disorder, it is not the only culprit. We often solely talk about the
adverse effects of media, because it
is readily visible and constantly in
the limelight. However, there are
many factors that influence eating
disorders that persist beyond eyesmeet. Similar to how we say, “eating disorders do not have a look,”

“National Mental Health Month”
by Jeff W. Gates was retrieved from
https://media.defense.gov/2010/
May/20/2000360787/-1/-1/0/100520F-JZ025-987.JPG

neither do the factors that influence the development of them.
Eating disorders appear to run in
families, suggesting that genetic
factors may predispose certain individuals to eating disorders. Several twin and family studies have
shown a link between eating disorders and genes, further promoting the idea that eating disorders

“An eating disorder is
not just a mental illness.”
are hereditary. While behavioral,
environmental, and familial practices greatly influence the development of eating disorders, genetics
may provide an underpinning for
this disorder. Certain careers such
as wrestling and modeling create
weight expectations, which may be
the catalyst for individuals already
genetically predisposed to an eating disorder. Likewise, stressful environments, and chaotic situations
may drive some toward eating disorders who already have genetics
predisposing them to anxiety and
obsessive-compulsive disorder.
Individuals with eating disorders
often display certain personality
traits or mood disorders including anxiety, low reward reactivity,
high punishment sensitivity, depression, and obsessive behaviors.8
Many neural pathways play overlapping roles in these personality
traits or mood disorders and eating
disorders.9 Different brain areas
and neural pathways are responsible for and activated in response
to food intake, reward, and mood.
Variations in activation and specific neurotransmitter levels may
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correlate to how individuals with
eating disorders approach food.
Deficits or other changes from
“normal” within specific neural
pathways may further reflect upon
attitudes and behaviors toward
food: reward or punishment.8

“Appetite Beef Big” by Robert Owen-Wahl is licensed by CC0.

Serotonin—the “Feel Good”
Molecule:
Several neural pathways in the
brain are linked to reward, emotion, motivation, body weight
regulation, appetite, and impulse
control, all of which contribute to
thoughts and attitudes and play a
role in symptoms associated with
eating disorders.8,10 Specifically, research shows that individuals with
eating disorders have disturbances
in the serotonergic and dopaminergic systems.8 The serotonergic
pathway is important for regulating appetite, mood, emotional behavior, and sleep.11 Recent
studies demonstrate that changes
in serotonin (5-HT) levels and
5-HT receptor functionality affect
different areas of the brain, causing changes in satiety, mood, and
impulse control.8 Ill or recovered
individuals with eating disorders

“Anxiété Nuage De Mot” by Mary Pahlke is licensed by CC0.

have an increased 5-HT1A binding and reduced 5-HT2A binding.11 These receptors (5-HT1A
and 5-HT2A) are responsible for
serotonin uptake into postsynaptic neurons, which leads to further
excitatory or inhibitory effects.
These effects differ from normal
when 5-HT receptor binding affinities vary, as seen in individuals
with eating disorders. They have
been shown to contribute to anxiety, depression, stress, impulsivity,
and eating disorders.8
A polymorphism is a discrete genetic variation that results
in several different types or forms
of a single gene in an individual
or a group of individuals.9 While
polymorphisms are quite common
within populations, they may result in several changes that can
drastically change function and
behavior. Recent evidence suggests
that a polymorphism of the serotonin transporter gene (5-HTT),
a protein responsible for serotonin
reuptake in presynaptic neurons,
increases the risk of developing depression and an eating disorder.9
Dopamine—the
“Reward” Molecule:
The dopaminergic pathway is an-

other important regulatory neural
pathway. Recent studies demonstrate that changes in dopamine
(DA) levels and DA receptor function cause changes in the rewarding effects of food, motivation,
and executive functions such as
decision-making.8 Ill or recovered individuals with eating disorders have increased DA D2 and
D3 receptor binding affinities for
dopamine.8 These receptors are
responsible for dopamine uptake
into postsynaptic neurons. The
increased binding affinity for dopamine may send dopamine centers in the body into overdrive,
resulting in increased anxiety and
compulsive behaviors as seen in
individuals with eating disorders.
Likewise, a polymorphism of the
DA D2 receptor has shown to
increase the susceptibility of developing an eating disorder.12 Interestingly, research suggests that
the DA D1 receptor plays a large
role in food intake. Stimulating
DA D1 receptors significantly increases food intake, while inhibiting these receptors greatly reduces
food intake.12 Can control over
these neurons affect individuals
hunger drive or subsequently, lack
of hunger drive?
33-50% people with an49
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“An eating disorder is not a choice”
orexia and roughly half of people
with bulimia have a comorbid
mood disorder (ie. depression).13
And roughly half of bulimic and
anorexic patients have a comorbid
anxiety disorder (ie. obsessive-compulsive disorder, social phobia).13
These statistics are astonishing and
show a strong connection between
eating disorders and other mood
or anxiety disorders, which are
often also associated with disturbances in the neural pathways previously described. Yes, societal and
environmental factors influence
mood disorders and eating disorders, but strong evidence suggests
that dysregulation of these neural
pathways contributes to changes
in personal reward, mood, body
weight, impulsivity/compulsivity,
and emotion, all of heavily influence disordered eating behaviors
and attitudes.8
Genetic heritability accounts for
50-80% of the risk of developing
an eating disorder and contributes
to many of the neurological factors
that affect eating disorders previously mentioned.8 While people
have been talking about the heritability of eating disorders for
“Fork, Tape Measure, Diet, Nutrition”
by minka2507 is licensed by CC0.
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years, scientists had yet to correlate
certain genetic mutations with an
increased predisposition for eating
disorders. This is, until recently.
New evidence studying large families greatly affected by eating disorders show that family members
with or recovered from an eating
disorder all had a point mutation
(single nucleotide change results in
an entirely different amino acid14)
in the ESRRA or HDAC4 gene.14
Had each family member with an
eating disorder been exposed to
the same Western media imagery?
From personal experience, I can
tell you I do not watch the same
shows or follow the same celebrities as my parents or grandparents.
So, is this genetic mutation just a
coincidence?
ESRRA and HDAC4
Association:
ESRRA (estrogen-related related
receptor alpha) is a gene in the
central nervous system that regulates metabolic processes for neuronal functioning.16 A point mutation of ESRRA would reduce the
number of receptors in the brain
and reduce metabolic functioning.
This has been shown to induce
several behavioral deficits in mice
that are symptomatic of eating disorders in humans: behavioral rigidity, social impairment, maintenance of body weight 15% below
normal, and reduced response for

a high-fat diet.16 In another family,
all members currently with or having a history with an eating disorder had a point mutation of the
HDAC4 gene. HDAC4 (histone
deacetylase 4) is a gene that re-

“Eating disorders are like a
gun that’s formed by genetics, loaded by a culture and
family ideals, and triggered
by unbearable distress.”
presses transcription (the first step
in DNA synthesis) and affects cell
progression and development.17 A
point mutation of HDAC4 has
been shown to induce similar behavioral deficits in mice symptomatic of eating disorders in humans
and the behaviors seen in ESRRA-null mice. These two pathways, ESRRA and HDAC4, work
in conjunction with each other, reducing mitochondrial function in
the brain, which may increase the

What is epigenetics?

A new and innovative field
worth mentioning is epigenetics. Epigenetics is a field
of study that looks at regulation and changes in gene
function without changes in
the DNA sequence. For example, it’s hypothesized that
the environment plays a large
role in obesity as well as thinness. The rise in high-fat and
carbohydrate dense diets may
increase the number of fat
related genes in individuals.
On the other hand, genes that
suppress appetite may be over
expressed in an environment
that promotes thinness. 15
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risk for developing eating disorders.17 These new findings are the
first to link specific genes to the
development of eating disorders.
Eating disorders are a very complex disease, with contributions
from social, environmental, neurological, and genetic factors. Often times, society blames the media, individuals, or their families
for causing eating disorders. While
environmental and social factors
do contribute, genetics have been
shown to predispose individuals to
the development of eating disorders through mutations in neurological pathways (serotonergic and
dopaminergic) and specific genes
(ESRRA and HDAC4).
With these new findings, research
is moving forward in a direction
aimed at finding a way to boost
or reduce certain neural pathways
to prevent or reduce and relieve
the effects of eating disorders.
Currently, there are many drugs
on the market to minimize anxiety, ADHD, OCD, depression,
and other mental disorders often
co-expressed in individuals with
eating disorders. These drugs often
times inhibit or facilitate reuptake
of certain neurotransmitters to induce a reversal of effects. Antidepressants such as Norpramin and
Prozac, anticonvulsants such as
Topomax, and various other drugs
have been utilized to treat eating
disorders, namely bulimia nervo-

sa and binge-eating disorders.18,19
While these drugs may be useful
in managing a mental disorder,
taking them does not affect the
initial development of eating disorders, nor contributes to recovery
through a natural process. Likewise, a pill does not teach individuals how to form self-worth or
love, or how to be less impacted by
the media and other environmental and societal factors.
Through new research,
we understand that the development of eating disorders is predominantly genetic related. While
environmental factors such as media messages fuel the fire of eating
disorders, genetics forms the base
for the fire to ignite. Children and
young adolescents are at the highest risk for developing eating disorders, because they are in a period
of their lives when they are trying
to figure out who they are as their
bodies begin to change, and the environment and peer influence can
greatly affect how they view themselves and their bodies. Eating disorders not only affect the individual, but also those close to them.
And often times, individuals with
eating disorders are looked upon
as being weak, easily influenced by
others, and having low self-esteem.
Likewise, families may be attacked
for causing the problem in the first
place. Educating families and society in general about the gene-environment combination of eating
disorders can replace many of the
simplistic conceptualizations that
exist surrounding eating disorders
as being either wholly social or entirely biologically based disorders.
An understanding of the layers of

an eating disorder (environmental
and genetic) may help to remove
the “blame” we often like to put
on certain factors or the individuals themselves.
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Deafness &
anguage
By Yara Al-nouri

A

ccording the World Federation of the Deaf, deafness
- or auditory deprivation - is the
third most common physical condition following arthritis and heart
disease; as such, it presents an interesting case for studying human
communication. As defined by the
Oxford Medical Dictionary, deafness refers to total or partial hearing loss in one or both ears (2016).
While deafness can be acquired
through injury or trauma to the
inner ear or through old age , it
can also be a congenital condition.
In the United States alone, an estimated two to three children out of
every one thousand are born with
profound hearing loss in one or
both ears every year (Hearing Loss
Association of America). For those
born with hearing loss and those
who lose their hearing before they
learn to speak, their deafness could
be categorized as prelingual deaf-

ness. Prelingual deafness poses a
challenge for language and speech
acquisition, given that auditory
input is necessary for the development of both processes. Further, as
Andrew Solomon writes, “the issue
of deafness in most societies is one
of linguistic exclusion” (2012:83).
Deafness can be isolating for many
because there is not so much a
physical barrier between them and
their social world, but an invisible
one wherein communication is effectively cut off.
However, this is not to say
that deaf individuals do not have
any language ability. In fact, many
deaf people learn to speak orally or
use alternative forms of communication, such as American Sign
Language (ASL). Additionally,
the development of technologies,
specifically cochlear implants, also
simulate the experience of hearing
for individuals with hearing loss;
therefore enabling them to more
effectively communicate with
the hearing world. However, the

debate surrounding cochlear implants is not so much about their
efficacy, but rather the ethics of the
implant. In this paper, I articulate
the debates surrounding cochlear
implants, and then move forward
to an examination of the neuroscience underlying language acquisition for prelingually deaf individuals.
Big “D” versus Little “d”
In examining deafness as a topic, it
is necessary to include a discussion
about the debate between Deafness as a culture and deafness as
a disability. The capitalization of
“Deafness” refers to culture whereas the lowercase “deafness” indicates the pathological condition or
impairment (Solomon 2012:50).
While those in the medical sciences see deafness as a disability,
there are many in the Deaf community who oppose this notion,
opting instead to celebrate their
difference as a cultural minority.
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In fact, those who identify with
Deafness as a cultural identity define their lived experiences as being enhanced by “Deaf gain”, rather than being tarnished by hearing
loss (Bauman and Murray 2010).
As a concept, Deaf gain shifts the
narrative of deafness from one of
impairment and loss to a narrative
of embracing and celebrating the
benefits of being Deaf (Bauman
and Murray 2010).
Part and parcel of Deaf
gain and the Deaf community is
the use of American Sign Language, or ASL, as a primary means
of communication (see Figure 1).
ASL is a type of language which
utilizes physical gestures, as articulated through the hands, face,
and body, to communicate (National Institute on Deafness and
Other Communication Disorders). As such, it is a highly visual
language; indicating that sensory
information for the deaf is usually obtained through vision (Lane
and Bahan 1998:298). It is a distinct language from English as it
has its own grammar rules. For
an estimated half million Americans, ASL is their primary language. Moreover, cultural and artistic endeavors have been created
using ASL. In other words, ASL
provides people in the Deaf world
a sense of connection, community, and identity (Lane and Bahan
1998:297). Additionally, those
in the Deaf community tend to
condemn the use of cochlear implants as they see the device as a
threat to their culture (Solomon
2012). In fact, some members of
the Deaf community are so averse
to cochlear implants that they ar-
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Figure 1 Visual representation of ASL. “ASL spelled out” by Psihedelisto is licensed by CC0.

gue that the implants are a form
of “genocide” against the Deaf
(Sparrow 2005:135). More specifically, cochlear implants represent
a threat to the linguistic component of Deaf culture as cochlear
implants are intended to boost
spoken communication while discouraging the use of ASL (Ringo
2013).
While the Deaf community exists, this does not mean
that all deaf individuals choose
to identify with the Deaf group.
Many deaf individuals choose to
identify as individuals with disabilities, and use English as their
primary form of language (Lane
and Bahan 1998:298). Additionally, many of those who identify
with Deafness as culture are Deaf
of Deaf, or Deaf children born to
Deaf parents, meaning that they
are often brought up within the
Deaf community (Mitchell and
Karchmer 2004). However, there
are also deaf children born to hearing parents. According to the National Institute on Deafness and
Other Communication Disorders,
more than 90 percent of deaf children are born to hearing parents
in the United States (2016). A
large number of these deaf children learn to use spoken English

through speech therapy and cochlear implants.
The commonalities between the two camps, however,
extend beyond the condition of
hearing loss. Because the society
and world we live in is made for
those who can hear, those who
cannot hear will always “be at a disadvantage.” As Andrew Solomon
phrases it, the question moving
forward is “whether people prefer
to be marginal in a mainstream
world, or mainstream in a marginal world, and many people quite
understandably prefer the latter”
(2012:107). In other words, those
who “prefer to be marginal in a
mainstream world” refers to those
who see their deafness as a disability, and those who “prefer to be
mainstream in a marginal world”
refers to those who see Deafness as
a culture. Yet the two are not mutually exclusive, and seeing your
deafness as a disability does not
necessarily encompass a sense of
self-loathing. Solomon invites us
to think more empathically about
the ways that we interact with difference, to think deeply about the
ways that we construct our society,
and to ask ourselves: how welcoming is our world to the other?
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A Brief History of America’s
Treatment of Deaf People
To understand the resistance of
the Deaf community to advocate
for and accept cochlear implants,
we must first look at the history of marginalization of the deaf.
Throughout history, and we see
evidence of this even in Aristotle’s writing, the perception of deaf
people has always been derogatory; as assumptions about deafness,
because of silence, were always associated with assumptions of stupidity (Solomon 2012:51)(Padden
2005:509). As such, one reason
why the Deaf community so vehemently defends ASL is because
ASL symbolizes a sort of liberation
as it gives them a voice to be heard

(Padden 2005: 509).
There is a history of the
segregation and exclusion of
deaf people from society. For instance, throughout American history, in every state, deaf children
were institutionalized (Padden
2005: 508). While the late 1970s
brought along a decrease in institutionalization as deaf children
were integrated with hearing children in education, deaf people still
face certain forms of discrimination and oppression to this day.
One of the most revolutionary
moments in American history is
the creation of educational and academic institutions specifically for
the deaf and hard of hearing. The
first American school for the Deaf
was founded in 1817. Springing

from it was the continued proliferation of these types of Deaf schools
throughout the nation, lasting until 1953 when the last deaf school
was built (Padden 2005:509).
These deaf schools segregated deaf
children from hearing children,
acting like boarding schools. They
also influenced the demographics
and locations of deaf communities
in the United States, by reorganizing deaf people into certain geographies based on the location of
deaf schools. While these schools
separated deaf children from other
children, they also brought together individuals who felt extremely
isolated because of their deafness
(Padden 2005:510). Deaf children were also able to learn sign
language at these schools, which is
of particular importance for those
born to hearing parents (Padden
2005:511).
Advancements in modern
technology, including cochlear
implants, such as cell phones and
digital means of communication
have opened up the social worlds
of the deaf and hard of hearing,
decreasing the communicative divide between the two.
Cochlear Implants

Figure 2 Visual Depiction of Cochlear Implant Mechanics. Taken from: Dorman, M.F.
& Wilson, B.S. (2004). The Design and Function of Cochlear Implants. American
Scientist, 92, 436-445.

Cochlear implants are neural prosthetics that use electrodes to electrically stimulate the cochlea or
inner ear: in turn providing the
recipient with functional hearing
or sound perception. The device
is surgically implanted. The implant consists of external (i.e a microphone, speech processor, and
transmitter) and internal (i.e. a receiver and electrodes) components
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(see Figure 2). The internal and external components of the cochlear
implant are able to communicate
via radio frequencies. A microphone picks up sound signals from
the external environment, sending
them to the speech processor and
transmitter, where these sound
signals will then move to the receiver-stimulator, where they will
be converted by the electrodes implanted at various points throughout the cochlea. Electrodes are
placed at different points along
the cochlea to code for different
sound frequencies and produce
a percept or stimuli that matches
the location of the electrode; in
other words, electrodes work by
frequency-to-place representation.
Because speech has many different frequencies, it is necessary to
place the electrodes throughout
the cochlea to electrically code
speech. The more electrodes, and
subsequently, the more channels,
the closer the cochlear implant
is able to get to detecting normal speech. The electrodes, then,
electrically stimulate the auditory
nerve endings, which send the information to the brain where it is
then processed (Dorman and Wilson 2004)(Namasivayam 2004)
(Macherey and Carlyon).
The first attempt at developing a neural prosthetic that
would mimic audition was in 1957
in Paris, France, and ultimately,
failed. In 1961, an American otologist, William House attempted
to recreate the device, deciding to
improve on the failures of the last
attempt by stimulating five different points along the cochlea, as
a way to make the implant more
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Figure 3 Diagram of the ear.
Taken from: Macherey, Olivier and Robert P. Carlyon.
Cochlear Implants. Current
Biology 24 (18)

sensitive to different frequencies of
speech. Again, this attempt failed
(Blume 1999:1258). However,
the 1970s brought along advancements in medical technology, allowing House and his cohorts to
develop a more successful model
of the device. As the technology
of the implant improved, so did its
global, professional recognition in
the 1980s. The FDA approved the
device in 1984, and six years after
that, the FDA moved to approve
minors for the implant in 1990
(Blume 1999:1258).
Given that cochlear implants essentially require an individual to
learn how to hear with the device
and that there is a critical period for

language acquisition, it is typically
recommended that prelingually
deaf children receive the implant
as early as possible. However, there
is an ethical dilemma surrounding
the surgical implantation of cochlear implants in children. There
are three primary ethical debates
about the issue. The first concerns
the fact that children are unable to
give informed consent, and that
medical practitioners do not take
into account the possible psychological and social effects of the surgery on children. The second concerns the culture clash between the
Deaf community and the hearing
world as they have different values
regarding cochlear implants. The
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third debate argues that policies
that allow children to be implanted
impedes on the rights of the Deaf
community, and is an attempt to
rid the world of deaf people (Lane
and Bahan 1998).

both the dorsal and ventral streams
(Fujii et al. 2016). Additionally,
spoken language is usually lateralized to the left hemisphere.

Neurological Basis of Hearing

As acknowledge by Olulade et al.,
most extant neuroscience research
on deafness has been conducted
primarily on deaf individuals who
are native signers, despite the fact
that this sample is not representative of actual deaf populations. In
fact, approximately 95% of deaf
Americans use English as their
primary language, and as such,
it is necessary to turn researchers
towards sampling methods that
accurately reflect the deaf population (Olulade et al. 2014: 5613).
Much like spoken language, deaf native signers also
exhibit lateralization of language
processes to the left hemisphere
as indicated by studies on unilateral stroke patients. Some studies,
however, have shown that deaf
native signers of ASL also exhibit
activity in their right hemisphere
(Campbell et al. 2007). These
findings suggest that language
processing “is not determined
by the auditory input modality”
(Campbell et al. 2007:5). In regards to specifically sign language
production, studies have been able
to corroborate that sign production is very much lateralized to the
left hemisphere. Further, neuroimaging studies have consistently
shown that left inferior frontal region activation for the production
of sign language, and that Broca’s
area is consistently utilized in this
process of sign production (Camp-

As a mechanical process, hearing
requires the conversion of sound
waves into neural impulses. As
the sound waves move from the
air, they are funneled into the eardrum or tympanic membrane by
the outer ear. The sound waves
then cause a vibration of the tympanic membrane, moving through
the tiny bones of middle ear or ossicles. From the ossicles, the sound
waves cause the movement of fluids contained inside the cochlea,
bending the stereocilia and tiny
hair cells lining the basilar membrane. It is at this point where
the physical sound waves are converted into neural impulses as the
auditory nerve is stimulated. Ultimately this auditory information
lands itself in the auditory cortex,
located in the temporal lobe.
Neurological Basis of Language
The traditional neurological bases
for language are considered to be
Broca’s area, Wernicke’s area, and
the arcuate fasciculus which serves
as a bridge between Broca’s area
and Wernicke’s area (Fujii et al.
2016). Wernicke’s area is responsible for language comprehension
whereas Broca’s area is responsible
for speech production; both areas
are located in the cerebral cortex.
Language is processed through
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bell et al 2007:13). Given this, we
can infer that the production of
sign language is similar to that of
spoken language.
While prelingual deafness
has potential for altering the development of some neurological
processes of language, that does
not exclude them the possibility of
language acquisition nor necessarily mean that they will be hindered
by their deafness.
Conclusion
In conclusion, the neuroscientific study of deafness is relevant to
society because it has larger implications for the ways in which
we think about disability, and the
quality of life for deaf individuals.
However, the neuroscientific study
of deafness is enhanced by thinking about the nuances underlying
deaf identities and Deaf culture.
While neuroscience contributes
necessary knowledge about the science of deafness, it can often tend
towards a conception of deafness
as a negative life experience. Deaf
culture invites us to celebrate difference, and re-conceptualize what
“normal” means when we think
about the body and ability.
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New Body,
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C

hange is the only constant in life. The human
body constantly transitions
throughout life; whether through
ageing, sickness, injury, or surgery,
the body is never static. People’s
thoughts, opinions, ideas, and
feelings – all elements of the mind
- are also constantly changing. The
body and brain are not two separate entities, but are inseparable.
The biological, emotional, and
mental changes from childhood to
adulthood characterize our experience as humans. As bodies grow
in the world, so too do the minds
they shelter.
But what happens when a
person’s body is degenerating, paralyzed, or sick, while their mind is
still active and capable? Drs. Sergio Canavero and Ren Xiaoping,
along with their surgical team,
believe that surgery has come far
enough to help patients with failing bodies but active minds. Their
solution? Head transplant surgery.
This technology has great potential for helping the sickest among
us, but with powerful technology
also comes great ability to abuse
that technology.
The Science
Head Transplant
Allo-head and body reconstruc-

“Birth to Death” is licensed by CC0.
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tion (AHBR), cephalosomatic
anastomosis (CSA), head transplant, body-to-head transplantation (BHT), are all different ways
of referring to head transplants.
But they all are attempting to
take the healthy head and brain of
one individual and put it on the
healthy body of a brain-dead donor. The hope is that after recovery
and therapy, a healthy individual
comes out on the other end.
The technology to complete the first human head transplant has been a long time coming.
Research into other types of transplants has been ongoing, including
recent success in hand transplants,
as well as the reconnection/regeneration of sensory neurons. Recent
advances in neuroprotection, neural fusogen (agents that reconnect
neurons after they have been cut),
immunosuppression, and recovery
therapy have lead Drs. Canavero
and Ren to be optimistic that this
surgery will work.
The first human head
transplant surgery is scheduled
for December 2017. Drs. Ren
and Dr. Canavero will conduct it
with a support staff through Harbin Medical University, in Harbin,
China, and conducted on a Chinese national (because it is more
likely for a body donor to become
available).10 The donor body will

“Giustizia Misura Scala” by OpenClipart-Vectors is licensed by CC0.

be a brain-dead organ donor,
and the head donor will be a patient who suffers from some level
of full body degenerative disease,
and who is willingly participating
in the surgery, with the promise of
obtaining a new body. The identity of the body and head donors
have not been released to the public.4
Feasibility
While this is an experimental surgery that has never been done on
human subjects before, the expectations of Drs. Canavero and Ren’s
surgery is that it will be highly
successful, and help the lives of
patients suffering from tetraplegia
(paralysis from the neck down),
multiple organ failure, intractable
cancer without brain metastases,
progressive muscular dystrophies,
or any number of genetic or metabolic disorders.
The operating theater on the day
of transplant will be busy. Two
surgical teams, each working in
concert on either the donor head
or the donor body, must perfectly
time the surgical proceedings. The
body donor and head donor will
both be situated in upright sitting
positions in order to maximize the
access to the site during surgery.
The HEAVEN protocol as laid out
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by Dr. Canavero in his 2013 paper
will build off the techniques discussed above in History. The procedure from White et al. (1971)
will be used as guidance for the
separation of the head from neck,
hypothermia technique, as well as
reconnection of the vascular system. The operation will open the
area between C4-C6 vertebrae
(this is the part of the neck about
4 fingers from the base of the scull
and about 2 fingers above shoulder
level), with the spinal cord and vascular system transected at the C5C6 level. The Thyroid complex of
the body will be kept intact, and
the head’s thyroid system left behind.1 The Thyroid is responsible
for hormonal regulation of many
different parts of the body.
The GEMINI protocol
will use a diamond blade to sever the spinal cord on both the
body and head. This will make the
cleanest cut possible; important
for giving the PEG fusogen the
best chance to fuse the two separate nervous systems together. In
order to effectively work, the cords
must be connected with fusogen
no more than 2 minutes after spinal cord severance or the PEG will
significantly decrease in efficiency.1,5
The surgeons must be fully
prepared to work under extraordinarily tight time constraints, and
be confident in their work. In order for this fast transfer to occur,
all other aspects of the surgery
will need to be prepped before the
transfer, so that as soon as the spinal cord is severed the head can be
seamlessly transferred to the body,
the PEG fusogen applied, and the

1900
1910

Early 1900’s Head Transplant Surgery first conceptualized. Challenges: reconnecting blood vessels 7
1908 Dr. Carrel (French) and Dr. Guthrie (American) successfully attached one dog’s head to another’s neck allowing for blood flow 7
1912 Received the Nobel
Prize in Physiology and
Medicine for work on limb/
organ transplantation7

1920
1930

Dr. Demikov’s two headed dogs7 (Adapted from Lamba, Holsgrove & Broekman)

1940
1950
1960
1970

1953 Dr. Demikhov of the Soviet
Union conducted the first coronary bypass surgery in dogs; the dogs survived 2
years post-surgery 7

1954 First dog head transplant surgery; survived for 29 days with some
motor movement and ability to lap
up water. Challenges: immunosuppresion 7

1970 Robert White an American Neurosurgeon conducted the first total head
transplant on monkeys. Challenges: High levels of immunosuppressant agents
killed the monkeys prematurely 7
First total head transplant in a monkey
(from White et al. 1971)7

1980

1990 1999 Immunosuppressant agents developed and can be delived in non-toxic doses
2000

2006 First successful face graft:
shows skin rejection will not occur
using new immunosuppressants 7

2012 Spinal Cord Stimulation therapy for regaining motor movement
after spinal cord trauma 9

2013 Dr. Canavero published the

2010 paper that outlined the proposed sur- Nov 2017 the first head transplant prac2020

gery HEAVEN and the protocol for
spinal cord reconnection, GEMINI1

ticed on a cadaver 4

Dec 2017 The first head transplant is scheduled to take place 10

spinal cords aligned, all within a 2
minute window.
Throughout the surgery,
the patient will be in a drug-induced coma, which will continue
for three days after the surgery.
As with all transplants, immunosuppressant agents will be used
to prevent organ rejection. After
the surgery there will be therapy
to assist the patient regain motor
movement with the help of spinal

cord stimulation (SCS).
There is still work that
needs to be done as far as smoothing out surgical challenges and
practicing further. The time
crunch mentioned under the spinal fusion, and the low rate of success with the SCS therapy are the
two biggest barriers to this surgeries success. Further testing needs
to occur before this surgery should
be tested on a human.
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The Ethics
Who wakes up on the other side?
This surgery asks the fundamental
Surgical Challenges

Blood flow and
circulation

Successful?

Yes

Immunosupression

Yes

Severed Spinal Cord

Yes

question of what makes a person
himself or herself. Is it their brain?
Is it their body? Is it some interaction between the two? If the fairly
significant amount of research that
Progress to date

suggests that embodied cognition
is correct is true,14 there should
be a totally new and independent
person who comes out of the surgery. Embodied cognition is a
Further Issues

1908 Carrel & Guthrie7:
two-headed dog
1954 Demikhov7: two-headed
dog
1965 White7: monkey head
transplant
2016 Ren et al.12: two-headed
mice
1950-60’s Development of azathioprine, 6-mercaptopurine, and
corticosteroids7
1999 Immunosuppressants that
are effective in preventing skin
rejection without toxic events7

No further issues to address
before the surgery

A diamond scalpel makes a clean
cut through the spinal cord.⁴

The cleaner the cut, the cleaner the
rest of the procedure will be.

There is always room for improvement, but current immunosuppressants should work for this surgery.

Human cadaver practice

Spinal cord fusion

Not Fully

2016 Kim et al.5: PEG fusogen
help with spinal cord reconnection
Human cadaver practice

Neuroprotection

Yes

Recovery of motor
movement

Not Fully

Pain Control
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Yes

While this technology is very powerful, and has had success, it must be
admistered within the first 2 minutes or the fusion will not occur, and
the spinal cord will not reconnect.1

2016 Ren et al.12
2017 Li et al.8 - EEG monitoring shows hypothermia provides
neuroprotection from ischemic
events in a two-headed mouse
experiment

Induced medical coma and localized
hypothermia at in both the donor
brain and the donor spinal cord will
give the surgeons time, there the surgeons will still need to work fast.

2012 Minassian et al.9 - SCS a
therapy that helps patients regain
motor control
2016 Kim et al.5 - the fusogen

SCS shows some promise, but does
not have a high rate of success. The
fusogen, again, need to be applied
quickly in order to work.

2007 Canavero & Bonicalzi2
- Central Pain Syndrome understood and treatment found

It is still uncertain if this will be
enough to treat all of the pain that
will arise from the surgery.
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theory of self that suggests that
the mind – our cognition – arises from how our bodies, including
the brain, interact in the physical
world - that the brain is not the
only part of the mind, but rather
that the body also participates in
the formation of self. This means
that not only are you your brain,
but you are also how your body
interacts with the world.14 Embodied cognition postulates that
the brain and body are greater as
a whole than as its parts, and that
together they make up whom you
are.3
The specific issue in head
transplant surgery is whether the
mind derives from the donor head
or donor body, or from the interaction of the two? If the surgery is a
success, when the patient wakes up
we have no way of knowing who is
waking up: is it the person whose
brain was donated? or the person
whose body was donated? Or is it
someone new altogether? This person has the genetic material of the
body donor, the memories of the
brain, and a major surgery to recover from. This new person will
at the very least be confused, will
likely need to work through some
basic metaphysical questions, and
may suffer from serious psychological complications, including

“Cranium, Head, Optical Illusion” by
Gordon Johnson is licensed by CC0.

mood disorders, suicidal ideation/
tendencies or psychosis.3 It will
be critical to the success of head
transplant surgery that trained
specialists be available to assist the
patient in his or her psychological
recovery, as much as in his or her
physical recovery.
Who has Reproductive Rights? If the
patient survives and thrives, and
wants to have a baby, what should
happen?
The genetic material of this new
person will be that of the donor
body, which comes from a person
who is brain dead. Does the donor
body – or since he or she was brain
dead – his or her family, have a say
in the new person’s reproductive
behavior? In an attempt to salvage
control over the genetic material
that they share, in the absence of
consent from the brain-dead body
donor or his or her family, and no
genetic material should be passed
along through this new person.
Is this the best use of a Donor Body?
The waiting list for livers, hearts,
lungs, pancreas, kidneys, and other
organs for transplant is years long.
Donor organs are hard to come by,
and must be used as soon as possible. In the case of a head transplant, a donor body is valuable as a
whole to possibly prolong one life,
in an extremely high risk experiment. But it is significantly more
valuable, and can potentially help
more people, by being distributed
to many people who could use a
number of different organs.
Given current circum-

stances, including long organ wait
lists, and the extremely experimental nature of head transplant surgery, donor bodies should be used
to help alleviate the most suffering. This experimental surgery has
not been proven to work - cadaver
cases do not count4 - and with an
over $100 million price tag for the
first attempt, this will be a costly
endeavor, not only in expendable
resources like money, but also in
biological resources which could
be distributed to numerous other
persons in need.
What are Future Uses, Abuses, and
Misuses?
There is always a risk that when a
powerful technology is developed
that – in addition to the great positive effects it may have – it also
will be misused and abused. In
the case of head transplant, when
the technology is refined it might
be used for a sex change, so a person can be the biological sex they
identify as. This surgery could be
used to change health outcomes,
swapping a diseased body for a
new one. Also, this surgery has the
potential to change your body’s
age, artificially elongating life to
far past what is considered normal
today. This surgery has the potential to be a ticket to immortality.
So for a moment let’s pretend like this surgery is already
perfected. The kinks have been
worked out as far as the technical
side goes, and we will say that the
head donor will be the person who
comes out on the other side of the
surgery, making the philosophical question of “self ” void. For
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the sake of this article, let’s imagine that a wealthy middle aged
to elderly man wishes to become
young again. All he has to do is
find a donor body, sign a waiver
and prepare himself for the surgery to come.
The outcomes of the surgery will mean a higher quality of
life - having a fit, young body again
- and also will elongate the elder
man’s life. A younger body means
the hormone levels and blood of
a younger person. These different
factors have age-protective effects
on the body, and younger blood
even has a neuroprotective effect
on the brain. The thyroid complex
will be that of the donor body.
This means that the hormones
that are released into the body,
and eventually introduced into the
new brain, are that of a younger
man. Recent work looking at what
causes age-related changes looks at
two hormones, growth hormone
(GH), and insulin-like growth
factor-1 (IGF-1). GH and IGF-1
have important mechanisms for
ageing, and restoring these hormones to aged animals restores
cellular protein synthesis, lean
body mass, immune function, skin
thickness, and vertebral bone density. It can be assumed that in the
aged head and brain this would
help with recovering from the surgery, and also preservation of the
aged head.6
For a long time blood was
thought to be our life force. Now
we know that blood is the transporter of nutrients around the
body, without which we would
not be alive, which while similar
in meaning, has a different con-
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notation from life force. But recent research showed that blood
could take on an almost supernatural ability. The Villeda lab group
showed that introducing the blood
of younger mice could counteract
cognitive decline in older mice.
There was improvement in neurogenesis along with synaptic
plasticity, which counteracts age
related cognitive decline. Also introducing ‘pro-youth’ factors from
young blood can help reverse age
related impairments in the brain.15
This shows that a new body, and
therefore new blood, will actually improve the older brain of the
head donor. This neuroprotection
will allow for the head donor to
have better health outcomes and
be healthier all around, not just a
stronger body but also a stronger
brain as well. This isn’t immortality in a classical sense, because
eventually the brain will decay;
however, this will be a method to
push the boundary of what old age
is.
Because this surgery holds
so much promise for a variety of
different populations, it makes
body donors highly valuable. Sex
change, health improvement, and
age adjustment, all face the criticism mentioned above that by
using this donor body for their
own purposes, they take the donor body out of circulation for all
other types of donorship. There
is already a black market for donor organs, and if this surgery
becomes viable the demand for
whole donor bodies will only increase. I believe that there is a real
opportunity for financially needy
people to be taken advantage of

“Greedy, Money” by Gordon Johnson is
licensed by CC0.

for the economic benefit to their
family. For instance, any of these
3 populations of head donors may
have the means to pay a person
to give up their body, for the economic gain of their family. While
this is an extreme postulation,
there are extreme situations that
happen all over the world, and it
would be naïve to turn a blind eye
to this ethical concern for the possible corruption of the technology.
However, we still have some time
before we have to truly start worrying about full donor body markets. Perhaps before that occurs,
we will put in place guidelines to
help us only use this technology
for diseases that have no other effective therapy or cure.
Is it worth it?
This is a risky surgery, not only because of high risk of patient death,
but also because it could lead to
a totally new, psychologically unstable person coming out on the
other side. The resulting “new
person” is an amalgamation of a
brain and body that have given
consent but the “new person” has
not consented to the uncertainty
of physical, mental and emotional
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recovery. Since the surgery and
technical tests give no certainty of
ever regaining goal-directed movement, which is what most patients
on the “brain” side are seeking,
and since the “body” side has the
most work to relearn rudimentary
motor skills9, there is a basic ethical dilemma facing the resulting
new person, and the mind that
controls it. And the psychological development and healing facing the patient is significant, with
virtually no known guidance on
how best to assist in this endeavor.
Moreover, basic ethical questions,
such as who should control reproductive rights, is this the best use
of a donor body and its variety of
useable organs, and how to avoid
black markets from developing for
use in head transplants, must be
considered and thoughtful plans
developed to deal with those issues. Doctors have a duty to their
patients, and to their profession,
to uphold the Hippocratic Oath.
The Hippocratic Oath states that:

“I will apply, for the benefit
of the sick, all measures [that]
are required, avoiding those
twin traps of overtreatment
and therapeutic nihilism…
Above all I must not play
God…”13
Given the substantial open issues
involved, perhaps it is time to step
back and re-evaluate whether the
world is ready for head transplant
surgery.
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Understanding Blindsight as
A Window to Consciousness
By Danielle Wald

Understanding Vision
From the Eyes

T

he process of vision begins
in one of the most complex
sensory organs: the eye. There are
two main visual pathways that begin at the retina in the eye. The
geniculostriate pathway begins
when light that hits the retina and
is transformed via a map of intercommunicating neurons, namely
photoreceptors, horizontal cells,
bipolar cells, amacrine cells, and
ganglion cells. After exiting the
eye, the optic nerve carries the information to the lateral geniculate
nucleus (LGN), which then relays
the signals towards the back of
the brain, ultimately reaching the
visual cortex (Figure 1).1 In the

Figure 1 Visual information
travels from the
eye throughout
the brain where
its ultimate goal is
the Primary Visual
Cortex.16
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second pathway, the tectopulvinar
pathway, signals from the retina
project to the superior colliculus.
From this location, the projections
continue to the pulvinar, where
they then finally end in the extrastriate cortex.2
To the visual cortex
Once the input has reached the
visual cortex, it is ready to begin
its journey through more complex
processing, resulting in higher order perception. The visual cortex
may be broken down into a hierarchy of different mechanisms
which work together to create the
experience of sight. This projection starts with Area V1, which is
also referred to as the striate cortex.3 Area V1 is an important loca-

tion for the conscious perception
of vision.4 After spending time in
Area V1, visual information is forwarded to the extrastriate cortex,
specifically Area V2 and Area V4,
where it is further processed and
then sent to regions of the brain to
be analyzed (Figure 2).1

When Something
Goes Wrong

Cortical Blindness and Blindsight
Cortical Blindness results from
a lesion to Area V1 of the visual cortex, causing the individual
to experience a lack of awareness
of visual input to the extent that
they report either partial or complete blindness.5,6 Despite feeling
as if they have a complete visual
deficit, these individuals still show
behavioral signs of lower level visual processing, including motion
detection.7,8 This phenomenon
most likely arises from the absence
of functionality of the geniculostriate pathway, leaving the tectopulvinar pathway to operate as the
sole pathway of visual perception
(CitationA).
Distinction from Typical Blindness
Cortical Blindness differs from
typical blindness in that typical
blindness results from a fault of
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Figure 2 Divisions of the Visual Cortex.17

sensation, a lesion to the eye, while
the former is caused by a deficit of
perception, damage to the visual
cortex.6

Famous Case Studies
Patient DB

Arguably, the most famous and
thoroughly investigated blindsight
patient is Patient DB, who became
cortically blind after the right
hemisphere of his visual cortex
was removed during surgery for
the purpose of eliminating a benign tumor. Despite the unilateral
removal of this area of the brain,
DB has shown that he is able to
discriminate between different
objects despite his inability to
consciously perceive them. Additionally, DB has demonstrated his
ability to utilize binocular distance
perception.9
Patient GY
Another well studied patient is
Patient GY who, due to an injury, suffered a lesion to Area V1

in his left hemisphere. GY has
the ability to detect movement.
Additionally, this
patient has provided significant
neuroimaging
evidence for the
basis of vision;
various
PET
scans have shown
an absence of activation in the lesioned Area V1,
demonstrating
that GY’s subconscious ability to
perceive vision is, in fact, independent of Area V1.
Patient TN
Patient TN suffered a stroke causing a bilateral lesion to his striate
cortex. As a result, TN experiences
complete cortical blindness. Remarkably, when presented with a
hallway cluttered with obstacles,
TN is able to successfully navigate
around these objects.11

Researching Blindsight
Contrast Sensitivity

There are various tests that researchers have created in order
to better understand the various
mechanisms that underlie blindsight. One of the most basic aspects of vision is contrast sensitivity, which refers to the ability to
detect stimulus on a background
when difference between the background and the stimulus continues to lessen. In patients with

blindsight, this test is presented as
a forced-choice paradigm.12 The
forced-choice model of research
is essential for many tasks when
working with blindsight patients,
because most patients will report
the inability to complete the task,
due to their lack of conscious
awareness of their visual field.
Goal-Directed vs. Discrete Response
Localization
Some researchers believe that the
interaction of the visual and motor
cortices may play a role in blindsight patients’ abilities to locate
an object on a two-dimensional
surface (i.e., a computer screen).
This specific hypothesis was tested on the aforementioned Patient
TN; the patient was tasked with
locating an object on a screen in
front of him. In part one of this
task, the subject must lift his hand
and point his finger to the object
on the screen (a goal-directed response). In this part, the subject is
exposed to both static and flickering stimuli. In part two of this task,
the subject must simply lifting an
index finger to signal the relative
location of the object within their
visual field (a discrete response);
in this part, the subject is only exposed to a flickering stimulus (Figure 3). According to the results
from Patient TN, the goal-directed response provides for greater
accuracy in this population.12
Effect of Stimulus Size on
Perception
In another forced-choice task,
blindsight patients are presented
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Figure 3 Goal-Directed Response vs Discrete Response Experiment.11

with stimuli of various sizes in order to determine whether the size
of stimuli has an effect on their detection ability. In this task, patients
are asked whether or not they see
an object on a screen. Previous
research in this area suggests that
larger sized objects are easier to
detect, but there is individual variability in ability to detect smaller
objects.13 This is to be expected of
a typically sighted group, thus, it is
possible that effect of stimulus size
doesn’t interact with blindsight
any differently than it does with
normal vision.

potentially dangerous stimuli.15
Because it is beneficial to the individual that the fear response to be
as quick as possible, the activation
of ventral stream occurs quickly
and automatically, bypassing the
normal level of consciousness in
humans.14
Because the automatic fear
response is such a key part of our
evolution, it is possible that the automatic nature of this mechanism
is indicative of an evolutionary
role of visual perception that lies
below the threshold of consciousness.

A Look at Consciousness

Is Blindsight real?

In examining the phenomenon of
blindsight, a certain question arises: What is the benefit of having
the ability to perceive vision below
the threshold of consciousness?
A potential answer to this lies in
the fear response. This automatic
mechanism is necessary to human
survival, thus possessing a significant evolutionary benefit.14 Like
other animals, human experience
of fear is essential in that it motivates avoidance of and escape from

One particular piece of literature
has been cited many times for its
significant arguments against the
existence of the blindsight phenomenon. Campion et al. point
out that it is possible that these
blindsight patients are not exhibiting behavior that is significantly different from that of typically-sighted individuals.15 The
lack of demonstrated confidence
in detection of stimulus by the
blindsighted population can be
compared to hesitance of a typically-sighted group when asked to

Perceiving visual stimulus below the
threshold of consciousness
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Criticisms

report on stimuli near their visual threshold. Thus, this argument
would support the idea that blindsight patients just have a visual
deficit, altering the threshold in
which they perceive visual stimulus.
The argument continues
with a more obvious point: could
the minimal spared areas of the
striate cortex be picking up slack
for their lesioned neighbors? This
argument has the most strength in
the cases of blindsight where damage is unilateral. In these cases,
one hemisphere of the visual cortex is completely intact, and thus,
could potentially be compensating
for the absence of that region of
the other hemisphere. Considering the sensory organ, itself, it is
possible that the intact retina is,
in fact, playing a more significant
role than previously thought in
perception of light.15
Campion et al. end their
argument in reference to subjects who are not cortically blind
throughout their entire visual field.
They suggest that these individuals
are simply using different methods
to describe or perceive their visual
experiences in seeing vs blind areas
in the visual field.15
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Reflection on Criticisms
While these criticisms contradict
or ignore certain evidence, they
are still significant to further research into blindsight and consciousness alike. It is important to
remember that science is advanced
by disagreement and questioning
is an essential factor in furthering
the understanding of our environment.

Future Research
The existence of a subconscious
pathway of visual perception in
humans that yields consistent
behavioral results across studies
inspires greater research into not
only the nature or purpose of consciousness, but it also the drives
the idea that there may be other
neural mechanisms that lie just
beyond our awareness.
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Let’s Get
Scent-I-Mental
By David Perez

H

ave you ever wonder how
important your nose is? For
some animals, sense of smell is
the most important type of sense.
Since a dog’s sense of vision is awful, their sense of smell is incredible compared to humans. Dogs
sense of smell is between 10,000
to 100,000 times more acute than
humans.13 An analogy to vision
of this would be, “what you and I
can see at a third of a mile, a dog
could see more than 3,000 miles
away and still see as well.”13 Even
though our nose isn’t as powerful
as dogs, we need our nose to survive. Our is nose is responsible for
more than picking up odors from
the air.
People who have lost the
ability to smell lose more than just
being able to smell things. Nick
Johnson, a person that lost his
sense of smell, can remember the
exact day he lost his sense of smell,
it changed his life forever. He was
playing hockey with his friends
and he fell and hit that back of his
head on the ice. He made a rapid
recovery, but a couple days later he
found himself trying a new beer
with his friends. “Can you smell
the hops in the beer?” and he
couldn’t “It’s got this pale biscuit
flavor” and he couldn’t taste it. He
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then realized that his loss of smell
hindered him from smelling and
tasting. Dr. Rachel Hertz says that,
“Sense of smell is essential to our
humanity: emotionally, physically, sexually and socially”. It’s also
clinically documented that acquiring anosmia often leads to anxiety
and depression. Even knowing all
this, people still ranking losing
sense of smell at the bottom and
people compare it to losing a big
toe. Some people don’t understand
how important the nose truly is.
Our nose is also necessary for
our safety. Our noses can detect
smoke, spoiled food and toxic gases.12 The nose is also responsible
for other things like humidifying
the air, shaping the sound of your
voice, and even helps you find a
mate.12 The nose is also important
for something indirectly. Everyone
knows the smell of freshly baked
chocolate chip cookie. For me,
I always remember baking them
with my grandma when I was a
kid. That memory always makes
me happy and smile. By being in
a good mood, I made good decisions based on my feeling because
I didn’t want to lose my current
mood. There also therapy sessions
that people can do that can alter
one’s mood by just using odors.

This line of succession shows that
the nose can alter people moods
and therefore could potential hinder their decision making through
the memories that are evoked by
odors.
Mechanism of Odor Detection
The exact mechanism behind
odor detection is still rudimentary. Knowing the exact mechanism
could unlock new ways people can
alter their decision making. Odor
molecules connecting to the olfactory receptors is the first step to
odor detection. Olfactory receptors are responsible for the detection of compounds that have odor
which gives us the sense of smell.
The olfactory receptors are in the
cilia synapses and the epithelium
tissue of the human airway. The
epithelium, a type of tissue that

“Woman Smelling Flowers” by Petr
Kratochvil is licensed by CC0.
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“Insect, fly, wing, macro, animal” is
licensed by CC0.

lines the cavities and surfaces of
blood vessels and organs, is highly permeable and therefore, highly
sensitive to various odors molecules and even various pathogens.1
The location of the olfactory is
unique to humans. In insects, the
olfactory receptors are located on
the antenna. In fruit flies, adults
have about 1200 olfactory receptors neurons (ORNs) on each antenna.2
In the epithelium tissue,
each ORN expresses only a single
type of receptor. So only one gene
is expressed by each receptor.4 According to the Human Genome
Project, humans have about 400
genes that codes for olfactory receptors, the rest of the genes of are
pseudogenes. Pseudogenes means
that the genes are similar enough
to the 400 genes, so that the olfactory receptors will express them.5
So, each receptor has the capability to detect more than one odor.
Even with the combining of genes,
humans can distinguish hundreds
of different smells. But other animals can smell more specific things
than humans13.
After the odor molecules
binds to the receptor, the receptor
will send electrical signals through
the ethmoid bone and to the olfactory bulb.15 The ethmoid bone
separates the nasal cavity and the

brain. The olfactory bulb is the
area where those signals are analyzed and processed.15 The olfactory bulb contains nerve tissues
called glomeruli that are formed
from branching ends of axons of
the olfactory receptors and from
dendritic branches of interneurons
known as mitral cells.6 So overall,
the axons of all the receptor cells
that produce a specific chemical
or range of chemicals with similar structures converge on a single
glomerulus, where they connect
to similar mitral cells and the mitral cells transfer the signals to the
brain.6 This way, similar information from many receptors can be
brought to the glomerulus together. The signals travel to different
brains areas like the hypothalamus

Did you know?
Sperm cells also express
odor receptors, which is
thought to be how sperm
can locate the eggs.3
and the amygdala, which can result
in bring up emotional memories.
The human odor detection can
discriminate between hundreds or
even thousands of different odorant molecules. It is very important
to discriminate these odors, especially for decision making because
each odor could produce different
memories.
Odors and Memories
Odors can evoke different types

“Olfaction” by OpenStax is
licensed by CC BY 4.0.
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Adapted from Herz & Cupchik 1992.7

of memories in humans. The type
of odor is very important for the
type of memories that is evoked.
Memories evoked by odors tend
to be emotional, very clear, specific and comparatively old.7 Odorevoked memories are also thought
of less and very emotional. This
shows that the most familiar odors
elicited the most memories. So,
for example, Table 1 shows an experiment where Peppermint odor
has the highest familiarity out of
the other 20 odors and which increased the potency 7. The ranking
system isn’t constant for everyone
though. Even though coconut is
ranked the most pleasant doesn’t
mean everyone in the word would

72

enjoy coconut. There also is a difference between the sexes. The females tend to use more emotion
descriptors in their memory description than did males which,
produced clearer memories7.
Odors can evoke memories, but
can other cues also produce the
same memories?
We use our five senses
every single day; sight, hearing,
touch, smell, and tasting. We need
these senses to thrive through the
day. Some people are missing at
least one sense which could hinder their way of living. These
senses actually work together, so
if one sense is not working, then
the other senses will take over and

make up for the missing sense.14
Although our senses are important
not all of them are able to evoke
memories. A study was done to see
which senses produced the most
vivid memories, vision, smell, and
hearing. The results showed that
memories evoked from odors are
talked about and thought about
less than when its evoked from the
other cues.8 Odors produce more
pleasant and more intense emotions.8 In sum, this study shows
that odor can evoke emotional
memories that are old. One reason
why these memories are not talked
about as much could be because
these memories are emotional.
These emotional memories could
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elicit a certain mood weather it
would be happy or unhappy.
Another study was conducted to see what type of emotions would arise from different
odors. The study used various
odors, the odors were either pleasant or unpleasant. This test is
interesting because people have
different standards for what is
pleasant and what is unpleasant.
Some people might think a certain
smell is pleasant when other people might think is unpleasant and
vice versa. In the study, subjects
that were given a pleasant odor
produced happy memories and
unpleasant odor produced un happy memories. The odors that were
given to them was shown to affect
the retrieval process rather than
the rating process.16 This shows
that odors do evoke memories and
not just how we rate them. These
studies have shown that odor can
evoke different memories for different people. Each person has different memories brought up from
odors if they are familiar enough
with them. The odors also produce
an emotional memory that could
eventually affect the person’s mood
and therefore their decision making.
Emotion and Decision Making
Once the odors recall a certain
memory, the memory is going to
evoke a certain emotional mood
and then that certain mood is going to determine what decision
you make.17 Decision making is a
very important thing for humans.
Wayne Dyer, an American philosopher, once said that, “Our lives

are the total of the choices we have
made”.17 Every day we are faced
with choices that we must make.
Some decisions are minor, and
we don’t think twice about them.
Some decisions are major, and we
must spend a lot of time thinking
about them. Even though those
minor decisions aren’t going to
affect our lives immediately, those
decisions could add up quickly
and become something bigger.
To make all these important decisions, we must be in the right type
of mood which is how our emotions come into play. For example,
a person who feel anxious about
an outcome of a risky choice may
choose a safer option rather than
the risky option.17 Emotions are
an integral part of a person internal state and therefore has big influences on one’s decision.17 There
are many theoretical approaches
that link emotions and decision
making. The agreed steps to decision-making are; Asses the available options, the selection of option based on value that has been
associated with it, and the outcome associated with the decisions
is evaluated and incorporated into
existing knowledge.18 Emotions
come into play by modulating the
assessment, selection, and the outcome evaluation of options. For
example, A sad mood may result
from an undesired outcome, but it
can lead to an increased salience of
negative attributes of options.18
The choices we make are also dependent on the type of option we
are given, the degree of the affect
associated with the option and
the nature of the presentation of
the option.18 Based on this, emo-

Adapted from Preston et al. 2007.20

tions effect the value and weight
computation of available options.
Also, the choosing of options is
based on the environment and the
individuals internal state.18 That
means the emotions of the person
making the decision can alter their
decision making. Some disorders
hinder the ability of decision making effectively.
Decision Making with
Anxiety and Stress
All of us have been in those situations where we have an important exam coming up and you have
cram as much as possible. Do you
remember feeling stressed or having anxiety about the exam? Well
stress has been seen to enhance
memory formation, but stress also
impairs memory retrieval and it
impairs the ability to update mem“Man Presentation Feeling” by Gerd
Altmann is licensed by CC0.
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The Iowa Gambling
Task14
•

There are 4 decks of cards (A, B, C, and D).
•
Participants choose a total of 100 cards, one at a time.
• Each time they choose a card, they get feedback about winning and/or
loosing money.
• Participants did not know what each card would yield in advance, like a
lottery.
•
Participants started with a “loan” of $2,000 and were told to make a
profit.
• Decks A & B always yielded $100. Decks C & D always yielded $50.
• For each chosen card, there is a 50% chance of having to pay
a penalty. Decks A & B have a penalty of $250, whereas
decks C & D have a $50 penalty.
ories in the light of new memory.19
Stress could hinder one’s ability to
succeed on those exams. Stress can
affect people’s ability to make decisions. This research ran an IGT
and during their test, the experimental group was told that they
had to give a public speech right
after. This made the people in the
experimental group to stress out.20
The people that were stressed were
slower to learn the task meaning
it took longer to shift toward advantageous decision making in the
IGT.20 So far in this magazine, I
have shown that odors can recall
certain memories, which then
could elicit certain moods and
those moods could alter your decision making. Maybe odors could
be used to de-stress people since it
has been shown to hinder people
Individuals with anxiety
disorders have shown to increase
bias towards threat-related content
and intolerance of uncertainty.
That would mean that the individuals with anxiety disorders will
lean towards bad content than the
good content. Which for the large
“Sunflower” by Dave See is licensed by
CC BY 2.0.
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negative consequences, individuals
with anxiety make more sensitive
and thus more aversive to the large
negative consequences.18 This
could be a good thing and a bad
thing. This could hurt individuals
with when a highly negative outcome is the best value. This situation could pop up when people
are deciding from two negative
outcomes and they must decide
the lesser of the worse. By being
more aversive to options with large
negative consequences, individuals
with anxiety perform better in the
Iowa Gambling Task (IGT).18
Overall, these studies have
shown that different emotional
states can hinder human’s ability
to make decisions which is a vital
thing. Since decision making is a
fundamental part of living, finding
a way to control emotions arising
during decision making is important. One form of therapy that has
been shown to decrease stress and
other mood using odors is aromatherapy.

Aromatherapy
Have you ever been anxious or
stressed and wish there was an easy
way to get rid of that? If only there
was a simple way to fix that. Good
thing there is aromatherapy to help
that. Aromatherapy have been in
use for therapeutic purposes for
nearly 6,000 years.21 Aromatherapy is the art and science of utilizing naturally extracted aromatic
essences from plants to balance,
harmonize and promote the health
of body, mind and spirit.9 Aromatherapy uses natural oils from flowers, barks, stems, leaves, roots, and
other parts of the plant. This process has been shown to enhance an
individual’s innate healing process,
stimulate brain functions and has
been shown to decrease stress.9,10
A study was conducted to examine the level of stress in nurses after
aromatherapy using lavender oil.
The results showed that the nurses
stress symptoms dropped for three
days and their stress dropped from
6.1 to 2.8 (a scale for job stress-related symptoms was used).21 By
decreasing stress, this allows nurses to make quicker and better decisions which will help immensely
in their line of work. Aromatherapy has also been shown to affect
moods in a positive way.
A study was done to see
how alert and how well participants can do in computational
tasks after a treatment of aromatherapy. The aromatherapy used
two different oils that have been
shown to produce two different
outcomes. Lavender oils have been
shown to relax individuals while
Rosemary oil has been shown to
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increase alertness.22 The results of
the study showed that lavender
produced a less depressed mood
therefore performed math computation faster and more accurately. The rosemary showed that the
participants were more alert and
showed faster math computations
than lavender group but not more
accurate.22 This shows that even
though the rosemary increases
alertness and therefore increases
awareness, the rosemary participants performed worse than the
group that was more relaxed. This
also shows that different odors can
evoke different moods and therefore lead to different results.
Aromatherapy has also
been shown to help patients
with anxiety and depression. A
study done by Louis and Kowalski 2002, measured the responses
of 17 cancer hospice patients to
humidified essential lavender oil
aromatherapy. The results showed
that there was a positive change in
blood pressure, pain, anxiety, depression and sense of well-being
when treated by lavender aromatherapy.23 The study also showed
that water humidification treatment caused a positive change.23
The results showed that repeated
lavender treatment sessions could
increase beneficial effects. Interesting enough, the caregivers also
experienced relaxation due to the
calmer atmosphere and environment after the lavender treatment.
This was not observed at the end
of the water humidification treatment.23 Aromatherapy, in general,
has a lot of potential of being a
valuable treatment of anxiety, depression and stress.

Odors are important for many
things because odors can alter
one’s decision. and it isn’t a huge
secret either. The fragrance industry spends up to millions of dollars trying to figure out what type
of scent would people like most.
Looking at what type of memories arise from certain smells could
help those fragrance company
figure out the perfect scent. You
might not know this but stores
around the world are already taking advantage of your sense of
smell. One store that takes advantage is Cinnabon. Cinnabon’s
cinnamon rolls has an infamous
scent that can persuade customers to buy a cinnamon roll. Cinnabon knows that their smells can
lure people into their store, so they
use many tactics to do so. One
thing Cinnabon does is that they
purposely put their ovens near the
front of the store.24 That way the
smell will linger out of the store
and into the hallways of the mall.
Kat Cole, the president of Cinnabon, told WSJ that sales dropped
significantly when the ovens were
moved to the back of the store.24
They also buy the “weakest hood
possible” that is legal for their
ovens.24 That way the smell can
seep through the oven and linger
through the halls. These are some
of the ways Cinnabon uses their
notorious smells. They know what
the power of scent and they use it
to their advantage. Cinnabon isn’t
the only company that uses smells,
Nike showed that adding scents
to their stores increased sales by
80 percent.25 Many companies are
already using odors to their advantage. It’s time for us to use odors

to our advantage. Odors have a lot
of power and has to ability to help
many individuals.
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Oxytocin & Vasopressin
HOW SOCIAL TIES ARE FORMED

By Rachel Arens

H

umans are socially bound
to one another in complex
and fluid ways that are distinct from other mammals. The relationships formed and sustained
between two Homo sapiens are
unique among the animal kingdom and are a large part of why
humans have been able to come
so far. There is no argument when
begged the question, “Which species is most developed?” or perhaps, “Which species is most powerful on Earth?” Humans clearly
win out here, as they have the
power to build and destroy. In just
the past 200 years humans have
completely changed the climate
and the biological makeup of the
Earth. They did this through innovation and elaborate collaboration
with each other, in which their
ability to form deep and meaningful social bonds was critical. For
example, humans have changed
the world with their extreme use of
fossil fuels. To use these fossil fuels
humans first needed to discover how to extract these fuels, and
even before that humans needed
a purpose for the fuels: machines.
To develop a machine, a drug, or
a new way of thinking requires a
group of people working together
towards that common goal. For
many hundreds of years, humans
have formed families and communities to reach these goals.
So why are humans able
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to form these social bonds that
enable them to change the world?
What is different about humans
that makes them special? Scientists have found that two neuropeptides, oxytocin and vasopressin, may be a part of the answer.
While other mammals have these
neuropeptides, studies have shown
that in humans these play a more
significant role in social bonds
than in these other animals. As
neuropeptides, oxytocin and vasopressin both act as hormones and
neurotransmitters. As hormones,
they produce physiological effects
including uterine contractions
or water conservation. As neurotransmitters, their functions are
widespread and not completely
understood, but revolve around
forming social bonds.
History
Starting in the 1800’s, scientists
began investigating extracts from
the posterior pituitary gland. First,
in 1906, Sir Henry Dale found
that an extract facilitated uterine
contractions in cats1. He named
the molecule “oxytocin”, because
it means “quick birth” in Greek.
As early as 1911, oxytocin was
used to induce labor in women1.
This practice is still used today,
however, rather than giving women oxytocin extracted from other
mammals, women are given a syn-

thetic version called pitocin. Pitocin has gained popularity in recent
years as many women schedule
the birth of their child due to the
inflexibility that often comes with
being employed2. Popularity has
also risen due to a shortage of hospital beds in large cities; this shortage pressures providers to get people in and out of the hospital as
quickly as possible. Natural labor
takes on average 8 hours, but with
pitocin this time is cut down to
only 6 hours2. Thus, women and
providers can be aided by this synthetic form of oxytocin, reflected
in the doubling of the frequency of
labor induction between 1990 and
20122. Oxytocin is often given the
abbreviation OT in scientific literature.
In 1913, the antidiuretic component of the extract was
discovered by Farini and Vongraven1. Because of its properties, it
was originally named antidiuretic
hormone (ADH). However, as the
hormone has gained popularity
in neuroscience research and literature, the name vasopressin has
also been used, originating from
the fact that it is a vasoconstrictor
and a pressor agent. In 1954, Vincent du Vigneaud won the Nobel
Prize in Chemistry for his organic
synthesis of ADH and oxytocin1.
Following this accomplishment,
ADH was frequently used as a
medication in the 1960’s-1980’s to
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treat diabetes and gastrointestinal
hemorrhage.
Physiology
Oxytocin and vasopressin were
both originally discovered and
known for their roles as posterior
pituitary hormones. As hormones,
oxytocin and vasopressin are critical for multiple physiological
processes. Understanding these
processes is important to understanding how these neuropeptides
affect the body holistically.
The role of oxytocin in
general physiology is centered
around reproduction. In relation
to this fact, the highest concentration of oxytocin receptors is found
in the magnocellular neurons of
the hypothalamic paraventricular
and supraoptic nuclei3. These nuclei are key in processes associated
with reproduction, stress, growth,
and metabolic rate. When a mammal encounters a stressful stimulus
or a stimulus associated with reproduction (like suckling) oxytocin is
released from the posterior pituitary into the bloodstream. In addition to these nuclei, oxytocin is
secreted by multiple other tissues,
including the uterus and testes, the
placenta, and the heart3. As mentioned earlier, oxytocin is critical
in the induction of labor through
stimulation of the smooth uterine
muscles. On a molecular basis, this
happens through an up-regulation
of oxytocin receptors in the myometrium and decidua, resulting
in an increase in a steroid called
PGF(2 alpha), which increases
the body’s sensitivity to oxytocin3.
In males, oxytocin is important

in the generation of spontaneous
erections and ejaculation.
Based on the physiological
processes in which oxytocin is involved, it is easy to imagine that
oxytocin may also play a role in
social bonding. Vasopressin’s role
is a little more elusive. Vasopressin
is involved in many physiological
processes, most of which have to
do with the maintenance of body
homeostasis, not reproduction.
The two main sites of action for
vasopressin are the kidneys and the
blood vessels, where its primary
function is to regulate the kidney’s
management of water4. This regulation happens when vasopressin
binds to V2 receptors located in
renal collecting ducts, increasing
water permeability via a cAMP
mechanism4. This process decreases the formation of urine while increasing blood volume. There are

also V1 receptors, which are involved in vasoconstriction, the secondary physiological function of
vasopressin. This process increases
arterial pressure through a complicated combination of the IP3
signal transduction pathway and
Rho-kinase pathway4. Release of
vasopressin occurs through stimulation of stretch receptors within arterial walls and large veins,
alerting the body to a decrease in
arterial pressure often due to dehydration or hemorrhage4. These
stretch receptors communicate
with the medulla, which sends
the message to the hypothalamus,
which then relays to the posterior
pituitary that vasopressin should
be released.
Neural Anatomy
While oxytocin and vasopressin

OpenStax, Anatomy
& Physiology. OpenStax CNX. Jul 30,
2014.
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have many roles within the body,
they also have roles in the brain. As
stated above, the highest amount
of oxytocin receptors is found in
the magnocellular neurons of the
hypothalamic paraventricular and
supraoptic nuclei, which are heavily related to reproduction. However, there are also high concentrations of oxytocin receptors in
the central amygdala5. Similarly,
there are high concentrations of
vasopressin receptors in the medial
amygdala, another section of this
brain structure5.
The amygdala is a brain
structure heavily associated with
the processing of fear, anger, and
emotion in general. Among the
neuroscience community the
amygdala is jokingly called “the
teenager center” of the brain. Specifically, the central amygdala is
the area that communicates with
the hypothalamus, alerting the
brain to stimuli that induce fear,
anxiety, or other strong emotions.
The hypothalamus then tells the
posterior pituitary to release oxytocin and vasopressin.
How does the placement of
oxytocin and vasopressin receptors
in the amygdala affect behavior?
Because the amygdala is associated with emotion and anxiety, the
fact that there are so many receptors here is good evidence for these
neuropeptides relating to these
feelings. Interestingly, these two
neuropeptides can have seemingly opposite effects, with oxytocin
producing maternal care and positive social interactions while vasopressin produces aggression and
anxiety. Although these neuropeptides may have different effects, on
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a cellular basis they both excite the
brain regions with which they are
associated. This circuit places the
role of oxytocin and vasopressin in
the realm of emotion, but exactly
what type of emotion and what
purpose does that serve?
Neurobiological Purpose
Through years of research, oxytocin and vasopressin have been
found to be critical in pair bonding. The most obvious example
of this is the bonding that occurs
between a mother and her infant;
during birth and breastfeeding
there is an up-regulation of oxytocin receptors, thus an overall
increase in sensitivity to the neuropeptide3. It has been found
that while oxytocin is critical to
the physiology of these processes,
there is also a strong psychological
component due to the upregulation of the receptors in the central
amygdala and other brain regions.
When women give birth, breastfeed, or even just hold their child,
they receive a burst of oxytocin
which bonds them to their infant.
The psychological side effects of this increase in sensitivity
to oxytocin include an increase in
maternal behavior, an increase in
feeling close to someone, and a
decrease in anxiety. A study found
that when virgin rats were given
an exogenous dose of oxytocin,
they behaved maternally to pups
that were not theirs and had no
relation to them6. This is interesting because the rats did not go
through any natural processes that
elevate oxytocin levels (e.g., labor,
milk production and let down),

yet exogenous oxytocin was sufficient to induce maternal behavior
including carrying the pups away
from a dangerous stimulus. This
same study looked at the effect
exogenous vasopressin had on the
maternal behavior of the virgin
rats. Interestingly, the exogenous
vasopressin did elicit maternal behavior towards the pups, but not
as “complete” as the maternal behavior triggered by oxytocin6.
Interestingly, these maternal bonds go both ways; the increase in oxytocin in females who
give birth and who breastfeed is
mirrored in their offspring. One
study found that when young
men were given an intranasal dose
of oxytocin, they looked upon
their childhood memories of
their mother more fondly7. With
exogenous oxytocin, these men
were more likely to say that their
mother was “exceptionally caring”
than men without exogenous oxytocin. This was especially true for
men that already felt close to their
mothers; the oxytocin amplified
the positive feelings that were already present7. This provides evidence that oxytocin is critical for
the bonding between a mother
and their child.
The ways in which oxytocin and vasopressin produce social
bonds goes beyond the formation
of mother-child relationships.
Curiously, these neuropeptides
facilitate the induction of many
different human relationships.
One study found that oxytocin increased participants’ propensity to
blindly trust others; for example,
there was one participant that was
more or less at the mercy of anoth-
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er participant8. Individuals who
were given a nasal dose of oxytocin
were much more likely to trust the
person who held all the power in
the situation. There was no discussion between the two participants
and they were complete strangers,
so there was no reason for one participant to trust the other, but with
oxytocin the participant trusted
against logic. Thus, oxytocin helps
build friendships and professional
relationships in addition to familial ties, critical for the formation of
the communities humans rely on.
With respect to familial
ties, we’ve previously only talked
about mother-child bonds. However, oxytocin, and to some extent
vasopressin, have also been shown
to be important in the formation
and strength of relationships between spouses. In a study where
they administered small blister
wounds to spouses, they measured
levels of oxytocin, vasopressin, and
the rate of wound healing in relation to the relationship between
the spouses9. Amazingly it was
found that spouses that reported
feeling closer to one another and
had very positive relationships
had the highest levels of oxytocin
and vasopressin as well as the fastest rate of wound healing9. This
demonstrates how complex and
widespread the effects of oxytocin and vasopressin are in the relationships that humans form as
well as how these neuropeptides
are involved in a human’s stress response.’

http://www.
publicdomainpictures.net/view-image.php?image=234052&picture=mother-and-child

Evolutionary Significance of
these Social Bonds
Let us return to the original question of why these neuropeptides
are so important to humans.
For the entirety of our existence,
Homo sapiens have been very social creatures. The social nature of
humans has evolved over time to
increase the survival rates of humans.
Humans are known as
“high K organisms” meaning that
they only have a few offspring and
they spend significant time and
energy on these few offspring to
ensure their success and survival.
In humans, there is a long gestation period and a long period of
dependence on the parents after
birth. When humans are infants,
they cannot even lift up their head
without the help of a parent. This
makes infants extremely vulnerable, why it has become so important for parents to be bonded with
their children and to have an intrinsic desire to take care of their
young.

During labor and then afterwards through breastfeeding,
the infant and the mother spend a
significant amount of time together, with the survival of the infant
being completely dependent on
how the mother cares for it. Additionally, it has been argued that
humans are born prematurely so
they can fit through the birth canal. This early birth makes human
offspring especially vulnerable and
the parental care of the offspring
even more important. The chances of an offspring surviving to
adulthood were much higher for
humans if a parent was around to
protect the offspring and teach it
how to hunt, find shelter, etc. This
dependence is one of the ways
which oxytocin, and to some extent vasopressin, had the potential
to evolve into a neuropeptide that
has the power to form social bonds
in addition to impacting physiological processes.
Beyond the mother-infant
relationship, humans are incredibly social creatures. On a daily
basis, neurotypical people work
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closely with others to complete
projects, come up with new ideas,
cook dinner, and raise families.
Humans have consistently formed
communities and chosen to gather and work together rather than
be on their own for thousands of
years. Many other mammals also
form cohorts or packs as this increases survival rates; if there are
many animals, there is a high
probability that many will escape
a predator. There is strength in
numbers. So then why have humans done this to a much greater
extent than other mammals? Why
is simply having a large cohort not
sufficient, why do humans have
these intense, deep social bonds?
Humans first started to
stand out from the rest of the
mammals when they started forming communities with gendered
roles, hunting and gathering. Theoretically, each human could hunt
or gather food on its own. However, humans developed a complex
system where they depended on
one another; the women gathered
fruits and vegetables while the
men hunted meat. All of this food
was critical for survival at the time.
From this original setup developed
towns, cities, and countries.
Medical Uses of Oxytocin
and Vasopressin
Because oxytocin and vasopressin
are so important to the development of social bonds, many have
hypothesized that an exogenous
dose of these neuropeptides may
be useful to those who have disorders that affect one’s social interactions with others. Autism spec-
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trum disorder (ASD) has gained
the most attention in the field.
Many researchers have investigated whether additional oxytocin or
vasopressin can help people with
ASD be less anxious in social situations and if it can help these individuals better interpret and understand others’ emotions.
One of the greatest struggles individuals with ASD face in
social interactions is the deficiency or lack in ability to recognize
the emotion of others’ faces. This
poses a problem because someone
may look sad or angry, but a person with ASD, unable to recognize that emotion, could say or do
something that may make the other person feel worse. Luckily, the
intuitions that scientists have had
regarding these neuropeptides has
been supported by research. Many
studies have shown that children,
adolescents, and adults with ASD
have much more success and ease
with understanding how other
people feel and what their facial
expression means when they have
an exogenous dose of oxytocin10,11.
Unfortunately, although a great
deal of literature has supported the
potentiality of oxytocin as a treatment for social deficiencies in people with ASD, it has not become a
widespread medication. This may
be due to insufficient research,
the extremely short half-life of the
drug, or potential side effects not
discussed in these studies.
Another mental illness that
has received attention from this
field is Generalized Anxiety Disorder (GAD), especially people with
social phobia. In this disorder, the
amygdala, the brain structure dis-

cussed earlier, is hyperactive. This
hyperactivity makes people feel
fearful or anxious when there is no
real danger. Because oxytocin helps
decrease anxiety and facilitate the
formation and maintenance of
social bonds, researchers expected
individuals given oxytocin to have
a less hyperactive amygdala. As hypothesized, researchers have found
that individuals suffering from
GAD have lowered amounts of
amygdala hyperactivity, and thus
less anxiety, when administered
oxytocin12. This makes oxytocin
an interesting target for further research on potential clinical applications for these neuropeptides.
Oxytocin and vasopressin
are two neuropeptides with a myriad of physiological and psychological purposes. They regulate many
biological processes in humans,
including the process of relationship formation. The ways in which
humans interact with one another
and form friendships, fall in love,
and connect with their children
are the central interests of many
academic fields, including neuroscience. Further, understanding of
the ways in which humans bond
could help us form humans bonds
where they are most needed: in
the face of hate, discrimination,
and war. These are terrible and
common parts of the human narrative that occur because people
are divided, but if we understand
the neurobiological basis of the
interactions that bond us, we may
be able to form bridges between
groups currently in opposition of
one another. What will we learn
about these neuropeptides next?
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Spinal Cord Injuries: The Life After
By Woo Jeon

H

ow many times have you
driven in a car? Or, how
many times have you taken
a hard fall? For most individuals,
these events are not uncommon
occurrences. Within a split second, a car crash or a bad fall can
change an individual’s life forever.
Among the various consequences following an accident, one of
the most catastrophic injuries are
Spinal Cord Injuries (SCI). SCI
are devastating conditions for two
main reasons. First, SCI are usually sustained randomly or out of
the blue. As seen in the example
above, SCI can happen to anyone
at any time doing normal daily
activities. Second, the social exclusion that results from the inability
to be physically and socially active
can be a high barrier to overcome.
For example, an individual with a
SCI may not be able to go out to
dinner with their friends as easily
or that individual may feel as if
they’re a burden on others which
can result in alienation. It is only
with a functional and intact spinal
cord that simple daily tasks such
as brushing your teeth or taking
a shower aren’t viewed as strenuous activities. SCI are biologically
complex and life-disrupting conditions that can affect an individual’s life in various respects. There
are many health consequences of
SCI such as autonomic dysreflexia,
a condition with a sudden onset of
excessively high blood pressure, or
pressure ulcers that can be prevented given the proper care. In addi-
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tion to the health impact of SCI,
this condition can affect many
social aspects of an individual’s
life such as their occupational status, education, relationships with
family/friends, marital status, and
many more. These personal and
social challenges are the barriers
that individuals with SCI have to
overcome in order to live a life that
is of both high quality and good
health. Due to the permanent nature of SCI, individuals with SCI
experience a wide range of medical care such as surgery, intensive
care, rehabilitation, etc., and can
therefore reflect how well overall
the health system works and what
policies need to be addressed. As
a result, it is crucial that interventions for SCI work to improve the
survivability, and quality of life for
individuals affected by this condition. Additionally, by looking at
the main causes of SCI, preventative measures can be taken in order to reduce the risk of sustaining
such injury.
What is SCI?
It is important to understand the
anatomy and biological consequences of SCI because the level
of severity determines a large part,
the resulting lifestyle experience
The spinal cord is positioned within the spinal column, and extends
down from the brain to the L1−
L2 vertebral level, ending in the
conus medullaris. The spinal cord
consists of 31 spinal cord roots:

8 cervical, 12 thoracic, 5 lumbar,
5 sacral and 1 coccygeal. Figure
1 represents well the organization
of the spinal cord and the functions of each segment. The range
of impairments induced by SCI is
dependent on the location of the
lesion along the spinal cord. The
most severe cases are cervical SCI’s
which commonly cause sensory
and motor loss in the arms, body,
and legs, a condition called tetraplegia. Individuals with a lesion of
C4 or higher may require a ventilator. Thoracic SCI’s generally
cause sensory and/or motor loss
in the trunk and legs, a condition
called paraplegia. Lumbar SCI’s
typically cause sensory and motor
loss in the hips and legs. The extent and severity of sensory, motor
and autonomic loss also depends
on whether the lesion is “complete” or “incomplete”1. A complete SCI exhibits complete loss of
sensory and motor function below
the level of injury, and incomplete
SCI’s preserve some sensory and/
or motor function below the level of injury. Regardless, both cases
are no less serious and can still result in severe impairments.
A Global Picture on SCI
Quantifiable data in terms of
the magnitude and cost of SCI
are limited, and only a select few
high-income countries have the
means necessary to provide national statistics1. Therefore, the
best available data on SCI can only
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Figure 1 Spinal Cord organization and responsible functions1.

vitamin B121. It is important to
distinguish the two when looking at the epidemiological data
because the approach in creating
preventative methods can vary.
Prevalence of SCI

provide a general epidemiological
picture. However, this epidemiological picture of SCI is required in
order to assess the socioeconomic
impact of the condition. There are
three main epidemiological indicators for SCI that can be quantified: prevalence rate, incidence
rate, and etiology. These data are
useful in determining primary and
secondary prevention methods.
Prevalence and incidence rates
give insight to life after sustaining
a SCI, and from this data, secondary prevention methods involving
the proper management and care
following the injury can be implemented. Etiology looks at the
main causes of SCI which is useful
for planning primary prevention
methods which involves the re-

moval of the initial causes.
Types of SCI: There are two
types of SCI; traumatic (TSCI)
and non-traumatic (NTSCI).
TSCI are most commonly a result of road traffic crashes, falls,
and violence1. Whereas NTSCI
result from communicable and
non-communicable diseases such
as tuberculosis and cancer, as well
as nutritional deficiencies such as

TSCI prevalence data show a range
from 280 per million in Finland as
high to 1298 per million in Canada5,9. The fivefold difference may
not be an exact representation of
the prevalence due to the various
years the studies were performed.
The studies also vary in methodologies which may have contributed to the variability of the data.
Regardless, it still goes to show
locations that need improvements
in secondary prevention measures.
NTSCI prevalence data from Canada and Australia show that ageing
demographics may be the primary
reason for increasing NTSCI prevalence1.
Incidence of SCI
It is estimated that global SCI incidence is 40 to 80 new cases per
million population per year, which
means that 250,000 to 500,000
people become spinal cord injured1. In 2016, the United States,
with a population size of 314 mil-

General Etiology of all TSCI
Vehicular,
Other/Unkn,
39.2%
9.7%
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Created by Woo Jeon.
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cidence to increase steadily with
age9. This is mainly due to the
increase in risk resulting from ill
health with increasing age.

Figure 2
Distribution
of TSCI by sex
and age group.
Source 1;
Adapted from
34, 35

lion, had an annual SCI incidence
of approximately 54 cases per million population, or approximately
17,000 new cases each year5. Although these numbers are low relative to other more common diseases and disorders, they still goes
to show that SCI impacts a significant population. A few trends
can be recognized from the TSCI
country-level incidence data, and
these trends can show which areas and what type of preventative
measures need to be taken.
The incidence rate of TSCI
is increasing, decreasing, stable depending on location. Studies from
two Norwegian counties showed
an increase in the incidence of
TSCI between 1952 and 20013.
Developed countries such as the
US, Finland, and Australia have
noticed a decrease in incidence of
TSCI1. Data from France showed
the incidence rate of SCI to remain stable6.
TSCI occurs much more frequently in males than in females. A
study based in the US showed that
males have a much higher rate of
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TSCI across all age groups especially from ages 16 to 217,8. These
results show that gender roles may
play a role in the SCI incidence
rate, where differences in alcohol
consumption, driving behavior,
and participation in high-risk
sports that manifest after childhood may attribute to the fact that
males more commonly sustain
TSCI1.
TSCI occurs mostly in young
adults and the elderly. Data from
a study in Canada revealed that
two common age-associated peaks
of TSCI occur in young adults
(males 20-29; females 15-19) and
in the elderly (males 70+; females
60+) (2), however, this increased
incidence in the elderly has been a
relatively recent development. Another study in Australia showed an
overall increase from 4% to 12%
in SCI incidence over a time period of 25 years8.
There are far fewer studies
on NTSCI incidence. However,
a study in Australia revealed that
NTSCI varies both by age and sex.
This study found that NTSCI in-

TSCI. As mentioned before, road
traffic crashes are the leading cause
of TSCI. As Figure 3 represents
well, vehicle crashes account for
70% of TSCI in 3 African countries, 40% in South-East Asia,
and 55% in the Western Pacific.
Studies revealed that the common factor among these vehicle
crash induced TSCI were the lack
of and non-use of seatbelts which
illustrates the importance of such
safety measure10,11.Falls are the second leading cause of TSCI. As represented in Figure 3, falls account
for approximately 40% of all TSCI
cases in the Eastern Mediterranean
and South East Asia. Violence, including self-harm, makes up the
third leading cause of TSCI, and
constitutes approximately 14%
of cases in the Americas, 12% in
Africa, and 11% in the Eastern
Mediterranean. Areas such as Afghanistan where violence is high
due to the effects of war, a study
found 60% of all TSCI cases being
related to violence12.
NTSCI. There are few reliable national data concerning the etiology of NTSCI. Limited data has
found showing that in countries
such as India, Peru, and Sweden,
the leading cause of NTSCI are tuberculosis and other infectious diseases13-15. However, a compilation
of studies suggests that the general
leading causes of NTSCI are neo-
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plastic tumors, degenerative conditions of the spinal column, and
vascular/autoimmune disorders1.
Prevention of Spinal Cord
Injuries
SCI whether traumatic or
non-traumatic, a large proportion
of these injuries are preventable
through primary and secondary
prevention methods. Primary prevention involves steps to remove
the initial cause of SCI before the
problem arises. Secondary prevention involves proper management
and care for individuals with SCI
following the injury.
Primary Prevention Methods
The Safe Systems Approach
Road traffic crashes being the leading cause of TSCI, reducing the
incidence of such events is a significant element in preventing TSCI.
The adoption of a safe systems
approach to road traffic crash prevention is crucial in reducing these
types of cases. This approach recognizes that a properly managed
system of vehicles, people, and
roads reduces injuries resulting

from crashes16. A successful implementation of road safety action
requires effective advocacy, broadbased community acceptance,
multisectoral intragovernmental
cooperation, and the cooperation
of industry and nongovernmental
organizations such as automobile
associations, the medical profession, and road safety advocacy
groups16.
Falls
Although the act of falling or an
item falling is an uncontrolled
random event, there are steps that
could be taken to prevent such
outcomes. These methods include
the elimination of clutter, loose
carpets, and uneven floor surfaces,
and the provision of good lighting,
hand rails, and appropriate level
seats, toilets, and beds17.
Violence
Sub-Sarahan Africa has the highest reported proportion of violence-related TSCI in the world
making up approximately 38%
of all cases18. As expected, there’s
evidence that jurisdictions with
restrictive firearms legislation and

lower firearms ownership tend to
have lower levels of gun violence
which includes bans, licensing,
age requirements, and background
checks1. Additionally, strategies
other than those aimed at reducing access to guns and knives, such
as developing safer relationships
among children, reducing availability of alcohol which is a risk
factor of violence, promoting gender equality to prevent violence
against women, and a change in
cultural and social norms that support violence can be implemented
to reduce violence-related
TSCI1.
Secondary Prevention Methods
Secondary prevention methods involve everything after the event of
a SCI which includes two things:
management of the secondary
conditions, and improvements in
policies surrounding the health
system for individuals with SCI.
Secondary Conditions and
Rehabilitation Needs
Individuals with SCI are at risk
for a variety of secondary conditions which can be a major cause

Figure 3 Etiology of TSCI among WHO
regions. Source 1; adapted from multiple.
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of morbidity and mortality1. Some
of the major secondary conditions
include autonomic dysreflexia,
deep vein thrombosis (DVT),
sublesional osteoporosis, chronic
pain, and pressure ulcers.
Autonomic dysreflexia is a
condition characterized by a sudden increase in blood pressure,
and this condition is most commonly found in individuals with
SCI at or above the T6 level19. If
left untreated, it may cause serious
consequences such as strokes, seizures, and death. Awareness of the
necessary treatment procedures
following autonomic dysreflexia
by caregivers is crucial.
Deep Vein Thrombosis
(DVT) is a high risk secondary
condition of SCI and is characterized by a blood clot in a deep
vein. DVT can lead to pulmonary
embolism and death. Anticoagulant medication as well as wearing
compression stockings have been
proven to help with DVT22.
Sublesional Osteoporosis results from the immediate loss of
bone mass following SCI. Osteoporosis poses a risk for easy bone
fractures from simple activities
such as transfers1. Interventions
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such as bisphosphonates in junction with vitamin D and /or calcium have had efficacy in improving
osteoporosis23.
Chronic Pain can significantly impact quality of life for
individuals with SCI. A significant
number of individuals with SCI
experience neuropathic pain characterized as burning, stabbing, and
aching20. Musculoskeletal pain
from overuse is also a common experience among individuals with
SCI. Thus, pain management can
be approached with medication,
exercise, massage, acupuncture,
psychotherapy, meditation, and
relaxation24.
Pressure Ulcers, which results from impairments in sensation and mobility, poses another
high risk secondary condition for
SCI affected individuals. Preventing pressure ulcers is the most
important aspect of care for individuals with SCI, and can be done
through regular skin checks, pressure-relieving methods, and adequate bowel/bladder care21.
Health System Strengthening
Appropriate legislation, policies,
and strategies ensure individuals
with SCI to have adequate access
to health care and rehabilitation
centers, which ultimately result in
a higher quality of life1. However,
this is much easier said than done.
Areas in a health care system that
need constant improvement include delivery service, human resources, health technologies, and
financial support.
Delivery Service

Adequate availability, accessibility, and acceptability of health care
services for individuals with SCI
is vital in maintaining a healthy
lifestyle following SCI. Therefore,
it is important to ensure appropriate access to all necessary specialized services in order for effective
continuation of treatment for individuals with SCI following discharge from the hospital setting1.
Additionally, caregivers and family
members need to be well informed
of the post-hospital medical care
available according to their specific needs.
Human Resources
Individuals with SCI require access to a wide range of specialized
service personnel such as medical
doctors, nurses, paramedics, psychologists, therapists, and many
others. It is crucial to promote access to specialist trai ning programs
in order to produce more suitably
trained personnel so that individuals with SCI have adequate access
to these resources1.
Health Technologies
Health technologies such as assistive technology and wheelchairs
are essential for safe and effective
prevention, diagnosis, treatment,
and rehabilitation for individuals
with SCI1. Studies have found that
access to these technologies, which
improve quality of life, can be limited due to eligibility issues. Other
factors such as input, sustainability, appropriateness, and impact
of these technologies also need
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to fit into a given environment25.
Therefore, it is important to establish transparent and fair eligibility
guidelines to enable people with
SCI with access to assistive technology, and identify cost-effective
models for the provision of assistive technology1.
Financial Support
Individuals with SCI require ongoing medical care and rehabilitation from the time of injury, and
therefore both the initial and ongoing costs associated with SCI
is significant26. As a result, there
needs to be sufficient funding for
specialized services in order to ensure access to comprehensive and
affordable health insurance to individuals with SCI.
Conclusion
Clearly, it is evident that SCI’s can
cause significant changes to the
quality of an individual’s life. Does
this mean that individuals should
treat each day as if they were going to sustain such a devastating
injury, and not participate in their
daily activities? Absolutely not.
But SCI’s are serious conditions
where primary and secondary prevention methods work not only to
treat and improve the lives of individuals affected by a SCI, but by
reducing the risk in the first place.
Hopefully, with a better implementation of these methods, the
risk and rate of SCI’s will significantly reduce.
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MINDFULNESS
FOR THE MASSES

By Emma Klug

Nearly two thirds of Americans

are smartphone users.1 As of 2015,
64% of Americans owned smartphones, and it is reasonable to suspect that this proportion has only
grown within the past 2 years. As
we are spending more and more
time interacting with these devices, scientists are beginning to ask
how this technology is affecting
our brains, bodies, and behavior.
This inquiry is highly warranted,
as it has been reported that we
check our smartphones about 85
times each day, accumulating to a
total of five hours.2 These numbers
might seem shocking, and recently,
a number of studies have reported
the negative effects of smartphone
use on our wellbeing, particularly
regarding attention and mood regulation.

Media multi-tasking describes a person’s consumption of
more than one item or stream of
content at the same time. For example, switching back and forth
from writing an email to responding to a text, all while scrolling
through your Facebook feed. Historically, evidence has indicated
humans are poor multi-taskers.3
This prompted researchers at Stanford University to question how
our simultaneous use of numerous
applications on our smartphones
affects our cognition. They found
that media multitasking places
new demands on our cognitive
processing, specifically our allocation of attention.4
Consistent with the notion that we are not predisposed to
multitasking, participants classified as “heavy” media multi-taskers

Screenshots of the app, Headspace, taken by Emma Klug.

88

“Smartphone” by
OpenClipart-Vectors
is licensed by CC0.

performed consistently worse across
three measures of
attention
compared to “light”
media multi-taskers4. Unsurprisingly, heavy media multi-taskers
were less capable of filtering out irrelevant information or thoughts.4
What is perhaps most troubling
about these results is that they
suggest the effects of our media
consumption persist even after we
lock our screens.
Not only has smartphone
usage placed unwelcome strains on
our cognitive load, but a growing
body of evidence suggests it may
also negatively effect our wellbeing. Older generations of smartphone users have reported feeling
“happy” and “productive” when
engaging with their devices1.
However, younger smartphone
users seem to experience a wider
range of emotions, also reporting
feelings such as “distracted” and
“angry”.1
In line with this, a 2014
study of more than 300 universi-
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ty students revealed higher smart
phone usage was correlated with
increased depression, anxiety,
poor sleep quality, and daytime
dysfunction.5 Further analyses
demonstrated that high levels of
depression, anxiety, and younger age were predictive factors of
smartphone overuse, demonstrating the vulnerable position
of young smartphone users who
grow increasingly more dependent
on their devices.5
The rise and spread of
smartphone technology has been
accompanied by the rise of the field
known as mobile health. While
smartphone use has been associated negative health outcomes, the
mobile health field recognizes the
incredible staying power of this
technology. Therefore, it aims to
take advantage of the overwhelming presence of smartphones in
people’s lives in order to deliver effective healthcare interventions. Specifically, in its Mental
Health Action Plan 2013-2020,
the World Health Organization
recommended “the promotion
of self-care, for instance, through
the use of electronic and mobile
health technologies”.6 Ironically, while accumulating evidence
suggests smartphone usage wages
war on our cognitive systems, they
may also provide an easy and effective opportunity to get some piece
of mind.
Mindfulness: A Brief History
Mindfulness is famously described
by scientist and educator Jon Kabat-Zinn as a way of paying attention on purpose.7 It is a state

“Stethoscope Medical Health” by
StockSnap is licensed by CC0.

of being aware of what is taking
place in the present moment, in
an accepting, compassionate, and
nonjudgmental manner.8 Simply
put, mindfulness is pretty straight
forward– when your mind is fully
attending to whatever you’re doing, seeing, or experiencing, you’re
being mindful. Many have developed this way of approaching the
world through years of meditation
training. Lucky for us, the foundations of mindfulness are now available on the app store.
The most downloaded
mindfulness app is Headspace.8
The creator of the app, a former
Buddhist monk, describes the app
as a “gym membership for your
brain”.8 Headspace consists of
daily, guided meditations, teaching beginners the fundamentals
of mindfulness-based meditation
practices. Users begin with the
“take 10” program, practicing
mindfulness meditation just 10
minutes daily, for 10 days. Users
build on this practice for an additional 20 days until they have
completed the foundations course,
at which point they are given access to advanced content related to
health, relationships, and performance.
Mindfulness meditation
dates back to over 2,500 years ago
to the Buddhist vipassana meditation techniques practiced by Gau-

tama the Buddha, himself. In the
mid-20th century, mindfulness
practices began to evolve into key
components of secular psychological interventions, due their ability
to reduce stress and improve emotional wellbeing. Currently, mindfulness-based programs have proven successful in treating a number
of disorders, including anxiety,
depression, post-traumatic stress
disorder, and addiction.9-11 Further studies also support the use
mindfulness practice in improving
the wellbeing of nonclinical populations.12
Advocates of mindfulness
interventions boast it has the ability to improve one’s self-control,
capacity to deal with stress, regulation of emotions, and concentration.9 But does this bite-sized
Buddhism have the power to
counteract the deleterious effects
of smartphone overuse? As mindfulness has gained popularity over
the past 2 decades, researchers have
set out to answer this question.
Your Brain & Mindfulness
Much of the research surrounding
the efficacy of mindfulness train-

“Meditation Yoga” by Clker-Free-Vector-Images is licensed by CC0.
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ing looks to define existing differences in experienced mindfulness
meditators compared to inexperienced individuals. For example,
studies show that mindfulness
meditators with years of experience perform better on laboratory
tasks probing attentional processing compared to non-practicing
control subjects.13 Specifically,
participants experienced in mindfulness were significantly better
at directing and re-directing their
attention, most likely a result of
years of practice in efficiently engaging and disengaging from stimuli in their environment.
Interestingly,
differences in attentional processing can
be observed even after just brief
mindfulness training.14 Research
shows that after just five, 20-minute meditation sessions, novice
mindfulness meditators exhibit
improvements in measures of executive attention, or our ability to
resolve conflict between discrepant incoming information, detect
errors, and plan responses.14,15
Not only did participants display
marked improvements in attentional processing, they reported
decreased feelings of depression,
fatigue, anxiety, and anger, and
increased feelings of vigor, all previously reported benefits of mindfulness.14
The brief mindfulness
training also affected the way
participants’ bodies responded to
stress. Cortisol is a hormone released in response to stress, and
acts as a common laboratory measure for tracking how we respond
to stressful situations. To induce
stress, participants in this study
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What is Myelin?
Myelin is a highly specialized membrane that wraps around axons, the
long thin projections that extend from the main body of the neuron.
Myelin acts as an electric insulator, increasing the velocity of signals being transmitted from the neuron cell body to its target. Myelination of
axons occurs differently in the central and peripheral nervous systems.
Specialized cells in the central nervous system called oligodendrocytes
reach out and wrap sections of multiple axons. In the peripheral nervous system, a different specialized cell known as a Schwann cell, individually wraps around a single axonal segment. Myelin is essential for
proper nervous system function, as exhibited by the debilitating effects
of demyelinating diseases such as multiple sclerosis.
“Derived Neuron” adapted by Actam
is licensed by CC BY-SA 3.0.

were challenged with mental math
task. Those who had received the
five-session crash-course in mindfulness meditation displayed lowered salivary cortisol levels after
the math test compared to participants who had completed the
same amount of time practicing
standard relaxation techniques.14
These results indicate that the
mindfulness intervention promoted regulation of the participants’
physical response to stress.
From attentional processing to hormonal regulation,
changes in our bodies and behavior are precipitates of changes in
our brain. Synaptic plasticity refers to the capacity of neural activity generated by an experience to
modify the strength of neural circuits.16 This, in turn, modifies our
subsequent thoughts, feelings, and
behaviors. In other words, when
we change our habits, our brain is
happy to change with us. Therefore, structural and functional adaptations are made in the brain as
a result of mindfulness practice,

resulting in improved attention
and mood, and reduced stress.
Tang’s group at the Dalian
University of Technology in China, along with collaborators at the
University of Oregon, have conducted comprehensive research
on the capacity of mindfulness
meditation to change the structure and function of our brains.
Indeed, they have strong evidence
that mindfulness training leads to
changes in our brain’s white matter, or myelin, specifically in areas
known to regulate attention and
emotion.17
The anterior cingulate
cortex (ACC) has connections to
both the “cognitive” pre-frontal
cortex and the “emotional” limbic
system.18 The ACC is a part of a
circuit involved in a form of attention that serves to regulate both
cognitive and emotional processing.19 Tang and colleagues report
that mindfulness training was
able to strengthen the connectivity in this region, either through
prompting increases in myelin-
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ation, or the reorganization of existing myelin tracts.
Our brain is composed of
gray matter in addition to white
matter. Gray matter is the darker
tissue in the central nervous system, consisting primarily of neuronal cell bodies and their branching
dendrites. Regional differences in
gray matter are generally assumed
to arise due to repeated activation
of the region.20 This makes sense
as differences in gray matter have
been associated with performance
abilities and the acquisition of new
skills, suggesting that increased
gray matter corresponds to improved functioning in that particular brain region.21
Dr. Britta Hölzel’s group
at Harvard Medical School identified increases in gray matter density in multiple brain regions associated with some of the generally
accepted benefits of meditation.21
For example, the temporoparietal junction has been suggested
as a crucial structure for the conscious experience of one’s self. Furthermore, the posterior cingulate
cortex, not far from the anterior
cingulate cortex mentioned previously, is associated with assessing
the relevance or significance of a
stimulus for oneself. Taken together, Hölzel suggests that mindfulness practices increase gray matter
density in these regions as a result
of repeated activation during the
meditative process.20
Your Body & Mindfulness
Beyond changes in our brain,
mindfulness interventions have induced measurable changes in our

physiological functioning, especially in response to stress. Mindfulness-Based Stress Reduction
is a standardized 8-week training
program that includes mindfulness education and practice.22 This
practice has proven efficacious
in reducing blood pressure in response to stressful situations.22
Furthermore, participants in this
same study reported lower levels
of perceived stress and negative
mood after the intervention, complementing previous research that
mindfulness meditation also improves our overall wellbeing.12
Researchers have attempted to measure these differences in
physiological responses to stress in
a number of ways. Rosenkranz’s
group at the University of Wisconsin-Madison
demonstrated
that individuals experienced in
mindfulness meditation displayed
significantly reduced cortisol levels
in response to a laboratory stress
challenge compared to a group of
inexperienced participants.23 To
further probe just how all-encompassing the effect of mindfulness
practice is on physiological responses, the researchers measured
a skin response to capsaicin, the
active component of chili peppers
known to trigger inflammatory responses in any tissue with which
it comes in contact. Remarkably,
they observed that experienced
meditators displayed a less severe
inflammatory skin response compared to inexperienced individuals.
Despite this research, it
remains unclear how mindfulness
meditation reduces our physiological response to stress. One

possible explanation could be that
through extensive practice, experienced mindfulness meditators
have learned a controlled, diminished stress response. This diminished response would be characterized by reduced activation of
inflammatory compounds that are
normally triggered when we find
ourselves in stressful situations.23
Control of physiological responses at this level suggests that the
effects of mindfulness meditation
may extend into processes regulating how our DNA is interpreted
and expressed.
Your DNA & Mindfulness
Epigenetics was first described
by Conrad Waddington in 1942
as, “the branch of biology which
studies the causal interactions between genes and their products,
which brings the phenotype into
being”.24 Since Waddington, the
field of epigenetics has evolved,
and there are several existing definitions. For our purposes, epigenetics can be seen as how our
environment impacts our DNA.
Specific biochemical changes are
made to our DNA that influence
how it is read and transcribed, resulting in the unique expression of
genes without changing the actual
DNA. With this knowledge, researchers have questioned if mindfulness meditation can induce
changes in our epigenome.
Evidence from the lab of
Rosenkranz’s Barcelonian counterparts demonstrated that after a day of intense mindfulness
practice, experienced meditators
exhibited lower levels of key epi-
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genetic modifiers compared to a
group of untrained participants.25
More specifically, these modifiers
are proteins known to be key regulators of inflammatory pathways.
In light of this, researchers also
examined whether or not meditators would exhibit reduced expression of known pro-inflammatory
genes. Indeed, they found medita-

Epigenetic Modifications
DNA methylation is a process
in which methyl groups are added to DNA molecules, changing the activity of a segment
of DNA without changing its
sequence. DNA methylation is
critical to normal development,
and plays a role in silencing repetitive DNA sequences in organisms from fungi to humans,
inactivation of the X chromosome in female mammals, and
mammalian imprinting. Irregular methylation has been implicated in many human cancers.28
“DNA White
Male 3D” by
Peggy und Marco
Lackmann-Anke
is licensed by
CC0.

In our chromosomes, DNA
is tightly wound around histones. The addition of chemical
groups to histone proteins alters this structure, making our
DNA available for transcription, and therefore, expression.
Further, these modifications
often recruit the transcriptional
machinery to specific segments
of the DNA.28
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tors exhibited reduced expression
of two pivotal genes that regulate
inflammatory processes, supporting the notion that after years of
mindfulness meditation, these
participants’ bodies had learned
how to better regulate responses to
stress.25
Further interested in how
mindfulness could be affecting
stress-induced inflammation, researchers measured participant’s
levels of the stress hormone cortisol after performance of a laboratory task shown to induce psychosocial stress. Interestingly, they
reported that lower levels of the
aforementioned
DNA-modifying proteins were correlated with
faster recovery of resting cortisol
levels. Taken together, these findings suggest that a day of intense
mindfulness practice triggers an
anti-inflammatory response in experienced meditators that is not
observed in inexperienced control
subjects.25
Mobile Mindfulness
The benefits of mindfulness meditation have been widely documented. Not only do meditators
self-report feelings of increased
attentional capabilities and elevated mood, but a great body of
evidence shows that this practice
holds the power to change our
bodies in addition to our mind.
The rise of mobile health offers
a unique opportunity to deliver
these positive interventions to a
wider population by increasing
access and reducing time commitments. However, the majority of
studies reporting the benefits of

mindfulness have utilized in-person delivery methods. Therefore,
the question remains whether or
not the many apps on your mobile
device are capable of delivering
a mindfulness practice with the
same efficacy.
Researchers have begun to
investigate whether these applications will provide the same beneficial results as in-person methodology. Bennike’s group, based
in Denmark, asked whether or
not mindfulness training via the
Headspace app could improve laboratory measures of cognitive performance as well as reduce mind
wandering.26 After 4 weeks of
training with Headspace, researchers reported decreased mind wandering, measured by better performance on a laboratory measure of
sustained attention.
Results of participants
using the Headspace app were
compared to those using another app, Luminosity, for the same
period of time. Luminosity is a
“brain training” app, reported to
show improvements in a number
of cognitive abilities including
memory, attention flexibility, and
problem solving. This comparison
allows us to make direct conclusions about the beneficial effects of
mindfulness practice specifically, in
contrast to another app that claims
similar cognitive improvements.
Other researchers have
investigated if the positive effects
on mood seen after traditional
mindfulness meditation are still
visible with use of the Headspace
app. Howell’s group at the University of East London recruited
active “happiness” seekers to par-
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ticipate in the Headspace “take
10” program. Researchers investigated positive affect by measuring
participant’s satisfaction with life,
positive and negative affect, as well
as depression. In line with previous research, they saw significant
improvements in positive affect
and depression levels in Headspace
users compared to control participants who had interacted with
a neutral app. These results led
researchers to suggest that smartphones are an effective method of
delivering mindfulness interventions that make people significantly happier.27
Currently, Headspace is
the only app to be utilized in randomized control trials. However,
scientific evaluation of more apps
is beginning to take place. Researchers well-practiced in mindfulness, as well as professionals
who had delivered it as a part of
their psychological practice, developed an expert rating scale quan-

Screenshot of the app, Headspace, taken
by Emma Klug.

tifying the features of high-quality
mindfulness apps.29 High quality
apps share features with many of
your favorites— quality graphics,
and simple and easy to use interfaces. Additionally, these apps require mindfulness education and a
soothing voice for guided practice
to earn high expert ratings.
Most importantly, high
quality apps need to provide an
“app community” — a social network allowing users to identify
mutual meditators and share experiences. While mobile health
technology is highly accessible,
versatile, and cost-effective, its
most powerful feature may be the
opportunity to engage with an active community of users. A supportive app community provides a
forum to share and discuss accomplishments and challenges of daily
practice.
There is no current evidence indicating sharing user status on other social platforms, or
engaging with an app community
increases the effectiveness of appbased interventions. However, developments over the past decade
have demonstrated the power of
social networks— like Twitter,
Facebook, or Instagram— to guide
and change our behavior. If similar
networks can be built to encourage
healthy habits, like mindfulness,
we may see welcomed increases in
the wellbeing of the smartphone
society. So, download one these
mindfulness apps now, and spend
a fraction of the five hours you’ll
spend on your phone today feeling
mindful.
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The
Genetics of
Being a
Lightweight:
Tipsy Genes
By Jessica Khrakovski

I

t is a standing tradition that every annual Thanksgiving dinner commences with each legally
aged member of my family giving a toast to something they are
thankful for. Once this ceremony is finished, so is every glass of
wine. It is also a standing tradition
for my Aunt Rebecca to be visibly
and positively tipsy after only two
toasts.
Why is it that some people, like my Aunt Rebecca, are unable to hold their liquor and seem
intoxicated after merely sniffing
alcohol, while others seem to be
unaffected by multiple servings?
What is it that earns someone the
label of a lightweight drinker?
The designation as a
“lightweight” is typically earned
by those who feel the psychological, physical, and emotional ef-

fects of low doses. The lightweight
drinker likely gets intoxicated at a
disproportionately rapid rate. The
lightweight drinker is someone
who is more likely to get sick from
alcohol or someone who generally is incapable of holding their
liquor. Needless to say—my Aunt
Rebecca is a lightweight drinker. It
is likely that you have encountered
multiple lightweight drinkers, and
perhaps you even are one!
For convenience and ease,
the behavioral response to alcohol
use is generally discussed with respect to the blood alcohol content
(BAC).1,2 Though there is minimal
consensus on standardization, it
is a commonly used tool for estimating the concentration of alcohol in the blood and the expected
behavioral effects resulting from a
certain number of drinks.

Beyond purely the number
of drinks consumed, there are numerous physiological and molecular factors that affect BAC, and
consequently the level of response
to alcohol. Thus, genetic factors
are largely responsible for individual reactions to ethanol consumption and could dictate why someone is, or is not, a lightweight.
Why do females get
drunker than males?
Sexual Dimorphism of Muscle and
Blood Content It is well established
that equal quantities of alcohol
consumed in the same time frame
will disproportionately affect females when compared to males.1,2
This phenomenon is partially
attributable to the fact that males,
on average, are larger than fe-
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Figure 1 “Pathway of Hepatic Alcohol Metabolism” was created by Jessica Khrakovski.

males. However, after accounting
for differences in size, it is evident
that differing alcohol distribution rates result from sexually
dimorphic muscle mass and blood
volume, both of which are disproportionately greater in males than
in females.3,4 Conversely, females
have higher subcutaneous fat
content and smaller liquid compartments for the dissolving and
distribution of alcohol.4,5
Ethanol, the active ingredient in drinking alcohol, is both
water and lipid-soluble and travels
though the blood to disperse into
tissue for processing.3,6 Because
muscle tissue is highly vascularized, with more extensive blood
vessel connectively than fat, alcohol is more rapidly distributed
throughout the male body. In females, alcohol remains concentrated within fat because it is unable
to disperse through the blood as
rapidly.7 The accumulation of alcohol within fatty tissue prolongs
its duration in the body, leading
females to maintain higher BACs
for longer.2
Enzyme Concentrations Not only
does the rate of alcohol distribu-
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tion contribute to the maintenance of higher BACs in females,
but also the rates of alcohol processing and metabolism. The
majority of alcohol metabolism
occurs through hepatic enzymes
in the liver, where ethanol is converted into other molecules for excretion and clearance from the system.2,8,9,10 The process begins with
the breakdown of ethanol into
a metabolite called acetaldehyde
(Fig 1.). This conversion is catalyzed by alcohol dehydrogenase
(ADH), the enzyme in metabolism
that is directly responsible for decreasing BAC.10,11,12 Acetaldehyde,
a compound even more toxic than
ethanol that can produce unpleasant and even detrimental effects, is
then transformed into acetate by
aldehyde dehydrogenase
(ALDH).13,14
Though the primary metabolic pathway for alcohol is conserved in the livers of both males
and females, the contribution of
gastric first-pass metabolism is
not.2,13 Males contain ADH not
only in their livers, but also in
their stomachs, where alcohol can
be broken down as soon as it enters the body. Thus, prior to he-

patic ethanol metabolism, up to
30% of alcohol consumed by a
male will be converted into acetaldehyde in the stomach, allowing
for a substantially lower amount
of ethanol to circulate through
the bloodstream and absorb into
tissue.7,10,12,14 On the other hand,
females have nearly negligible
amounts of ADH in their stomachs, such that their BACs are
virtually unaltered until alcohol
reaches the liver for hepatic metabolism.2,9
By nature of design, females are less efficient than males
at spreading alcohol throughout
their systems, and consequently
at metabolizing alcohol in preparation for excretion, resulting in
higher BACs and more behavioral symptoms. Nonetheless, the
sexual dimorphisms of alcohol
processing are insufficient to explain what exactly it is that makes
someone a lightweight. Although
my Aunt Rebecca is female and all
of these factors undoubtedly contribute to her inability to process
alcohol well, sexual dimorphism
fails to account for lightweight
males. What else could account
for the unleveled playing field regarding alcohol consumption?
The Lightweight Traits
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Aldehyde Dehydrogenase (ALDH)
Within the pathway of hepatic ethanol metabolism, aldehyde dehydrogenase (ALDH) is the enzyme
that catalyzes the conversion of
acetaldehyde to acetate.10 Though
ALDH does little to reduce BAC,
it is essential in clearing the body
of acetaldehyde, a compound that
is markedly more toxic than ethanol itself.13, 14 The accumulation
of acetaldehyde within the body
during metabolism leads to perceived hangover effects such as
headache, nausea, dizziness, and
hypnotic sedation.8,15
Generally, ALDH is more
efficient than enzymes that oxidize
ethanol into acetaldehyde, such as
ADH, and works concurrently to
clear acetaldehyde faster than it
is produced.7 Thus, within most
individuals, the toxic, hangover
symptoms of residual acetaldehyde
are apparent after a night of heavy
drinking, during which the metabolism system is oversaturated
and ALDH cannot outpace acetaldehyde production.7,10,15
In some instances, consuming even the smallest amount
of alcohol has the same effect as
flooding the entire system. Individuals in which this phenomenon
occurs possess an allele, or a gene
variant, called ALDH2*2, which
encodes a dysfunctional version of the ALDH enzyme.15,16
ALDH2*2 delays the clearance
of acetaldehyde so drastically that
the accumulation of acetaldehyde
manifests as immediate sickness in
response to alcohol.16
While it is estimated that
nearly 50% of individuals of
Eastern Asian descent possess the

ALDH2*2 allele, the variant is
almost nonexistent in those of African and European descent.10,16
Thus, the alcohol flush reaction
and reddening of the face that is
common in ALDH2*2 individuals has been colloquially termed
“Asian flush.” Additionally, markedly lower rates of alcoholism in
Asian populations are thought to
be attributable to the high numbers of ALDH deficiency acting
as a protective mechanism. The
ALDH2*2 enzyme produces a
similar response to ethanol as does
Antabuse (Disulfiram), a drug
used to treat alcoholism that interferes with functional ALDH. The
inhibition of ALDH causes toxic
acetaldehyde sickness that should
prevent consumption in alcohol
abusers.15,16
Since alcohol flush due to
the ALDH2*2 allele induces sickness and toxic effects, there must
be another tipsy gene that accounts for different sensitivity to
alcohol.
Cytochrome p450 2e1 (CYP2E1)
Though the majority of alcohol
within the body is metabolized by
ADH in the liver, a small but significant portion is metabolized in

the brain within the microsomal
ethanol oxidizing system (MEOS).
The MEOS normally accounts for
up to 10% of ethanol oxidation to
acetaldehyde in the body, but it increases activity to ameliorate oversaturation of the hepatic pathway
when BAC is elevated.14,17,18 Cytochrome p450 2e1 (CPY2E1) is
the brain enzyme that helps breakdown ethanol into acetaldehyde
through an unstable intermediate
called a gem-diol.17,19
In a similar vein to ALDH,
there are multiple genetic variants
of the CYP2E1 enzyme, some of
which are linked to behavior. Alleles that increase CYP2E1 The
Microsomal Ethanol Oxidizing
System (MEOS) (MEOS) expression, such as the CYP2E1*5B allele that specifically increases gene
transcription, are associated with a
heightened level of response to alcohol.20 Elevated levels of CYP2E1
not only produce greater concentrations of toxic acetaldehyde, but
also generate high amounts of unpaired electrons as a result of oxidation. These free radicals form
reactive oxidative species (ROS)
that cause oxidative stress, inflammation, and cellular damage in the
brain and interfere with cell pro-
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cesses.19,20 The oxidative stress that
results from high levels of CYP2E1
increases ethanol sensitivity and
the prevalence of sedative/hypnotic effects of alcohol.20,21 Counterintuitively, high levels of the
CYP2E1 enzyme marginally lower
BAC, but result in unprecedented
alcohol sensitivity due to oxidative
stress. It is estimated that 10-20%
of the population is affected by
this tipsy gene!20
The tipsy genes work to
increase behavioral sensitivity to
alcohol, but there are also factors
that shift the response to alcohol
in the opposite direction.
Does drinking more eventually
turn you into a “heavyweight?”
The human body, in particular the
brain, is an ever-adapting, plastic
organism that adjusts its connectivity and functions to accommodate for changes in alcohol intake.
In other words—it learns.12 Theoretically, a female who heavily uses
alcohol might process and metabolize alcohol faster than an equally sized male who rarely imbibes.
It is essential to note that chronic use of alcohol will eventually
have detrimental consequences on

Figure 2 Created by Jessica
Khrakovski.
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one’s health, not the least of which
include addiction, liver disease
and cirrhosis, and heart disease,
22,23
and that the body cannot be
trained to combat these effects.
However, the body of a cautious,
occasional, social drinker will develop ways in which to more efficiently respond to alcohol and
build tolerance.
Tolerance A brain can undergo
pharmacodynamic changes in response to alcohol, in which the
receptors that ethanol binds to,
such as the GABA A receptor, are
affected.
The GABA A receptor is responsible for the anxiolytic and sedative-hypnotic effects of alcohol.23
With time, the receptors could ei-

ther become desensitized to alcohol or decrease in density of these
receptors to become downregulated.24 Thus, ethanol levels that were
once sufficient to activate the receptors would no longer produce
effects of the same magnitude,
leading the drinker to consume
more.
Alternatively, concentrations of metabolizing enzymes that
breakdown alcohol, particularly
ADH, could elevate with time to
account for increased alcohol in
the system.24,25 This pharmacokinetic tolerance results in increased
metabolic activity that allows for
faster alcohol processing, lowers
BAC at an elevated rate, and produces a sort of behavioral tolerance
to higher doses of alcohol.
Risk of Addiction Although tolerance might seem like a positive
thing for those are not genetically
endowed with the means to process
or metabolize alcohol efficiently,
the development of tolerance is a
risk factor for addiction. As tolerance increases and the body becomes more efficient at processing
higher concentrations of alcohol,
previously effective doses become
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insufficient to provide the desired
sensations. Consequently, increasingly higher doses of alcohol are
required to achieve effects.
Overview and Recap
While BAC charts may be useful
in estimating one’s blood-alcohol
concentration, there are underlying genetic mechanisms that
might explain why my Aunt Rebecca cannot be classified with
such a table. Beyond the amount
consumed, sexual dimorphism
and differing enzyme concentrations result in gendered differences
in alcohol processing that affect

BAC and behavioral and physiological sensitivity to alcohol.
Further, tipsy genes result
in deviation from behavior predicted at certain BACs. Though it
is unknown exactly how prevalent
the ALDH2*2 and CYP2E1*5B
alleles are within the population,
further research is critical in understanding the vast effects than
alcohol can have on an individual.
The creation of BAC tables that
link expected behavioral effects to
the amount of alcohol consumed
is not a trivial task. It is still unknown what percentage of the
population is affected by tipsy
genes and shows disproportion-

ate behavioral effects to seemingly small amounts of alcohol. This
could have implications for reform
regarding the legal driving BAC
of 0.08 in the United States,26 at
which Aunt Rebecca surely would
be incapable of safely driving.
While the development of
tolerance through increased consumption trains the body to process more alcohol, it is also linked
with a higher risk for alcohol dependence and addiction. Perhaps
the lightweight trait is not the
most desirable, but it does provide
inherent protection against alcoholism. I do not know for sure if
Aunt Rebecca has the tipsy gene,

99

SCIENTIFIC KENYON

but I definitely do not anticipate
her ever developing a tolerance!
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BATTLE OF THE SEXES:

DOES SEX MATTER IN
CANNABIS USE?
By Toneisha Stubbs

C

annabis is a widely used
illicit drug in the US with
the 2016 National Survey of Drug
Use and Health (NSDUH) reporting that an estimated 24.0 million
Americans aged 12 or older are
current users of cannabis (Figure
1)1. Delta-9-tetrahydrocannabinol
(THC), the primary psychoactive
component of cannabis, is reported to decrease anxiety, induce a
“high”, produce perceptual changes, and impair both psychomotor
and cognitive performance, including working memory2. Overall, these effects are subjective and
vary from user to user. Cannabis
and its chemical components have
also been shown to possibly have

medical uses ranging from the
treatment of eating disorders to
chronic pain3. In 1996, California
became the first state to legalize
the use of cannabis for medical
purposes and, since then, medical
cannabis has been legalized in 28
states including The District of
Columbia4. Recreational cannabis
use has also been legalized in 8 of
those states as well as DC (Figure 2)4. While studies show that
men use cannabis more frequently
than women5, a growing number
of women report cannabis use for
medical purposes6. This increase
makes it important to look at possible sex differences in the effects
of cannabis as well as its proposed

therapeutic uses.
Many studies states that
females are more sensitive to the
subjective effects of cannabis and
are more prone to THC withdrawal symptoms (Figure 3)3. While no
one answer has been given to why
this may be, researchers have come
up with three possible reasons why
females may be differently affected by cannabis use. In this paper I
set out to talk about the differences seen in research and, hopefully,
help us reach a conclusion to if
sex matters in cannabis use. While
there is not extensive human research done on sex differences in
cannabinoid effects, we will examine data from experimental and
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Figure 1 Substance Abuse and Mental Health Services Administration. (2017).Retrieved
from https://www.samhsa.gov/data/

the examples I’ve already mentioned fit into these mechanisms.
Through my research on this topic
I have identified two other factors
that may also relate to the factor of
sex and those are body fat percentage and age.
Is it the hormonal cycle?

survey based human studies, as
well animal studies.
Sex Differences in the
Endocannabinoid System?
When THC and the other chemical components of cannabis enter the body, they interact with
the endocannabinoid system.
The endocannabinoid system is
comprised of two receptors, endogenous cannabinoids and their
metabolite enzymes. The two receptors in the system are the CB1
and the CB2 receptor, the CB1 is
primarily found in the brain and
the CB2 receptor is found in the
peripheral nervous system. There
are two common endogenous
cannabinoids and they are anandamide and 2-arachidonoylglycerol (2-AG) which are metabolized
by fatty acid amide hydrolase (or
FAAH for short) and monoacylglycerol (or MAGL for short) respectively7.
According to research7 differences in this system occur early
in the development of rats as it has
been found that rats younger than
21 days show a huge increase in
CB1 receptor density followed by a
decrease in density during late adolescence. Another sex difference
102

in this system is that peak levels
of CB1 receptors are reached earlier in female rats than male rats7.
Later in life this system is greatly
affected by the hormonal cycle,
which we will discuss later. Sex differences in the endocannabinoid
system have yet to be identified in
humans. Based on the research reviewed for this paper the endocannabinoid system is the foundation
for the sex differences observed by
researchers. It is within this system that researcher has identified
three possible mechanism behind
why sex may be a factor in cannabis use. Those three mechanisms
are the hormonal cycle, pharmacodynamic factors, and pharmacokinetic factors. As you will see

When sex differences are observed
in any study, the first culprit to
be pointed out is the hormonal
cycle of females. To study the relationship between the hormonal
cycle and cannabinoid effects researchers typically ovariectomize
the female rats, meaning they remove their ovaries and/or administer hormones such as estradiol
and progesterone to females. One
such study was done by a lab out
of Washington State University.
They found that the administration of these hormones could alter the effects of THC in females
including antinociception (the
ability to block pain) and alter
CB receptor density and affinity in certain areas of the brain8.
Other studies looking at the role
hormones might play in sex dif-

Figure 2 By Toneisha Stubbs
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Figure 3 Adapted from Lynch & Ware (2015)
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ferences in cannabinoid effects
found that female rats with their
ovaries removed, were more like
males in cannabinoid self-administration. In humans there is also
evidence that hormones may influence the endocannabinoid system, with endocannabinoid tone
being shown to vary across the
human menstrual cycle21. Plasma
levels of the natural cannabinoids,
such as anandamide, are observed
during ovulation and positively associated with estradiol, luteinizing
hormone, and follicle stimulating
hormone9. However, not many
studies have examined the effect
of the menstrual cycle on cannabis use or effects. In summary
what this data tells us is that the
hormonal cycle of females may be
responsible for differences in the
effects of cannabis. To relate this
idea to a larger picture in terms of
the potential increase in the use of
medical cannabis, it may be important for medical professionals
to consider this factor, particularly
when treating women. While this
may seem like enough to determine that sex should be a factor
considered in cannabis use, we’ll
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also take a look at the other proposed mechanism and see what
the results tell us.
Is it pharmacokinetic factors?
Pharmacokinetic factors include
differences in the metabolism, distribution, and absorption of THC
Animal studies have identified the
possibility that cannabinoids are
metabolized to active and inactive
metabolites differently in males
vs females. With females preferentially metabolizing THC to its
highly active metabolite, 11-OHTHC and males to multiple compounds10. In males, the formation
of 11-OH-THC from THC depends on the CYP2C11 isozyme
whereas, in females, it is the CYP2C6 isozyme10. Differences in
the distribution and absorption
of THC have also been found, as
Wiley, et al., (2014) reported that
after repeated THC administration, the concentration of 11-OHTHC (main active metabolite)
was higher in the brains of female
adult and adolescent rats than that
of males11. It was also shown that
even when blood levels were equal,

females have higher brain levels of
THC11. It is safe to assume that
if the metabolites are reaching the
brain faster, then females are also
feeling the effects faster. In humans given an oral dose of THC,
women had significantly greater
Cmax, meaning higher maximum
plasma concentration of THC was
observed12. The same study also
found that females had a shorter
tmax, meaning it took less time for
females to reach peak concertation
of THC and greater AUC (area
under the curve), which means females experience exposure to the
drug longer than males12. These
findings relate to the THC metabolite 11-OH-THC and indicated
a difference in elimination of the
metabolite. While this study does
not measure the metabolites like
that in the animal studies, it still
shows that THC is reaching higher levels in females and is doing so
relatively quickly. Taken together
these results appear to show that
females produce more of the active metabolites of THC and those
metabolites seem to reach the
brains of females faster and stay
in the body longer. It is probably
safe to assume that females could
be feeling the effects of THC faster and for longer durations than
males. Thus, we may have another
point in favor of sex being a factor
in cannabis use.
Is it pharmacodynamic factors?
The third mechanisms that is believed to play a role in the sex differences observed are pharmacodynamic factors that affect the way
the drug acts on the body. Phar-
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macodynamic factors include differences in receptor density and/or
affinity. Animal studies have indicated sex differences in CB1 receptor density in several areas of the
brain including the mesencephalon, striatum, limbic forebrain
and pituitary, with males showing
greater density and/or affinity than
females (Figure 4)10. CB1 receptor
density has also been shown to
fluctuate across the estrous cycle in
female rats particularly in the hypothalamus and anterior pituitary
(Figure 4)10. Although no consistent sex differences in cannabinoid receptors have been found

in humans, one study did report
that CB1 receptor protein expression in leukocytes was reported to
be greater in women than men13.
Other studies using human subjects have found greater CB1 receptor density in men than women in the cortico-striato-thalamic
circuit (Figure 5)14. Together, these
results show that males have a
higher density of CB1 receptors
in certain brain areas than females,
which goes against the fact that
females feel more of the effects of
cannabinoids than males. While
in the other two factors we’ve discussed so far, the hormonal cycle

and pharmacokinetic factors, we
have relativity consistent results in
the sex differences, the results for
the pharmacodynamic factors go
back and forth, at least in humans.
Despite the lack of inconsistent
data, the influence of sex and the
hormonal cycle on CB1 density
and affinity is an important factor
to be looked at when it comes to
the use of THC as a medical treatment as well as in its recreational
use.
Other Factor that
Intersect with Sex

Figure 4 Crane, N. A., Schuster, R. M., Fusar-Poli, P., & Gonzalez, R. (2012). Effects of Cannabis on Neurocognitive Functioning:
Recent Advances, Neurodevelopmental Influences, and Sex Differences. Neuropsychology Review,23(2), 117-137. doi:10.1007/
s11065-012-9222-1
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Despite the extensive research
done on the three factors discussed
so far, there are some other factors
that don’t fit into the categories of
PD, PK or hormones but also play
a role in creating the sexual dimorphisms in cannabis effects. One
such factor is fat deposition. Cannabinoids are lipophilic, meaning
it is found in high concentrations
in fat tissue15. This factor is interesting in that human females tend
to have higher percentage of body
fat than males, whereas animal
studies have shown the opposite in
rodents, with males having a higher percentage of body fat15. These
contradictory results make it difficult to fully translate preclinical
animal studies to human studies
as we would expect to see opposite
results with regard to this factor.
Another factor to consider is age.
On a societal level males tend to
start drug use, in this case cannabis, at younger ages than females.
This earlier onset of use can lead
to long term issues being seen in
higher rates in males than females.
With respect to age it was also
found that CB1 receptor binding
increases with age, especially in
the memory, limbic, and motor
circuits14. This could indicate that
older cannabis users are affected
more than younger users and if
we connect this to the point about
females starting drug use at older
ages, it further indicates a greater
effect among women. While there
is not much human research that
also examined these factors, the
studies (both humans and animal)
that have provided a good look at
what can possibly be observed in
clinical studies.

Spotlight on Human Studies:
Sex differences in potential
therapeutic effects
While human research looking
at sex differences in the effects
of cannabinoids is far less extensive than that done in animals, it
is still important to look at what
has been found. Before we dive
into the therapeutic effects, let’s
discuss some of the overall trends
in cannabis use. A survey of over
2,000 cannabis users revealed that
men reported using cannabis more
often and in higher amounts than
women. Men were also more likely
to report using joints/blunts while
women reported using pipes or
oral administration more often6.
In terms of side effects, men were
more likely than women to report
increased appetite and improved
memory while high. Women,
on the other hand, reported side
effects such as loss of appetite6.
These results are from one survey
collected from a population in
Washington state and, while it is
not safe to generalize these results
to all cannabis users they offer a
quick glimpse into what cannabis
users might be experiencing and
how those experiences differ between the sexes.
Cannabis and its chemical components are believed to
provide several medical benefits
for medical issues such as chronic
pain, chemotherapy induced nausea, anxiety, PTSD, neurological
disorders and several other health
conditions21. It is important to
note that some of these conditions
have more research support behind

Figure 5 Taken from Fattore & Fratta
(2010).

them than others. Clinical trials
such as those conducted by Lynch
and Ware16 coupled with the reported use of cannabis to reduce
chronic pain6 provide support for
the pain relieving effects of cannabis. A 2008 study also suggested
that cannabinoids may be helpful
for women suffering from chronic
pain3. However, in another study
among daily cannabis smokers it
appeared that women were not
more sensitive to the pain relieving effects of cannabis. In looking
at the effects of cannabis on chemotherapy-induced nausea one
study found that based on self-reported measures of appetite women showed greater improvements
in appetite after an oral dose of
THC but no sex differences were
observed in ratings of nausea or
other measures17. From this data
it seems that while sex differences have been observed in some of
the proposed therapeutic effects
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of cannabis, they have not been
consistent. Due to these inconsistencies, more data is needed before
it is fully determined if sex should
be a factor considered in cannabis
use, medical or recreational.
But It’s Not All Good
While we can talk about the potential good associated with the
medical use of cannabis, we must
also discuss the negative side of it
use. One thing that has been suggested is that women may be more
sensitive than men to adverse effects such as dizziness induced by
cannabis exposure18. Chronic cannabis users have reported intense
bouts of vomiting and stomach
distress, which are symptoms collectively known as cannabinoid hyperemesis syndrome (CHS) and,
when reported, this condition is
more likely diagnosed in men than
in women3. With these adverse effects we must also talk about the
development of tolerance and dependence to cannabis, which are
both risks associated with its use.
The development of both conditions can lead to an increase in
cannabis/THC use, which is an
important issue to consider on
both the medical and recreational
sides of things. It has already been
shown that men have higher rates
of chronic use6 as well as longer
episodes of cannabis use disorder
(CUD) a condition associated with
the continued use of cannabis despite health distress19. A study that
looked at abuse-related subjective
effects showed that while males
and females did not appear to be
differently sensitive to stimulus
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effects of oral THC, women were
more sensitive to the lowest does
tested by the study and reported
higher ratings related to abuse liability20. An earlier study looking at
the effects of smoked cannabis reported that even though men and
women did not differ in ratings of
“intoxication”, females were more
sensitive to the subjective effects
as they related to abuse liability
which includes ratings of liking
the drug, and willingness to take
the drug again21. Sex differences have also been explored in the
craving for cannabis, which serves
as a measure of addiction severity.
One study found that there was
no difference between men and
women in their ratings for craving3, indicating that there was no
difference in chances of reinstating
drug use. However, another study
found that women had significant
decreases in compulsivity after
oral THC treatment compared to
men22, which can indicate higher chance of reinstating drug use.
Studies looking at withdrawal effects have also found differences
in the withdrawal effects reported by men and women. Men are
more likely report effects such as
cannabis craving and sleep disruptions than women, while women
are more likely to report nausea,
irritability and anxiety3. Unlike
the biological underpinning that
affects the three mechanisms discussed earlier in the paper the sex
differences in the effects in this
section are influenced by societal
structures that affect “acceptable”
drug use in certain groups or hinder the willingness to report health
issues to name a few.

Gender Influences on
Cannabis Use
With all the possible biological
mechanisms, the role of age and
weight, the differences in reported
effects, use, and adverse side effects
being considered, we must briefly
discuss how social factors can affect results, particularly self-reported data. One finding from
the Washington survey not mentioned earlier was that men were
more likely to report recreational
use than women, with women being more likely to report medical
use 6. While we may like to think
we’ve moved past gender norms
it is possible that women still feel
societal pressures creating the idea
that drug use among women is
not acceptable and are therefore,
likely to report recreational use.
This might change as legalization
of cannabis use spreads and as social change continues but is at the
moment still heavily influenced
by cultural/familial norms. When
it comes to self-reporting adverse
effects, gender norms can cause a
lack of confidence in men reporting their withdrawal symptoms
or other health issues caused by
their cannabis use, such as pain. If
men are less likely to report these
issues because of how they think
it would be perceived, then this
could skew results in the area. Just
when we thought we had enough
confounding factors to deal with,
the changing and variable gender-based social expectations surrounding cannabis use adds another.
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So, what does any of this mean?
Should sex be considered a
factor?
If we expect states around the
country to follow the lead of the
states that have already legalized
the use of medical and recreational
cannabis, it is important that we
understand not only the effects of
the drug but also the factors that
lead to those effects. One of those
factor is biological sex, and while it
may come with other confounding
variables, it should be a major factor considered when medical cannabis is prescribed to patients and
even in it recreational use. Cannabis is a difficult drug to study due
to the differences in legality across
the country and the terms of legality in states where it is legal (such
as being legal for medical use but
not recreational, or legal for both)
but an important drug to continue
to look at. As mentioned throughout the paper more concrete identification of sex differences in the
effects of medical cannabis could
have clinical implications. However, finding these sex differences are
not the final piece to the puzzle.
Once these differences are identified and shown to be significant,
it then needs to be determined
exactly how treatment and dosing
will change to accommodate for
them. For example, if large sex
differences are found in the potency and efficacy of medical cannabis, this could indicate the need to
increase drug dose/concentration,
which can lead to problems such
as tolerance and dependence. It
will be important for clinicians
to find the balance between doses

that are effective enough to overcome possible sex differences and
doses that produce tolerance and
dependence. So, with all this being said, if asked if sex should be a
factor considered in cannabis use,
my answer would be yes, and as
research related to cannabis and its
chemical components continues, I
hope that sex is incorporated into
both preclinical and clinical studies.
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Eureka
Zika!

How the feared virus may be
the key to treating Gliobastoma
By Samantha Palicz

W

ith the recent surge of
women in Central and
South America giving birth to
babies with abnormally small
heads, the Zika virus has become
a popular topic of discussion in
the media. The Center for Disease
Control has issued travel warnings
for pregnant women and those of
childbearing age regarding traveling to countries where Zika is
prevalent.1,2 The virus is a mosquito-borne infection that is spread
either from the bite of a mosquito
or passed sexually from one partner to another.1 For most, the infection goes either unnoticed or

results in mild flu-like symptoms.1
It is how the virus spreads from
mother to fetus during pregnancy that is concerning. But even
though the fears of pregnant women are justifiable, this virus may be
the key to unlocking a treatment
for Glioblastoma, a form of brain
cancer.
Zika and Pregnancy:
A terrifying tale
When a mother is infected with
Zika during pregnancy, it can
cause deleterious effects on the
fetus throughout development.

Among these are birth defects and
problems including miscarriages,
stillbirths, and extreme degrees of
microcephaly.1 Of these, the most
common and simultaneously severe birth defect is microcephaly.
Microcephaly can be simply defined as an abnormally small brain
that is indicative of incomplete
brain formation.1,2,3 Physically,
microcephaly is characterized by a
reduction in head circumference.
Behaviorally, microcephaly results
in motor, visual, hearing and cognitive impairments.3
The transmission of the
virus from mother to child during
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??

Did You Know?
The Zika virus has been
identified in and carried by
mosquitoes in Miami, Florida now.1

pregnancy results in these drastic
fetal brain abnormalities because
the virus can cross the mother’s blood to the developing fetal
brain.4 It remains unknown how
the virus is capable of this, but it
appears that the Zika virus then
only attacks undifferentiated and
still developing fetal brain cells
that would otherwise be growing
into brain cells with specific functions.5 It is these undifferentiated
brain cells that grow and form the
brain. The presence of the virus in
the brain is associated with both a
decrease in the production of and
death of the fetal undifferentiated
brain cells resulting in a smaller
and underdeveloped brain.
Recent reports from the
Brazilian Ministry of Health suggest that the number of cases of
microcephaly in newborns has
increased by a factor of about 20
with the presence of Zika.3 A research team followed the case of a
25-year-old pregnant woman who
was infected with Zika during

“The Embryo”
by gdakaska is
licensed by CC0.
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her first trimester. The researchers
wanted to look into the passing of
the virus from mother to fetus, as
well as, the effects of the virus on
the developing fetus.3 At 32 weeks,
fetal brain imaging showed evidence of brain abnormalities that
were indicative of severe microcephaly.3 The pregnancy was terminated at this point and further
studies were run.3 The results were
shocking. It was found that the fetus was only in the fifth percentile
for body weight and the head size
was in the first percentile.3 Furthermore, the placenta weight was
only in the third percentile and the
whole brain weight was four standard deviations below average.3
They also found that the Zika virus was local to just the brain and
not found in any other organs.
This is a very important finding as
it demonstrates that Zika only infects and attacks brain cells.
In a similar study, another
pregnant woman who contracted Zika early in pregnancy was
followed by researcher and they
found similar and equally upsetting.5 Between weeks 16 and 20 of
pregnancy, the fetal head circumference decreased from the 47th
percentile to the 24th percentile
and at 20 weeks, substantial brain
abnormalities were observed.5 The
fetus did not survive pregnancy
and postmortem analysis revealed
severe microcephaly and high levels of the Zika virus present both
in the placenta and in the brain
tissue.5 However, an important
finding was obtained from this
devastating case; the virus only
caused cell death in the undifferentiated fetal brain cells and not

“Microcephaly” by CDC is licensed by
Public Domain.

in developed brain cells.5 This was
apparent as no microscopic abnormalities were found in the eyes,
spinal cord, spinal nerves, or in
the well-differentiated neurons of
brain areas such as the basal ganglia and limbic.5
Why Zika is causing so much
trouble now
The Zika virus was first initially isolated in 1947 in Uganda so
why is it just now causing so much
trouble?3,5 From sequencing the
genome of Zika virus samples isolated from infected people and fetuses, researchers discovered that a
single change in a sequence of the
viral DNA that codes for a structural protein of the virus seems to
have occurred in 2013.6 It has been
proposed that this one mutation is
responsible for why the virus now
has the ability to aggressively attack fetal brain cells resulting in
the observed developmental abnormalities such as microcephaly.6
Studies involving mice, each with
a differently mutated strain of the
Zika virus, demonstrated that this

??

Did You Know?
Since 2013, there have been
just over 4000 cases of babies
born with Zika related to microcephaly.1
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one specific mutation causes the
most damage. This new, modern
strain of the Zika virus kills more
fetal brain cells than the ancestral,
or older, strain.6
A fear for some, but a blessing
for others
While the modern Zika virus has
calamitous effects on the developing brains of fetuses, in the near future, this feared virus may be an effective treatment for glioblastoma,
a deadly brain cancer. A research
group from Washington University School of Medicine in St. Louis
and the University of California
San Diego School of Medicine
has shown that the Zika virus kills
brain cancer stem cells.7 This is incredible as these stem cells are the
most resistant to the current treatments provided for glioblastoma.
Glioblastoma are brain
tumors that arise from cells in the
brain called astrocytes, which are
supportive, star-shaped cells found
in the brain.8 Glioblastoma are
considered especially dangerous
because they grow quickly.8 The
fast growth of these tumors results
in symptoms that are the direct
result of increased pressure on the
brain.8 Some of these symptoms
include headaches, dizziness and

sudden changes in vision.8 Despite the current treatment of surgery, chemotherapy, and radiation,
glioblastoma remain lethal with an
average survival rate of fewer than
two years.9
Every year, about 12,000
people are diagnosed with glioblastoma in the United States and it is
the most common form of brain
cancer.7 The standard treatment is
aggressive with surgery, followed
by chemotherapy and radiation.
Yet, most tumors recur within six
months and less than ten percent
of patients diagnosed will live to
five years post their diagnosis.8
The cancer is so aggressive in its
growth because the glioblastoma stem cells survive the current
treatments offered and continue
to divide, thus producing new tumor cells to replace the ones being
killed during treatment.8
Unlike other cancers, glioblastoma do not spread to other
parts of the body.9 In fact, in most
patients, the tumors continue to
grow from their original locations,
even after the majority of the tumor has been surgically removed.9
This is because glioblastoma have
root-like projections that contain
glioblastoma neural stem cells

“Glioblastoma” by Christaras A is
licensed by CC BY 2.5.

??

Did You Know?
Gliobastoma is the same
brain cancer that took the
lives of Ted Kennedy and
Gary Carter, and is the
cancer that Senator John
McCain was recently diagnosed with.

from which the tumor grows.8
The projections of glioblastoma
take root and this makes them
very hard to remove. Surgeons are
especially cautious when they are
removing tumors in brain regions
that control important functions
such as vision, language, and coordination.8,9 Since glioblastoma have this unique trait of not
spreading and regrow from their
roots, researchers have begun to
investigate using viruses as a way
to attack theses cancerous roots.4,9
The effects of the Zika
virus on fetal brain cells versus
developed brain cells has led researchers to think of the Zika
virus as a potential treatment
method for glioblastoma.9 This
may be possible because the virus
has shown to differentially attack
only fetal brain cells, such as neural stem cells. These types of cells
also happen to be the cells found
in the root projections of the glioblastoma tumors.
There are many similarities between glioblastoma neural
stem cells and the brain cells in a
developing fetal brain.9,10 Glioblastoma stem cells resemble fetal neural stem cells both in their
neurological origins and ability to
grow and create new cells.8 One
of the only differences between
the two is that neural stem cells
111

SCIENTIFIC KENYON

and fetal brain cells stop growing
in response to environmental cues
within the brain once they have
developed, whereas glioblastoma
stem cells do not respond to these
cues to stop growing.10 It was the
similarities between fetal brain
cells and glioblastoma stem cells
that led Dr. Zhe Zhu to consider
the potential use of the Zika virus to target and destroy the tumor-specific stem cells of glioblastoma.10
In lab studies, when Zika
was added to dishes containing
human glioblastoma stem cell cultures, the virus completely infected and killed the glioblastoma cells
and no regrowth was observed.9
When speaking about their results,
Jeremy Rich, M.S., stated that,
“Zika very specifically killed brain
tumor stem cells with little effect
on differentiated tumor cells and
adult neural cells.”10 Furthermore,
mice models with glioblastoma
tumors survived much longer
and at greater rates when injected with a mouse-specific strain of
Zika.9 These results suggest that
Zika can preferentially target the
glioblastoma stem cells that drive
tumor growth. Since traditional
treatment for glioblastoma fails
to eliminate the stem cells, the

“Planta Cérebro Coluna” by OpenClipart-Vectors is licensed by CC0.

tumors continue to regrow. By introducing Zika into the treatment
plan, the virus would help combat
this problem as it would attack
just the glioblastoma stem cells in
the roots of the tumor.
So, overall, how does this
work? When combined with the
current treatment methods, Zika
literally gets to the root of the
problem. When introduced to a
tumor, Zika spreads through the
tumor, infecting and killing the
tumor stem cells. Then a combination of radiation, chemotherapy, and surgery could be used to
kill the bulk of the tumor. Imagine
that your yard is full of dandelions. Sure you can temporarily get
rid of them by mowing or plucking them, but that is a temporary
fix. This is the same problem when
treating glioblastoma. Sure we can
remove the bulk of the weed, or in
this case the tumor, but if the roots
are left, the weed will grow back.
That is where Zika comes in. Like
a weed spray or a patient gardener, Zika gets down and kills at the
roots to prevent any regrowth.
What does this all mean?

Adapted from Zhu et al. (2017)
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Now that early studies have shown
that Zika specifically targets only
neural stem cells and has no effect
on differentiated brain cells, where
to next? First, more research needs
to be done before this becomes a
feasible treatment option because
we cannot just inject people with
the modern and active Zika virus
as it is now. Researchers are already looking into bioengineering
the virus to be more safe, while
still being as effective.10,11 They are
looking to introduce additional
mutations to prevent the infection
from spreading after being therapeutically introduced. Excitedly,
one of the researchers stated that
“Once we add a few more changes,
I think it’s going to be impossible
for the virus to overcome them
and cause disease.”7 Additionally,
the researchers are cautious as it is
possible that the virus may behave
differently than has been observed
when introduced to an active glioblastoma in a person.11 It is also
still unknown how long the virus
remains active once in the body.
Bioengineering: Making good
out of the bad
While this idea of using Zika, a
feared and dangerous virus, to
treat brain cancer seems revolutionary, researchers have actually

“Influenza Flu” by Sabine Kroschel is
licensed by CC0.
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been bioengineering treatments
out of deadly viruses and toxins
for quite some time. For example,
back in the 18th century, Edward
Jenner used cowpox to protect
humans against smallpox.12 Fast
Forward to the 1960s, and “vaccinating” was supported and campaigned for by the World Health
Organization and this resulted in
the elimination of smallpox.12 The
success of vaccines has also led to a
drastic decrease in the occurrence
of polio and measles and are also
proving to be helpful in preventing hepatitis B and human papilloma virus induced cancers.12 Recently, the measles virus has also
been bioengineered and may have
an ability to specifically target a
known marker for tumor-initiating cells in glioma, colon and hepatocellular cancer as evidenced by
success in mouse tumor models.13
In addition to the use of
viruses to fight cancers, over the
years, a neurotoxin has become a
popularly used substance to treat
a variety of disorders. Botulinum
toxin is the neurotoxin that is
responsible for botulism.14 The
toxin works by interfering with
the release of a neurotransmitter,
acetylcholine, that is responsible
for muscle function.15 The toxin
blocks the release of acetylcholine,

thus resulting in a form of paralysis.16 Botulinum toxin is one of
the most poisonous biological substances known, but bioengineers
and researchers have found a way
to harness the power of this toxin and turn it into a “miracle poison.”16 Botulinum toxin, or more
commonly referred to now as Botox, is now widely used to treat
a variety of medical conditions
including problems with muscle
spasticity, migraines, hyperhidrosis, and even for cosmetic purposes to reduce the effects of aging on
appearance.16
Botox has shown to be
beneficial and even life-changing
for people who suffer from cerebral palsy.17 Children with cerebral
palsy often suffer from spastic, or
rigidly tense, muscles.17 Despite
early interventions with physical
therapy and bracing, these tense
muscles can lead to permanent deformities in the legs and feet and
thus will negatively impact an individual’s ability to walk normally
or at all.17 This is where controlled
injections of Botulinum Toxin
Type A work as a therapeutic treatment. The toxin works by reducing the rigidity of the muscle and
the muscle tone by disrupting the
release of the acetylcholine that is

“Cerebral palsy” by National Institutes
of Health is licensed by CC BY-NC 2.0.

Did You Know?

??

Since 2000, Botox-A injections
have been the #1 medical procedure in the United States.18

causing the muscle contractions.
With muscles that over contract
and do not release, the toxin is a
blessing. Botox injections into the
leg muscles allow the muscles to
relax just enough to allow for the
development of proper walking
habits during physical therapy,
strengthening of surrounding support muscles, and improved balance.17 Together, this all leads to
an overall improved quality of life.
Botox has also become
a method of treating severe migraines. As with treating muscle
rigidity in patients with cerebral
palsy, botulinum toxin-A has
shown to reduce pain associated
with muscle spasms that can lead
to migraines.15 Controlled injections of Botox-A into the forehead
are effective in reducing migraine
frequency, severity, and associated
vomiting as it reduces muscle contractions believed to be causal, at
least in part, to migraines.15 Studies, like the one done by Dr. Stephen Silberstein, have also shown
that the toxin may be inhibiting
the pain pathway as well.15 Additionally, the effects seem to last for
up to 3 months at a time and with
limited side effects at proper dosage levels.15
As if helping kids with
cerebral palsy and lessening the
intensity of migraines were not
enough, Botox-A has also been
clinically proven to help those
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with hyperhidrosis (overactive
sweat glands).14 In addition to relaxing spastic muscles, Botox-A
also inhibits sweat gland activity.14
The inhibitory action of Botox-A
extends beyond muscles and includes inhibition of other nerve fibers such as those in sweat glands.
Hyperhidrosis commonly results
in the overproduction of sweat on
the hands, and/or forehead, and/or
underarms.14 Botox-A has shown
to be an effective method at temporarily reducing the amount of
sweat produced when other medical treatments fail. It is a more
feasible and less dramatic option
for many than having their sweat
glands surgically removed as some
level of perspiration is still necessary to cool the body and prevent
friction irritation.14 Controlled injections of Botox-A are effective for
many at reducing sweating when
injected into the hands, forehead
and/or underarms.14 A clinical
study demonstrated that Botox-A
was successful in reducing sweating with no reported side effects
and can last anywhere between 6
and 11 months depending on the
injection site.14
The future with Zika
The history and success of the clinical use of biologically engineered
viruses and toxins as treatments
speak for itself. These once feared
viruses and toxins have improved
and continue to improve the lives
of people of all ages, backgrounds,
and economic status worldwide. It
appears now, that the Zika virus is
next up to save lives, rather than
destroy them. With continued
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studying, the power of the Zika
virus may help cure brain cancer.
Viruses and toxins exist
in our environment and all function in specific ways with specific
targets. By further studying what
we biologically fear, not only can
we treat these infections more effectively, but we can also use these
viruses and toxins to treat other illnesses. It is feasible to believe that
within the next decade, the Zika
virus could be adding years to lives
by attacking and destroying cancerous tumor stem cells.
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The Enteric Nervous
System: Meet Your
Second Brain
By Sabrina Serrano

I

magine that it is noon and time
for your lunch break. You decide on eating something you
can buy quickly and easily, like
Taco Bell. After a few hours, you
notice that you are groggy, maybe
even sleepy, and are having a hard
time concentrating on work. You
also find yourself feeling more
stressed out than usual, Maybe it’s
because you’re not being efficient
enough. The only way you can

gain a temporary spurt of energy is
through a highly caffeinated drink
like coffee. You’re probably wondering... why is this happening? Did
I get enough sleep last night? There is
a good chance that your symptoms
of fatigue, stress, and inattentiveness could be due to processes
other than those occurring in your
head.
The Enteric Nervous System (ENS) is an autonomous part

of our nervous system that many
people are unaware of. An autonomous part of your nervous system that many people don’t know
, is the enteric nervous system, or
the ENS. The ENS has important
implications to complex cognitive
behaviors, such as stress and anxiety. The ENS is made up of all
of the neurons that activate your
digestive gut.1 Most of the func-
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Did You Know?
Your ENS, located in the digestive gut, has hundreds of
millions of neurons, or nerve
cells. This is about 1/200 of
the amount that your brain has
and about 5X as much as your
spinal cord!14
tions of your digestive system, including breakdown, movement,
and discharge of food, is completed through the activation of your
ENS.1 This part of your body is
more important than many people
realize: studies have shown that
the neurons in the ENS are highly
influenced by your gut’s bacterial
composition and nutrient composition.7 The ENS acts as a mediator between your central nervous
system (CNS) and the digestive
gut. That means any alteration of
the ENS will heavily affect both
the digestive gut and the CNS,
both crucial for bodily functioning. Therefore, in the context of
digestive pathology, even minor
pathologies like the “2pm energy
slump,” it is important to under-

stand the functioning and impact
of the ENS as well as its interaction with the digestive gut.
What makes up the ENS?
The location of the ENS exhibits
its importance in gut function.
The ENS is hugely important for
the activation of basic bodily functions such as movement through
the intestines, proper absorption of
water/electrolytes, and regulation
of local blood flow.4 The human
ENS is located in your gastrointestinal (GI) tract. The human GI
tract is made up of four layers: the
mucosa, the submucosa, the muscularis externa, and the adventitia/
serosa.3 The ENS is located within
2 layers of the GI tract, forming
two different plexi: the myenteric
plexi and the submucosal plexi.
The myenteric plexus, located
between the inner and outer and
muscle layers of the GI tract’s muscularis externa, is responsible for
muscular functioning. The other
plexus, the submucosal, located in
the submucosa, regulates the mu-

“Enteric Nervous System Plexus” is licensed by Creative Commons.
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cosal functions.2
Why is this important?
Nowadays, there are many disorders in which the ENS function is
abnormal, called enteric neuropathies.4 These enteric neuropathies
are much more familiar with the
common person’s ear than you
think. One of them is Irritable
Bowel Syndrome (IBS). IBS shows
symptoms such as abnormal bloating and the feeling that your food
moves too quickly or too slowly
through your digestive system,
causing unexpected changes in
your bowel movements.15 Public
health researchers have estimated
a 11.2% global prevalence of IBS,
or about 836,000,000 people!
Another major ENS neuropathy
is diabetic gastroparesis, which is
a disorder that slows or stops the
movement of food from the stomach to the small intestine. Diabetes itself affects about ~10% of the
global population, with the symptom gastroparesis affecting approximately 5-12% of the diabetic
population.6 Most major enteric
neuropathies are the result of improper communication between
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neurons in the ENS. This results
in subsequent dysfunction of the
digestive system, which is manifested through symptoms like
bloating, nausea, diarrhea, chronic pain, and sensitivity to foods.6
These neuropathies are also highly
correlated with having high rates
of depression, anxiety, and abnormal bacterial infections.15 However, not all symptoms of dysfunction of the ENS are necessarily
linked to having severe digestive
system disorder like IBS. Having
symptoms such as stress, anxiety,
or even inattention, could also be
the result of certain interactions
occurring within the ENS. With
such a high prevalence of people
having these symptoms, with varying severity, it is important to understand the different factors playing into proper ENS regulation.
Comprehension of these factors
will allow us to pinpoint possible
mechanisms that play into enteric
disorders and symptoms.
Food and the ENS
Have you ever heard the idiom,
“You are what you eat?” This serves
as a realistic interpretation of the
way in which your ENS is affected
by food. The kind of food we eat
has been shown to have correlations with, not only the functioning of our digestive system, but
also higher-order cognitive abilities, like memory functioning.
The Western Diet, which
consists of highly refined/processed foods with high sugar, fat,
and salt content, is a common diet
that makes up approximately 63%
of the US’s food consumption.16

“Average American Diet Infographic” is licensed by Creative Commons.

Studies have pinpointed significant correlations between the development of enteric neuropathy
symptoms and the consumption
of Western-like diets. One particular study conducted by Ohland
et al., tried to understand how
memory functioning and weight
gain correlated with a Western
diet. Ohland fed mice lacking the
IL-10 gene, a gene that predisposes them to digestive illness. They
found that the mice fed a Western
diet, lacking the IL-10 gene, had
decreased memory functioning,
specifically working and special
memory, only after a few weeks.7
They also found increased anxiety
behavior and weight gain in mice
fed a Western diet.7 Mice fed the
Western diet also had higher rates
of Proteobacteria, which is the major phyla of bacteria that include
pathogens such as salmonella and
E. coli, suggesting growth of “bad”

bacterial infection.7 This goes to
show that genetic predisposition
to enteric neuropathies, in combination with a Western-influenced
diet, has the ability to negatively
affect memory function. On top
of that, a diet high in fat and sugar
can increase symptoms like anxiety and weight gain.
Another study investigated memory function and bacterial
composition within high-fat (42%
fat), high-sucrose (66% sucrose),
and normal diets in mice. After
only two weeks of weaning on the
high-sucrose diet, mice had greater
difficulty with cognitive flexibility,
or the mental ability to switch between thinking about two different concepts, and to think about
multiple concepts simultaneously.8 They also found that the mice
had difficulty with their working
memory.8 They also found that,
when comparing the high-fat and
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high-sugar fed mice to the normal
diet fed mice, mice had greater
percentages of the bacteria Clostridiales and lower percentages of
the bacteria Bacteroidales.8 The
high presence of both of these
bacteria types were also correlated with poorer performance on
cognitive flexibility tasks.8 Even
though the exact function of both
of these strains of bacteria is not
precisely known, this study goes to
show that the even the most specific types and amount of bacteria
in the gut is very important for
proper functioning.
Both of these studies indicate that high-sugar and highfat diets, which are likely the diet
composition of whatever food you
are going to buy at fast-food chain
restaurants like Taco Bell, can have
a notable impact on your gut bacteria. Manipulation of your gut
bacteria has been shown to be
linked to higher-order cognitive
function, like long and short-term
memory as well as anxiety, making
it vital to understand how food affects the bacteria in your gut. Even
though none of the mice in these
two studies were diagnosed with

a specific enteric neuropathy like
IBS, it is important to note that
there are correlations with Western diets and cognitive functioning that begin to closely resemble
the symptoms of enteric neuropathies.
Gut Microbiome and the ENS
We have seen firsthand how diet
composition, specifically one filled
with high-sugar and high-fat, results in changes in higher-order
memory function, with possible
correlations to bacterial composition. Now let’s see specifically the
direct interaction between the gut
bacteria and the enteric neurons.
A 2014 study revealed that
the presence of normal bacteria
in your gut is important for the
formation of proper nerve density and formation in the ENS.10
They found that mice raised in
a bacteria-free environment had
decreased number of enteric neuron cell bodies in their small intestine.10 Bacteria-free mice also
showed decreased small intestinal movement compared to mice
raised in normal bacterial condi-

Licensed by Public Domain

tions, confirming that gut bacteria
is important for normal digestive
functionality. This is especially
applicable to neo-natal care unit
babies that are frequently given
antibiotics and raised in specific
hygienic environments that may
be inhibited from normal exposure
to microogranisms.12 These babies
may exhibit similar symptoms to
that of the bacteria-free mice who
were found to have ENS developmental defects.
Normal development of
the ENS is also needed for proper
maintenance of bacterial equilibrium. Another study that looked at
zebrafish lacking the gene, sox10,
which mimics the complete absence of a functional ENS, found
that the zebrafish had some specific bacterial strains exhibiting
overgrowth and others showing
undergrowth.12 This further suggests that bacteria are involved in
some of kind of intestinal homeostasis that is disrupted with lack of
regulation by the ENS.
What Can Probiotics Do?

“Good and
Bad Bacteria”
is licensed
by Creative
Commons.
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As mentioned earlier, gut bacteria
and the ENS have an important
interdependence, and if disrupted,
can significantly disrupt digestive
functionality. What is a way we
can heal this dysfunction? Multiple studies have looked at the effects of probiotics on dysfunction
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of the gut and enteric nervous
system. It has been found that
certain probiotic therapies have
the ability to restore some or all
normal digestive functions. However, some studies have also found
that probiotics work more significantly depending on your state
of health. In a study discussed
previously, it was found that the
probiotic treatment with L. helveticus significantly reduced gut
inflammation, corticosterone levels, and number of Proteobacteria
in the IL-10 gene deficient mice
on the Western diet.7 However,
this probiotic treatment increased
brain stress levels in WT mice fed
the Western diet, indicating that
probiotic treatment will differ in
effect depending on both the genotype and diet of the host.7 Another study looked at a probiotic
combination L. helveticus and B.
longum effects on stressed mice,
also revealing reduced corticoste-

rone levels.13 The probiotic treated group also showed restoration
of central neuronal activation and
neurogenesis.13 This is especially
important because chronic stress
often reduces the activation of the
hypothalamus, a part of your brain
important for memory and learning. They also observed decreased
corticosterone levels in the HPA
axis, which is heavily involved in
your body’s “fight or flight” response.13
Therefore, probiotic treatment, specifically through the
combination of the strains B.
longum and L. helveticus, can help
restore normal levels of stress required for proper behavioral functioning.13
Probiotic treatment therefore has the potential to ameliorate the negative symptoms caused
by both diet and environmental
stress. This is likely due to probiotics’ ability to restore normal gut

bacteria populations that subsequently allow for proper innervation of the ENS. This restoration
of normal innervation of the ENS
suggests that restoration of normal
digestive functioning is directly a
result of gut bacteria influence.
Conclusion
Given the large influence of both
diet and the gut microbiome on
the ENS, it is important to understand the ENS in the context of
understanding animal and human
behavior as a whole. Research has
shown that the ENS is an important regulator of not only digestive
but physical and psychological behavior.
There are numerous pathologies, as previously discussed,
that occur because of some abnormal interaction between gut bacteria and the ENS. These pathologies, although the direct cause not

“Gut and Brain Connection” is licensed by Creative Commons.
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completely understood, should be
more researched in a holistic context, where the emotional behavior, gut physiology, and lifestyle of
person are taken into account. Given the small amount of common
knowledge of the ENS throughout
societies, it is a field that needs a
lot more understanding of in the
context of larger neuropathology
and neurobiology fields.
Further study of the ENS
has potential to be incredibly important for human health. For
these reasons, the general public
needs to be better educated on its
existence and maintenance. Additionally, the significance of a
healthy diet on not just your physiological health but also your mental health needs to be stressed.
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THE GOOD,
THE BAD,
AND THE
CORTISOL
By Christina Ennis

T

hink about the last time you
felt stressed. Did your heart
beat faster? Did your stomach tie into knots? Maybe your
hands went cold, or possibly started shaking? The brain is in control
of all of these physiological changes, and is actually trying to help
you survive what it interprets as a
potentially life-threatening situation. It’s commonly thought of as
the fight-or-flight response; either
your body prepares to run away
from the problem or readies itself
to stay and tackle the threat.
The pathway in charge of
this response is known as the hypothalamic-pituitary-adrenal axis,
or the HPA axis for short (see
Figure 1). It is so important for
survival that it has been conserved
by evolution, appearing in some
form in even the earliest of vertebrate species (Denver, 2009). The
HPA axis consists of a complicated
series of steps that begin in the hypothalamus, where a specific group
of cells secrete corticotropin-releasing hormone. This hormone

is then able to travel through the
brain to reach the pituitary, which
is the pea-sized gland sitting just
behind the bridge of the nose.
Once the corticotropin-releasing
hormone interacts with this gland,
it stimulates the release of adrenocorticotropic hormone. Because
of the location of the pituitary, adrenocorticotropic hormone is able
to be transported throughout the
body until it eventually finds cells
on the adrenal cortex with which it
can interact. This hormone works
to stimulate the production of the
steroid hormone cortisol. Once
cortisol enters the bloodstream, it
has significant effects all over the
body.
The Many Roles of Cortisol
Cortisol greatly impacts both metabolism and digestion. Specifically, it is associated with glucose,
the sugar that converts into every
cell’s energy supply known as adenosine triphosphate. Cortisol,
by influencing gene transcription,

stimulates gluconeogenesis, which
is the process of forming glucose
from precursors other than carbohydrates, during periods of fasting
(Khani & Tayek, 2001). This response allows the liver to use glucose that the peripheral tissue does
not need and converts it into liver
glycogen, thus preparing the body
should it encounter a food shortage and starvation (Barcellos et al.,
2010). In addition, cortisol plays
an important, though indirect, role
in both liver and muscle glycogenolysis, which is the breakdown
of glycogen once the body needs
to use its stored glucose (Barcellos
et al., 2010; Coderre et al., 1991).
Cortisol is able to do this by influencing and interacting with glucagon, the hormone that regulates
the usage of glucose (Lecavalier et
al., 1990). Because of the many
interactions between cortisol and
glucose, researchers believed and
have, ultimately, demonstrated
that HPA axis activity is enhanced
in many patients with diabetes
(Chiodini et al., 2015).
Besides affecting glucose
processes, cortisol influences electrolyte balance. Cortisol is a diuretic, preventing cells from losing

Did You Know?
Some scientists believe that cortisol’s
original purpose may have been
sodium transport. They have found
that freshwater fish use a cortisol-based system to bring sodium in,
whereas saltwater fish use it to expel
extra salt (Laurent & Perry, 1990;
Maetz et al., 1967).
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sodium as well as promotes potassium excretion, thus helping to
regulate bodily pH (Knight et al.,
1955). Maintaining a pH between
6.0 and 7.5 is important because
of the negative consequences of
having too much acid, known as
metabolic acidosis, or bicarbonate,
known as alkalosis, in the blood,
which range from muscle twitches
to lung collapse (Arruda & Kurtzman, 1977).
Cortisol also affects the
immune system. It prevents the
release of substances that cause
inflammation, such as IL-12,
interferon, IFN-gamma, and
TNF-alpha, by antigen-presenting cells and Th1 cells, while also
upregulating anti-inflammatory
substances, such as IL-4, IL-10,
and IL-13, by Th2 cells (Elenkov,
2004; Franchimont, 2004). Because of these effects, cortisol is
often used to treat conditions such
as rheumatoid arthritis, vasculitis,
lupus, and allergies, as well as skin
problems like rashes and eczema
(Vane & Botting, 1987).
Circadian rhythm is also
greatly impacted by cortisol. Normal cortisol secretion, meaning
when it is not induced by the activation of the HPA axis, undergoes diurnal variation: the levels

peak around 8:00am and bottom
out around midnight (Chung et
al., 2011). This pattern contrasts
that of melatonin secretion, with
melatonin being the hormone responsible for regulating sleepiness
and wakefulness. In the morning, melatonin levels are low, and
eventually rise at night once the
brain’s pineal gland is activated by
the hypothalamus (Monteleone et
al., 1992). Researchers have found
that cortisol and melatonin actually work to counteract each other,
with a high concentration of one
inhibiting the activity of the other
(Monteleone et al., 1992; Zisapel
et al., 2005).
Finally, cortisol works to
inhibit the further production of
itself in a negative feedback loop
(see Figure 2). The presence of
high concentrations of the hormone within the bloodstream inhibit the release of both more corticotropin-releasing hormone and
more adrenocorticotropic hormone (Gold et al., 2002; Wood
& Rudolph, 1983). There are
similar points of negative feedback
along the HPA axis, namely how
high concentrations of adrenocorticotropic hormone prevents the
secretion of additional corticotropin-releasing hormone (Abelson

Figure 2 Here, you can see the many negative feedback loops (pictured in pink) involved in the HPA axis. Created by Christina Ennis.
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et al., 2007; Yehuda et al., 2006).
These loops exist because of the
dangers associated with high levels of cortisol, and actively work
to ensure that these levels are not
reached.
Stress and Development
Researchers have found that prenatal stress can influence HPA
axis regulation after birth and later in life. In animal experiments,
exposure to prenatal stress causes a hyperreactivity of the HPA
axis. Prenatally stressed rats, for
example, have higher basal levels
of corticosterone, their version of
cortisol, as well as abnormal circadian rhythms (Koehl et al., 1999).
They also require a longer period of
time after the presence of a stressor
for their hormone levels to return
to their baseline. Other studies
have demonstrated that prenatally
stressed animals have high blood
glucose levels, as well as have fewer
glucocorticoid receptors in some
areas of the brain (Weinstock et al.,
1992). Switching over to human
studies, there is growing evidence
that prenatal stress impacts HPA
axis regulation. Children that
were stressed prenatally have been
shown exhibit abnormal cortisol
rhythms (Glover et al., 2010; Gutteling et al., 2005). Additionally,
prolonged maternal stress is associated with mild impairments of
intellectual activity and language
development in their children,
and is linked to disorders such as
attention deficit hyperactivity disorder, schizophrenia, anxiety, and
depression (Weinstock, 2008).
However, the effect of early
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life stress on HPA axis functioning
is less understood. Differing levels
of stress seem to have opposing effects later in life: exposure to mild
or moderate stressors early in life
enhance HPA regulation whereas
early-life exposure to extreme or
prolonged stress can induce hyperreactivity of the HPA axis and thus
contributes to a lifelong vulnerability to stress (Flinn et al., 2011;
Liu et al., 1997). Several mechanisms have been proposed to explain these conflicting impacts of
stress. Some believe that there is
a critical period of development in
which the levels of stress hormones
within the bloodstream permanently calibrate the functioning of
the HPA axis (Champagne et al.,
2003; Macrì & Würbel, 2006).
Others, however, hypothesize that
such effects are mediated by maternal care, either through inducing
epigenetic changes or promoting a
sense of calmness in the offspring
(Champagne et al., 2003; de
Kloet et al., 2005; Schechter et al.,
2015). Whatever the cause, prolonged early life stress is thought
to sensitize the HPA axis, thus resulting in the hypersecretion of the
various hormones involved in the
pathway. This aspect of sensitization is supported by the findings
that adulthood victims of childhood abuse have increased concentrations of adrenocorticotropic
hormone and corticotropin-releasing hormone after exposure
to a psychosocially stressful event
(Heim et al., 2001).
Hyperactivity of the HPA Axis
You may be wondering why

Did You Know?
Yoga and meditation have proved to be effective techniques in reducing stress and regulating HPA axis stimulation. It also triggers alpha brain wave activity, which
is thought to promote relaxation and creativity while
minimizing depression (Kamei et al., 2000).

non-life-threatening events, such
as a meeting with a boss or a final
exam, are able to trigger the activation of the HPA axis, and thus
the production of cortisol, in some
people. In the face of periods of severe stress during adulthood, such
as those caused by negative work
or family relationships or combat
exposure for example, the dynamics of the HPA axis change (Stephens & Wand, 2012). Specifically, chronic stress triggers a shift in
the normal diurnal release of cortisol as well as in the stress-induced
levels of this hormone (Juster et
al., 2011; McEwen, 2007; Stephens & Wand, 2012). In short,
this means that chronic stress increases the baseline levels of cortisol in the body while also increasing the sensitivity of the HPA axis,
resulting in its activation during
times where typically it would and
should not be. It is here, when
the HPA axis is inappropriately or
persistently activated, where problems start to arise.
Clearly, the hyperactivity
of the HPA axis has a role in anxiety disorders. Anxiety disorders,
including generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, posttraumatic
stress disorder, and social phobias,
are the most common psychiatric
illnesses, affecting up to 33.7% of

the population (Bandelow & Michaelis, 2015). Often, these maladies are treated with drugs such as
selective serotonin-reuptake inhibitors and benzodiazepines, which
work by altering the levels of neurotransmitters able to interact with
brain cells. However, researchers
have identified a secondary action
of these drugs: they correct HPA
axis hypersensitivity (Lenze et al.,
2011; Lopez et al., 1990). These
findings are significant because the
process of directly assessing HPA
axis functioning is difficult and
complex. Since this pathway is
activated during stress, measuring
cortisol levels in the bloodstream
after exposure to various triggers
would be too specific to each individual since not everyone has the
same reaction to the same stimuli, if not cruel to all of the participants of the study. Therefore, the
ability to study HPA axis dysfunctioning in patients with anxiety
disorders through their treatment
plans is optimal.
In addition, the HPA axis
has been shown to dysfunction
during psychotic episodes. One
model of psychosis posits that predisposing biological factors make
some individuals more sensitive
to stress, and thus more vulnerable to developing psychosis after
stressful events (Mondelli et al.,
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with autoimmune disorders. The
treatment options for this disease
are limited, with surgeries resulting in complete remission in 60%
of cases (Sharma et al., 2015).

Did You Know?
Caffeine stimulates the release of
cortisol. However, if you consume
moderate levels of caffeine, meaning
300 mg, or three cups of brewed
coffee, daily, then cortisol secretion
is less than if you do not (Lovallo et
al., 2008).
2010). Following this assumption,
first-episode psychosis patients display HPA axis hyperactivity and
high basal levels of cortisol, acting
as both a causal and exacerbating
factor of their clinical symptoms
as well as cognitive impairments
(Gallagher et al., 2007; Herz et
al., 1985; Lammers et al., 1995;
Sachar et al., 1970; Tandon et al.,
1991). However, some theorize
that this hyperactivity contributes
to the pathogenesis of psychotic
disorders by increasing brain dopaminergic activity (Mondelli et al.,
2010; Walker & Diforio, 1997).
This idea is supported by the fact
that antipsychotic drugs, in addition to regulating dopamine levels, have a secondary function of
lowering HPA axis activity (Cohrs
et al., 2006; Lammers et al., 1995;
Mondelli et al., 2010).
HPA dysregulation has
been identified in many other
mental health disorders. In particular, depression has been extensively studied as cortisol has a
multifaceted role in its symptomatology. In over half of the cases
of major depression, the diurnal
rhythms of this hormone is disturbed and the negative feedback
loops that prevent its accumulation are nonfunctional (Burke et
al., 2005; Herbert, 2012). Addi-
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“Coffee” by Julius Schorzman” is
licensed by CC BY-SA 2.0.

tionally, patients with major depression have been shown to have
significantly higher levels of cortisol than in those with either panic
disorder and schizophrenia (Yehuda et al., 1993). It is thought
that cortisol contributes to major
depression by altering the volume
and metabolism of various brain
regions, including the prefrontal cortex, the amygdala, and the
hippocampus (Gold et al., 2002).
Interestingly, cortisol has been
shown to activate the genetic basis of major depression in the same
way as environment events amplify the risk of this disorder, with its
influence beginning prenatally but
continuing into adulthood (Herbert, 2012).
However, there is a disease
in which cortisol hypersecretion
is present without a hypersensitivity of the HPA axis: Cushing’s
syndrome. This disease, though
rare since it affects on average only
one person per million per year,
can have devastating effects on the
health of those affected by it (Sharma et al., 2015). Cushing’s syndrome is usually caused by a tumor
somewhere along the HPA axis,
such as on the pituitary or adrenal
glands, or is induced by high levels
of exogenous glucocorticoid exposure, as is the case in some patients

At this point, you may be thinking that cortisol is a dangerous
hormone, and that less of it would
lead to a healthier and happier
life. However, this is not always
the case. There is a life-threatening disease, known as adrenal insufficiency or Addison’s disease, in
which the adrenal glands do not
function properly, resulting in the
body producing too little cortisol.
Affecting only 100 people per million, it impairs quality of life by
causing problems with circadian
rhythm, weight loss, low blood
pressure and sugar, as well as triggering stomach issues (Bensing et
al., 2016).
Just as in hyperactivity,
there are also disorders in which
the HPA axis is abnormally inactive. Perhaps the most common of
these is chronic fatigue syndrome,
as it affects nearly 5% of the population (Johnston et al., 2013). Researchers have demonstrated that
the HPA axis in patients with this
disease have low basal evening levels of cortisol, yet high basal evening levels of adrenocorticotropic
hormone, and even hypothesize
that the disease is in fact caused by
problems in this pathway (Demitrack et al., 1991).
The Bottom Line
Clearly, the HPA axis has a signif-
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icant impact on multiple aspects
of both physiological and mental
health. Though cortisol gets a bad
reputation, with multiple vitamin
and drug companies claiming that
it is at the root of any issue you may
encounter, this is not true. It is
only in the presence of chronically
high or low levels of this stress hormone where such problems arise.
However, that does not mean to
say that stressful periods are in
isolation healthy. While they are
necessary for both motivation and
even survival, times of stress can
result in discomfort and ultimately
lead to the development of various
disorders, including anxiety and
depression. So, the next time you
notice that you’re feeling stressed,
take into account the processes going on within your body and the
damage you may be causing if you
let stressors affect you too much.
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Hugs vs. Drugs
How zebrafish and the science of social attachment can help us understand America’s opioid epidemic
By Eduardo Vargas

Setting The Stage

T

he United States has a problem with drugs — specifically a $78.5 billion opioid drug
problem. Legally available only by
a physician’s prescription, many
synthetic opioids such as oxycodone (Percocet) and hydrocodone (Vicodin) are used to mitigate moderate to severe pain, and
in 2015 they were prescribed to
around 38% of American adults.1
Just last year, one in eight patients
were shown to misuse prescription
opioids, and of approximately one

million opioid overdoses, 64,000
resulted in death.2 A study by the
University of Pittsburgh in October 2017 identified how different
demographic subsets of the population are affected by the opioid
crisis (Fig. 1). These sub epidemic
statistics show that there is a soaring death toll caused by fentanyl.
These studies also report that contrary to the popular media narrative of the average overdose victim being middle-aged, rural, and
white, fentanyl and heroin victims
are actually younger, urban, and
more racially diverse.3 Additional-

Figure 1 Data collected by the CDC displaying death rates by overdose of different
opioid types. Not pictured is data from 2016-17, which shows that deaths from other
synthetic opioids such as fentanyl have far surpassed prescription-based overdose.2
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ly, it has been reported that most
victims are not chronic pain patients themselves but friends or
family of patients that obtain pills,
with some reports of people taking
veterinarian-prescribed medicine
from their pets.4
To tackle this massive epidemic, over the last couple of
years the FDA has supported new
proactive solutions to drug addiction aimed at preventing abuse
of prescribed opioid analgesics to
reduce the impact of drug abuse
on American individuals and families. Among these initiatives is
the push for more widespread use
of non-opioid painkillers, prioritizing the development of “additional alternative medications that
alleviate pain but do not have the
addictive properties of opioids”.5
Although the problem has been
clearly identified, both the impact on health and the economic
fallout are increasing the need for
comprehensive approaches to addiction treatment, and scientists
are racing to find the multi-billion
dollar solution. To understand the
behaviors of addiction in humans,
many drug studies on animal models have begun to show promise
for understanding the underlying
mechanisms of addictive behavior,
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and zebrafish provide interesting
opportunities for this kind of research.

The Case for Zebrafish
Neuropharmacologic
research
of drugs often relies on animals
to model the behaviors induced
by the drugs in question, and zebrafish (Danio rerio) happen to be
good behavioral models. Sometimes referred to as the ‘new lab
mouse,’ zebrafish are relatively
easy to raise in large quantities,
can be modified genetically, and
have neural mechanisms that respond to drugs in similar ways as
human mechanisms (Fig. 2). With
a 70% similarity in their genome
to humans, zebrafish brains conserve the dopaminergic and glutamatergic projections involved
in reward pathways found in humans, and display the same μ-opioid receptors that interact with
the synthetic opioid drugs such
as hydrocodone.6 More than just
having the same cellular and molecular underpinnings, zebrafish
are also capable of displaying behavioral hallmarks of addiction to

Figure 2 The zebrafish (Danio rerio) is
a type of tropical freshwater minnow,
averages around 4 cm in length, and has
lateral stripes of pigmentation. Their
genome has been fully sequenced, making them ideal for genetic studies and
manipulation. Image taken by NICHD,
licensed by CC BY 2.0.

drugs. Among these hallmarks of
addiction are differences in various
swimming behaviors and social
group behaviors.
The best evidence to support zebrafish as relevant addiction models was found in August
2017 at the University of Utah
by researchers who developed an
opioid self-administration assay
using zebrafish.7 First, the zebrafish were trained to swim over one
of two active squares in their tank
to trigger a food reward. Paired
with a light cue, the trigger was
activated by camera that detected the zebrafish swimming above
the correct square. The zebrafish
could not randomly swim over
the active platform, since a computer would calculate whether the
zebrafish were swimming above
the platform more than a pre-programmed threshold. Once the
zebrafish were trained to use this
trigger mechanism, the researchers tested whether they would do
the same if the trigger released an
opioid drug instead of food. Their
results showed that the zebrafish
would consistently swim over the
drug active platform, even when
the zebrafish were given obstacles
to the task. For example, the researchers attempted to keep the
fish from activating the platform
by placing it at an uncomfortably
shallow level in the tank, but the
fish still swam over it to receive
the drug. They performed another
test in which the fish would have
to progressively activate the camera an increasing number of times,
and the fish were still more likely
to continue to trigger the platform
until the drug was released. The

researchers, Dr. Gabriel Bossé &
Dr. Randall T. Peterson, claim that
this is indicative of drug-seeking
behaviors, especially given that the
zebrafish were displaying characteristics that resemble addiction.
The zebrafish had to actively perform a specific behavior to secure
the drug, and after long term exposure they would show heightened anxiety as measured by a reduction in exploratory behavior.
To ensure that their findings were a direct result of the
drug, the researchers also tested
whether the same behaviors were
observed when the zebrafish were
treated separately with naloxone
(an opioid drug antagonist), and
NMDA and dopamine receptor
antagonists which would effectively stop the reward pathways. Their
findings were consistent with what
was expected, and in all three cases
the treatment effectively removed
the zebrafish’s preference to activate the drug-releasing platform.
In the final part of the
study, zebrafish had been pre-exposed to hydrocodone and were
essentially made addicted to it. The
behavior of this treatment group
was tested against a naive group
that had not been exposed to any
kind of drug, but was trained to
use the triggering mechanism.
The dependent variable measured
was each group of zebrafish’s social cohesion, or shoaling (Fig. 3).
Like many other fish, zebrafish
are known to form shoals in the
wild for various benefits, such as
procuring food in new environments. Shoaling has been identified as a potential social behavior
in zebrafish, so the researchers
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Figure 3 Forming shoals provides
zebrafish with many fitness advantages,
including safety from predation, exploration of novel environments, and recovery
of food. “Zebra Fish” by Oregon State
University is licensed by CC BY-SA 2.0.

sought to compare how the behavior changed when groups were
affected by opioid exposure.8 By
measuring the space in between
each fish with computer tracking,
they found that the zebrafish that
had been preconditioned with
hydrocodone but were no longer
exposed to it displayed more anxious behavior and a closer, tighter
shoaling group indicative of withdrawal. By contrast, the group that
wasn’t exposed to hydrocodone
in the long term formed a looser
shoaling group, and displayed generally more exploratory behavior.
The findings of this study
provide strong evidence for zebrafish as a bona fide model for
studying drug addiction. But as
concrete as the evidence is for zebrafish to experience addiction and
withdrawal to opioids, how much
of this information can inform our
understanding of drug-seeking behavior in humans?

How Opioid Addiction
Works
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The neural mechanisms of addiction are well studied, especially
the pharmacokinetics of drugs of
abuse involving the dopaminergic
projections in the brain. An opioid
analgesic drug such as oxycodone
will act on the three kinds of opioid receptors in both the peripheral and central nervous system:
the mu-, delta-, and kappa- opioid
receptors. These receptors already
naturally interact with endorphins
secreted as an endogenous form of
pain relief — these are the same
neurotransmitters responsible for
the oft cited ‘runner’s high’ —
and they function by blocking the
sensation of pain by reducing a
neuron’s excitability, preventing it
from firing an action potential.9
Opioid drugs act on the
same exact neuron receptors, and
have slightly different mechanisms
of action depending on where in
the synapse they act. Binding to
the pre-synaptic opioid receptor
of dopaminergic neurons increases the release of dopamine in the
synapse. As it activates the next
neuron in the dopaminergic reward pathway, it is experienced
as a pleasurable, euphoric sensation. When the opioid binds to
post-synaptic opioid receptor, it

Figure 4 Acetaminophen/oxycodone
pills, a combination of and opioid and
non-opioid, commonly pr scribed for
pain relief. Image by Michelle Tribe,
licensed by CC BY 2.0.

antagonizes several different receptors and prevents them from receiving neurotransmitters, meaning that when acting on neurons
and interneurons responsible for
nociception, it will reduce the sensation of pain.9 This is where the
drug’s medicinal properties come
from.
To repeat this high, opioid users will need to continually
take higher and higher drug doses, which is due to the plasticity
of neurons. Over a long period
of sustained drug intake, the increasing amounts of dopamine
present in the synapse causes the
neurons to increase the number of
auto-receptors to compensate for
the excess neurotransmitter. The
increase in auto-receptors means
that dopamine is more likely to be
taken back up into the cell, so it
will be removed form the synapse
at a normal rate, thus diminishing
the euphoric feeling. This change
in receptors available is the pharmacodynamic basis of tolerance
(Fig. 5). The user may then compensate for this change by increasing their intake, further increasing
their pharmacodynamic tolerance
to the drug and, if enough of the
drug is available, becoming dependent on it to the point of addiction. The spiral of addiction is continued because the user is avoiding
the adverse effects of withdrawal,
and continuing to seek the reward
associated with the drug intake experienced in the earlier stages of
drug abuse.
Although we understand
how tolerance and addiction go
hand in hand at the molecular, cellular level, and behavioral level, not
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as much attention has been given
to the environment surrounding
the person suffering from opioid
addiction. As the more widely accepted behavioral model of alcoholism suggests, when looking at
addiction treatments we should
not only look at biological and
genetic mechanisms that facilitate
addiction, we should also take into
account the interactions between
the individual’s behavior, their
biology, and their environment.
One potential gap that remains to
be filled in the opioid crisis is an
understanding of the relationship
between addiction and social attachment, and zebrafish may help
us study the extent to which addiction is a product of biology and
the extent to which it is a product
of a person’s social environment.
Since previous research has already
established the hallmarks of the

Figure 5 Pharmacodynamic tolerance
occurs when a neuron compensates for
the effects of a drug by increasing or
decreasing the number of receptors available for the neurotransmitters involved.
Here, dopamine receptors are increasing
in response to the increased amount
of dopamine available in the synapse.
Image by National Institute on Drug
Abuse, licensed by Public Domain.

zebrafish’s social and addictive behavior, there is opportunity to use
these animal models to test out
different interactions between the
social environment and the chronic effects of drugs.

Addiction as a Form of
Social Attachment
We can take a look at this exact interaction by looking at how social
attachment and oxytocin can protect against addiction and stress.
Oxytocin is a type of neuropeptide
and hormone that, while implicated in many brain activities, is paramount to successful pair-bonding,
such as a mother-child bond, or
lifelong monogamous pair-bonding in voles.10 In these social interactions heavily involved in
reproductive success, oxytocin
receptors become up-regulated as
oxytocin availability increases.11
Oxytocin has also been implicated in learning and memory, which
has led some researchers to explore
how it affects the “learning and
memory processes involved in the
mechanism by which the addictive drug maintains control over
behavior”.12 While relatively little
is known about the direct mechanisms through which it could
affect addiction, research on oxytocin has found that it does have
a measurable effect on addiction.
One review of the literature found
that, regarding oxytocin, “in general, when the social interactions
occur outside of the drug-taking
context, positive, prosocial interactions are protective against drug
abuse-related behaviors, whereas social stressors facilitate these

behaviors”.12 In other words, the
presence of oxytocin can indicate a
social reward that can, to some extent, mitigate or even suppress the
reward of a drug-induced high.
Researchers at VU University Amsterdam further explored
the affiliative aspect of oxytocin,
and examine further evidence for
its palliative effects on addiction
processes. As it is heavily involved
in the formation of social bonds,
oxytocin specifically “is thought
to increase interpersonal trust, to
reduce stress responses, and to increase resilience, while protecting
against drug addiction and negative health effects of stress”.13 Their
research centers on the theory that
when people or other social beings
forge close and supportive social
relationships, they shift from novelty-and reward-seeking behaviors
to an appreciation of familiarity.13
The researchers attribute this shift
to the ventral and dorsal corticostriatal systems of the brain. The
corticostriatal pathway is a reward
circuit in the brain in which the
striatum receives the dopaminergic and glutamatergic signals mentioned previously. According to
the researchers, the positive and
euphoric rewards produced by
novel experiences corresponds to
heightened dopaminergic activity in the ventral striatum pathway, and it occurs when new social bonds are being formed. The
dorsal striatum pathway becomes
involved when the novelty seeking
behavior begins to shift from impulsivity to compulsivity.13 These
pathways can also apply to when
an individual is exposed to rewarding drug effects. At first, rec-
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reational use of a drug falls in line
with the novelty-seeking behavior
supported by the ventral pathway,
but over time, as the user begins to
seek out the drug out of compulsion to escape effects of withdrawal, their attachment to the drug is
maintained by the dorsal pathway.
These explanations of the behavioral underpinnings of addiction
suggest that a lack of social attachment can increase sensitivity to
drug addiction.
In mice studies, individuals experiencing various forms of
stress were more likely to become
addicted to drugs.12 It is easy to
imagine how this can apply to humans as well. We are familiar with
the narrative of individuals dealing
with economic hardship or social
isolation finding it easier to fall
into the downward spiral of addiction. Thinking of these behaviors
in terms of brain pathways can
give us a more nuanced picture of
how an individual’s social bonds
and environment can have an impact on addictive behavior. We can
begin to change our understanding
of addiction as a strictly biological
disease to include a model of addiction as a form of social attachment. If the presence of oxytocin
stemming from strong pro-social
bonds protects from stress and addiction, then what does this mean
for how we approach addiction
treatments moving forward?

The Future of Addiction
Treatment
The biosocial understanding of
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how opioid addiction functions
can have profound implications for
how we approach addiction treatments. In fact, the authors of the
study from Amsterdam University
urge other scientists to apply their
findings to animal models of addiction. The zebrafish model could
be a useful organism to use for this
type of research. As the self-administration assay showed, they
can display hallmarks of social, addiction, and withdrawal behaviors,
so they may prove useful in for exploring how social attachment and
cohesion play a role in addiction.
They could even help scientists
come up with novel, holistic solutions to treating addiction.
The rise in opioid overdose
victims has already pushed physicians to research new treatments
for addiction. Cannabis, for example, is gaining popularity as a
treatment since it helps victims
come off of their opioids without experiencing the debilitating
effects of withdrawal. In some
cases, other drugs such as weaker
opioid derivatives have been used
for a similar purpose, but with less
promising results. What might
treatment look like if we can take
a more interdisciplinary approach
to treating a person’s addiction? It’s
possible for the answer to be hidden in zebrafish, or another viable
animal model. While the solutions
remain varied and elusive, the concrete reality is one: the opioid crisis
is one of our generations biggest
unforeseen problems, and it will
require concerted contributions
from many fields before we start
seeing positive results of a similar
magnitude.
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TIRED TREMORS
Parkinson’s and
Sleep Disturbances
By Julia Wilson

W

e have all experienced the
pain of a sleepless night,
and thus we can all understand the consequences it has
on our cognitive, emotional, and
physical abilities. Sleep is, after all,
a vital physiological function, and
most of us feel deleterious effects
if we get about 2-3 fewer hours of
sleep than normal.
Now imagine if your sleep
was restless and disturbed for years
at a time; not only would this
disrupt your daily routine, but it
would begin to chip away at your
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physical and emotional well-being.
Many Parkinson’s patients
experience such a struggle. Parkinson’s is a chronic disease characterized by neurodegeneration,
which is premature deterioration
and death of neurons. Dopaminergic neurons, which produce
the neurotransmitter dopamine
and are most notably involved
in producing motor movements
and controlling mood, are the
primary cellular victims of this
process of neurodegeneration1.
Over time, neural degradation in
Parkinson’s produces symptoms
such as tremors, gait and posture
abnormalities, depression—and
sleep disruptions (see Figure 1).
The underlying cause of the disorder is still unclear, which presents
a challenge for research on and
treatment of symptoms1. Nonetheless, examining the etiology of
symptoms such as sleep disorders
in Parkinson’s is an important task.
Not only would clinical populations such as Parkinson’s patients
benefit from such an investigation,
but it would also provide us with
a more comprehensive view of
how sleep works, which is another
murky scientific subject. Thus, in-

formation from this research could
be used to develop treatments and
interventions for sleep disorders,
but it could also be applied to
non-clinical populations. Everyone sleeps—or at least everyone
should.
What is sleep and
how does it work?
Before we discuss the neural and
biological underpinnings of sleep
disruption in a clinical population, it is important to understand
what typical and atypical sleep
look like. Why we need sleep is still
a question shrouded in mystery.
Insufficient sleep can cause problems with the immune system, irritability, impairment in cognitive
processes such as memory, etc.2.

Figure 1 Cartoon depicting reduced dopamine in the substantia nigra and in a
close-up of the synapses, leading to movement disorders.16
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However, there is not a definitive
etiology of these effects. In other
words, sleep is clearly necessary for
normal, healthy functioning, but
we are not sure exactly why that is
the case.
Brain regions involved in
sleep. Sleeping and waking is regulated by the reticular activating
system (RAS) in the brainstem,
and other sleep-regulating areas
of the brain, such as the thalamus,
hypothalamus, spinal cord, hippocampus, and suprachiasmatic nucleus. Cells in the suprachiasmatic
nucleus regulate melatonin release,
which is a chemical that makes us
feel sleepy2. Anyone who has ever
experienced jetlag can attest to the
fact that melatonin is an important chemical, and when its cycle
of release is thrown off (by travel
or other factors, such as disease),
our day-to-day functioning is impaired.
Circadian rhythms. In addition to these brain regions that
regulate sleep, we also have internal “clocks” that regulate organ
function, body temperature, and
secretion of hormones over a 24hour period2. These are known as
our circadian rhythms. These circadian rhythms encompass both
our waking states and our sleep
cycles.
Stages of sleep. In a typical
person, sleep cycles through five
stages. There are four stages of
non-rapid eye movement (NREM)
sleep and one stage of rapid eye
movement (REM) sleep. NREM
sleep encompasses both light and
deep sleep throughout the four
phases. REM sleep is when brain
activity and eye movements spike

as we dream, but our muscles are
paralyzed to avoid movement.
When we go to sleep, we first enter
stage 1 of NREM sleep, in which
we are easily awoken. Stages 1 and
2 of NREM sleep are light sleep,
lasting about 10-25 minutes each,
whereas stages 3 and 4 are slowwave (deep) sleep. Stages 3 and 4
last about 20–40 minutes in the
first sleep cycle of the night. REM
sleep generally occurs for the first
time about 90 minutes after falling asleep. The lengths of NREM
and REM sleep change as we age,
as we spend less time in slow-wave
sleep and REM sleep2. In many
sleep disorders, the sleep cycles are
severely disrupted. For example,
in chronic insomnia, patients are
generally unable to fall asleep or
stay asleep, leading to a complete
disruption in the normal cycle of
NREM/REM sleep. In REM sleep
behavior disorder, a common sleep
disruption in Parkinson’s, the stages of sleep “blend” into each other.
For example, REM sleep is characterized by muscle paralysis, but this
pattern breaks down in REM sleep
behavior disorder, leading patients
to “act out” their dreams3. This can
lead to severe injuries. Thus, many
sleep disorders are characterized
by disruption in sleep stages and
circadian rhythms. These atypical
patterns of sleep, and sleep disorders, are more common in certain
clinical populations such as Parkinson’s.
Parkinson’s and Sleep
Our knowledge of sleep and the
atypical patterns that appear in
Parkinson’s beg the question,

Figure 2 An example of a single periodic
leg movement in the lower left limb in a
periodic leg movement disorder patient.17

“What exactly is Parkinson’s Disease? And how is sleep so closely
linked to it?”
As explained previously,
Parkinson’s is a neurodegenerative
disease primarily afflicting dopaminergic neurons. This neurodegeneration could be linked to sleep
in myriad ways. For example, it is
possible that degeneration of dopamine neurons reduces excitatory
connections and causes functional abnormalities in brain regions
regulating sleep and wakefulness,
such as the brainstem. There may
also be other pathological changes,
such as cellular and genetic abnormalities, associated with Parkinson’s that contribute to sleep disruptions. The most common sleep
disruptions in Parkinson’s patients
are REM sleep behavior disorder,
periodic leg movement disorder,
and excessive daytime sleepiness
and, therefore, these disorders will
be the focus of our inquiry. REM
sleep behavior disorder is the loss
of muscle paralysis during REM
sleep. Periodic leg movement disorder (Fig. 2) is repeated movement of upper and lower limbs
during sleep, and excessive daytime sleepiness is abnormally high
levels of exhaustion during the
day.
Many studies have at-
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tempted to answer the question of
how sleep is linked to a primarily
motor-related disease. Several of
these links appear to be secondary
or indirect relationships; before
we delve deep into the neural and
genetic underpinnings of sleep disruption in Parkinson’s, we will first
discuss a few surface-level links.
Dopamine
Medication.
There appears to be an unfortunate link between dopamine-increasing medications and sleep
disorders. One recent study found
that shorter time between the last
dopamine dose a patient takes, and
higher doses within a few hours
of bedtime, were associated with
worse sleep quality. Higher dopaminergic medication doses were
also associated with lower mean
percentage time in REM sleep.
Thus, dopaminergic medications
might reduce quality of sleep, particularly REM sleep, thereby possibly contributing to REM sleep
behavior disorder in Parkinson’s
patients4. Given the prevalence
of REM sleep behavior disorders
in Parkinson’s patients, this is a
critical finding. However, it raises
the question, does dopaminergic
medication intensify existing REM
sleep disruptions, or does it cause
the disruptions themselves? This
is a critical distinction, as sleep
disruptions must be treated at the
root; if dopaminergic medications
are not the root of the issue, but
merely an exacerbating factor to
existing disturbances, adjusting
dopamine doses will not completely resolve the problem. However, this is an important finding
because it provides a manner in
which medical policy can help
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Parkinson’s patients. For example,
prescribing physicians could recommend reduced dopamine doses
at night or a course of medication
that is only taken in the morning.
Age. Age is another seemingly secondary, but nonetheless
important, connection to sleep
disruptions in Parkinson’s. Younger Parkinson’s patients are found
to have sleep patterns that are not
significantly different than healthy
age-matched controls, but older Parkinson’s patients have fairly
disrupted sleep (insomnia, reduced average sleep per night, and
higher rates of excessive daytime
sleepiness)5. In addition, frequency of REM sleep behavior disorder
is higher and slow-wave sleep is
reduced in older Parkinson’s patients6. These results indicate that
age may play an important role
in the progression of sleep disturbances in Parkinson’s. We are quite
certain that sleep changes—and
sleep quality reductions—occur
naturally as part of the aging process. Unfortunately, the natural
process of aging cannot be effectively halted or reversed (though
we all wish it could!). This is bad
news in terms of addressing possi-

Figure 3 Orange regions indicate irregular regions of gray matter in REM sleep
behavior disorder, demonstrating severe
abnormalities.7

ble contributors to sleep disorders,
particularly in clinical populations
that already suffer from other
physiological stresses. However, it
is important to note that the rates
of sleep disturbances in Parkinson’s are indisputably higher than
in healthy elderly populations—
so age is likely not the only factor contributing to this phenomenon. So, what then? If age and
dopamine medications are not the
roots of sleep disturbances in Parkinson’s, perhaps we can find the
answer within the etiology of the
disease itself.
Structural contributions to sleep
disorders in Parkinson’s
Dopamine and age might exacerbate symptoms of sleep disorders in Parkinson’s, but a more
pertinent focus is from where the
symptoms are actually arising—
meaning that we must explore the
biological mechanisms of the disease.
First, structural issues may
play more of a role than we originally believed in producing sleep
quality changes in Parkinson’s. Recently, researchers have found severe thinning, volume reduction,
and shape abnormalities in gray
matter, particularly in the motor
cortico-subcortical loop, in REM
sleep behavior disorder patients
(see Figure 3). Impaired motor
function correlated with these
abnormalities in the motor cortico-subcortical network7.
While this was not a study
of Parkinson’s patients, it provides
interesting preliminary evidence
for a relationship between gray
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Figure 4 Examples of control, early Parkinson’s disease, and late-stage Parkinson’s
disease mVEMPs (from top to bottom).
Arrows point to the event-related spikes
in electrical activity, and responses differ
significantly from control to late-stage
Parkinson’s.8

mVEMP

matter degradation, motor abnormalities, and sleep disorders.
The nature of this relationship is
not yet clear, but a study on the
gray matter of Parkinson’s patients
would contribute to our understanding of it. Additionally, this
relationship between sleep disorders and gray matter degradation
in motor areas points to a potentially harmful feedback loop for
Parkinson’s patients; if Parkinson’s
Disease increases risk of sleep disorders, and sleep disorders are associated with degraded motor regions of the brain, sleep disorders
could diminish Parkinson’s patients’ already-deteriorating motor
abilities.

Another intriguing structural contributor to sleep disorders
in Parkinson’s is the brainstem.
There is evidence that vestibular-evoked myogenic potentials
(VEMPs), which are spikes in electrical activity in response to stimulation of vestibular receptors in
the brainstem, demonstrate functional abnormalities in both early
and late Parkinson’s compared to
healthy controls. Masseter VEMPs
(those involved in the motor control of the masseter muscle in the
face) in particular are more abnormal in late-stage Parkinson’s than
in the early-stage (see Figure 4).
This indicates progressive
degeneration of brainstem structures throughout Parkinson’s. Importantly, the number of altered
VEMPs and the total level of
VEMP alteration is found to be
associated with incidence of REM
sleep behavior disorders8. Thus,
REM sleep behavior disorder may
be related to brainstem abnormalities, arising out of multifaceted
degradation of brainstem structures. Therefore, sleep disturbances in Parkinson’s may be partly due
to an association between sleep
abnormalities and brainstem degradation. The precise mechanism
of this association is not fully clear,
but preliminary evidence does
suggest that structural changes—
such as gray matter and brainstem
degradation—may underlie sleep
disorders in Parkinson’s.

tural changes associated with sleep
disorders, there may also be cellular and genetic abnormalities
underlying sleep disturbances in
Parkinson’s, providing us with a
new micro-focused lens through
which to explore the foundations
of both typical and atypical sleep
patterns. In monkey models, dopamine deficiencies alone appear
to be enough to produce sleep
quality changes, including decreased REM sleep9. However, human research has found evidence
for cholinergic deficiencies contributing to sleep disturbances in
Parkinson’s. For example, there is
evidence for up to a 40% reduction in cholinergic neurons in the
pedunculopontine nucleus in the
brainstem of Parkinson’s patients
(see Figure 5), and this reduction
may contribute significantly to
sleep behavior disorders10. Thus,
cellular mechanisms are clearly
disrupted in Parkinson’s, and this
disruption likely contributes to
sleep disturbances in a complex,
multi-faceted way.
Hypocretin. In addition

Cellular and genetic contributions to sleep disorders in
Parkinson’s

Figure 5 Red pathways indicate cholinergic pathways that may be disrupted in
Parkinson’s. Both originate in the pedunculopontine nucleus of the brainstem and
project to midbrain structures, some of
which are heavily involved in sleep (e.g.,
the hypothalamus).10

In addition to pathological struc-
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to dopamine and acetylcholine,
hypocretin (sometimes known
as orexin) may also contribute to
sleep disturbances. Hypocretin
cells are implicated in the maintenance of sleep-wake cycles. Parkinson’s disease is associated with
lower levels of hypocretin, and
there is preliminary evidence that
hypocretin progressively deteriorates throughout the course of the
disease11. However, there is some
contradictory evidence in this
field, as other studies have found
that hypocretin levels do not differ
between Parkinson’s patients and
healthy controls12. Thus, cellular
research is inconclusive, but potentially points to multiple origins of
sleep disruptions in Parkinson’s. It
is possible that dopamine and acetylcholine both play a role in sleep
disruptions, but perhaps underlie
different sleep disorders (e.g., dopamine may underlie REM sleep
behavior disorder while acetylcholine contributes to excessive daytime sleepiness). Hypocretin’s role
is still uncertain, but it is possible
that it is only involved in sleep disorders relating to sleep-wake cycles
(such as frequent nighttime wakings), given its role in maintaining sleeping and waking patterns.
More specific research elucidating
the type of sleep disruption associated with cellular abnormalities
would be helpful in addressing
these ambiguities. Nonetheless,
there are clearly forms of cellular
disruption contributing to sleep
disturbances in Parkinson’s.
Circadian rhythm genes. In
addition to neural abnormalities,
there is also evidence that genetic
and circadian rhythm disruptions
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may underlie sleep disturbances in
Parkinson’s. In MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, an injected toxin used to
create a model of Parkinson’s disease) mouse studies, MPTP-treated mice showed behavioral markers of sleep disturbances and
demonstrate associated decreased
amplitude in circadian rhythm-related oscillations of gene expression13. In other words, the molecular “switch” that dictates when
circadian rhythm-related genes
turn “on” (are expressed) and turn
“off” (are silenced, not producing
proteins) is disrupted in MPTP
mice. This molecular disruption is
associated with behavioral markers
of sleep disorders. Thus, disruption of the molecular circadian
clock in Parkinson’s may contribute to sleep disturbances, and the
mechanism of that disruption may
be through gene expression.
This evidence from mouse
models has recently been replicated in human research as well. In
blood measurements of circadian
rhythm-related protein expression
and cortisol levels in Parkinson’s
patients, early Parkinson’s Disease
has been found to be associated
with sleep disturbances. These disturbances include increased sleep
latency (meaning it took longer for
patients to fall asleep) and reduced
REM sleep. These data mirror the
findings from the mouse studies,
demonstrating strong cross-species
evidence for genetic underpinnings of sleep disruptions in Parkinson’s. In humans, these genetic
disturbances included abnormalities in regulating hormones, such
as reductions in melatonin, and

reduction in expression of circadian rhythm-related proteins14.
Thus, there is strong evidence for a
molecular and genetic component
of sleep disruptions in Parkinson’s.
Future research may need to focus
upon exploring genetic and molecular therapies for Parkinson’s
patients to improve sleep disruptions.
Application of findings
There is not yet conclusive evidence for the basis of sleep disorders in Parkinson’s. Speculation
surrounds structural, neural, and
genetic underpinnings, but research has pointed to an extremely
complex association between sleep
disturbances and biological bases. While research must continue
in order to elucidate a more precise etiology of sleep disruptions
in Parkinson’s, clinical and treatment-based steps should be taken in the meantime to ameliorate
the quality of life of Parkinson’s
patients. Findings from neural research could be applied to clinical
use; for example, prescription protocol for dopamine medications
could include a recommendation
for lower doses at night due to
dopamine’s potential interference
with normal sleep cycles. Perhaps
physicians could also recommend
courses of over-the-counter melatonin tablets for Parkinson’s patients who have trouble sleeping, as
regular melatonin boosts at night
would likely improve symptoms
of excessive daytime sleepiness.
In addition, we could address the
potential role of hypocretin cells
in producing sleep disturbances in
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Parkinson’s through gene and stem
cell therapies. New treatments
are currently in development for
hypocretin-deficient
narcolepsy, such as introducing hypocretin-producing cells into the brains
of patients using stem cells15. Perhaps these new treatments could
be used in Parkinson’s patients as
well, as this would both clarify
whether hypocretin contributes
to sleep disturbances in Parkinson’s and potentially improve sleep
quality of these patients. Finally,
Parkinson’s patients may benefit
from government-funded courses
in sleep hygiene. If, for example,
sleep disturbances in Parkinson’s
arise from circadian rhythm irregularities, these issues could be
ameliorated (though admittedly not fully treated or resolved)
through careful maintenance of
good sleep habits. This would include going to bed and waking up
at approximately the same time
each day, keeping rooms dark and
quiet, and not eating or drinking
for an hour or so before bed. These
environmental cues are associated
with improved regularity of sleep
cycles, and it may benefit Parkinson’s patients in early stages of the
disease.
Sleep deprivation is a phenomenon that we can all understand. A clinical population, already suffering from other neural
and physiological stressors, cannot
afford to lose sleep. The physiological toll that sleeplessness takes
on us becomes more and more
costly if other internal systems are
already not functioning correctly.
Thus, sleep disorders in Parkinson’s are a pressing issue that faces

our scientific community today;
understanding the link will not
only remarkably improve the quality of life and outlook of Parkinson’s patients, but also it will inform our understanding of normal
sleep and how disrupted sleep may
arise in clinical settings.
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Nothing tastes as good as

SKINNY

feels

Unmasking the Neurobiological
Basis of Anorexia

By Louise Yang

F

ood is an unquestionable
need for basic human survival. It is also present at
most social events and celebrations
due to the central role it plays in
bringing people together. Yet for
some people, every single meal
and every single bite is a struggle.
This isolating and life-threatening condition is anorexia nervosa
(AN), a chronic illness characterized by excessively decreased caloric intake, disturbed body image,
and an intense fear of weight gain
(Park et al. 2014). It is a debilitating and heartbreaking disease not
just for the patient but for friends
and family who must watch their
loved one physically waste away
before their very own eyes. The
lack of proper food intake caused
by anorexia deprives the body of
essential proteins and nutrients
that give way to a domino effect
of health issues (Figure 1). This
puzzling, treatment-resistant disease has long been thought of as
Western culture-bound syndrome
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driven by toxic societal pressures
to diet and be as skinny as possible. How can it be that in countries
with such abundance women are
driven to starving themselves? Why
are some people more susceptible to
this disease? Is it their fault?
The interplay between environment and genetics is essential

for understanding the prevention
and development of anorexia. In
addition, discovering the neurobiological changes made by this
disease are essential for treatment
and grasping why recovery is so
difficult. There is no clear recovery plan for anorexia and current
treatments, such as psychotherapeutic or pharmacological ones
that target abnormal serotonin
systems, have proven inadequate
(Fitzpatrick & Lock, 2011). Researchers are shedding light on the
abnormal brain circuitry displayed
in anorexic patients in hopes of
discovering novel pharmaceuticals and better-targeted treatment
methods for this currently incurable disease.
History of Anorexia
Despite its reputation as a modern
disorder, the first medical report of
anorexia was made in 1689 by London physician Richard Morton.

Figure 1 Diagram of the physical effects of Anorexia Nervosa. http://
www.myedin.org/understanding-anorexia.html
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Figure 2 Meta-analysis of yearly incidences of AN cases in northern Europe. (Makino,
2004)

However, even up to the 1970s,
cases of anorexia were seen as clinical oddities that doctors rarely
saw, let alone knew how to treat
(Arnold, 2016). While rates of
anorexia had been steadily climbing since the 1950s (Figure 2), it
was not until the death of singer
Karen Carpenter in 1983 that anorexia hit mainstream awareness.
The young singer’s death from anorexia-induced organ failure led to
sensationalization of the disease
as the media speculated on why
teenage girls were suddenly “dying
to be thin.” Psychologists blamed
the cause of the disease on a troubled home life and pushy parents,
coupled with unrealistic standards
of beauty propagated by the media and supermodels. Anorexia
was seen as a willful choice made
by selfish young teenage girls who
simply had to choose to get better (Arnold, 2016). The answer
to anorexia is simply to eat, right?
Unfortunately, this backward approach was often recommended
to those who suffer anorexia, to no

avail. However, growing evidence
of the genetic and neurobiological basis behind this debilitating
disease have begun dismantling
these dangerous preconceptions
and brought about a new understanding of the cause and possible
treatment of this currently incurable disease.
Who is affected?
Anorexia affects around 1% of the
population, with 95% of anorexics being females. The average age
of onset is between 14 to 19 years
(Hudson et al., 2007). In addition,
anorexia has the highest mortality
rate among all psychiatric illnesses with one in five deaths being
caused by suicide. Patients with
AN show high comorbidity with
mood disorders such as depression
(35-50%), and around half have
comorbid anxiety disorders including social phobias and obsessive-compulsiveness (Ulfvebrand
et al., 2015). Anorexia is considered a chronic illness because

even though weight restoration is
manageable, relapse is a prevalent
issue (Zanadian et al., 2007). For
example, patients discharged from
the hospital will slowly but surely
return to their old unhealthy eating habits and continue the cycle
of hospitalization.
A study found the following five personality traits increased
the risk of developing an eating
disorder: perfectionism, inflexibility, rule following, excessive
doubt and caution, and a drive for
order and symmetry (Anderluh et
al., 2003). Patients with anorexia also have trouble zooming out
and seeing the big picture and,
instead, get stuck on the little details, which can cause difficulties
with decision making. In addition,
patients with anorexia show difficulty mentally switching from one
task to another (Arnold, 2016).
This strangely similar cluster of
characteristics shared by patients
with anorexia hints at the underlying biological factors behind this
disease because, in addition to predating disease, these traits often
persist after recovery.
Is Anorexia a Western Disorder?
Anorexia has long been thought
of as a western issue that primarily affects white women. Since the
late 20th century there have been
many reports of eating disorders
in Western countries, and few cases had been seen in non-western
countries other than Japan. However, a study in 2004 found that
while the prevalence of anorexia
in non-western countries is lower
than in western countries, it has
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been slowly increasing. Population
and patient-based estimates of AN
in non-western countries ranged
from .002% to 0.7% and was
associated with an increase in abnormal eating attitudes (Makino,
2004). This is, perhaps, an effect
of globalization and the spread of
Western beauty ideals through the
media. For example, before the
1990s there had only ever been
one reported case of anorexia on
the island of Fiji. However, after the introduction of television
to the island in the mid-1990s,
there was a sudden influx of cases.
In addition, in Japan the increase
in anorexia between 1985 and
1992 paralleled modernization.
It is argued that anorexia is more
prevalent during times of cultural change and confusion for immigrants and individuals who are
part of rapidly developing countries (Pke et al., 2015). Even with
this rise in anorexia, the numbers
still remain relatively low in comparison to the general population.
Therefore, the question must be
asked, why are some people more
vulnerable to developing the disease than others? Most people are
exposed daily to unhealthy beauty
ideals, yet never spiral into illness.

ing anorexia, while also contributing to the neurobiological factors
that underlie the disease (Kaye et
al., 2009).
A recent transgenic mouse
model demonstrates the interplay
of genetics, biology, and sociocultural variables that contribute to

the onset of anorexia. Researchers
transgenically created mice with
the BDNF gene, which is a gene
that has been associated with anorexia in humans. Adolescent
mice with the BDNF gene variant placed under environmental
stressors of social stress and on a

The Genetics Behind
Developing AN
While many people diet and express sentiments to lose weight,
only a small percentage actually
develop an eating disorder. This is
due to the highly genetic component of anorexia. Genetic heritability accounts for approximately
50 to 80% of the risk of develop-
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Figure 3 fMRI of the activation of the reward versus the cognitive circuitry of patients
with AN versus controls when hungry versus satiated. (Wierenga et al. 2015)
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calorie-restricted diet were much
more likely than controls to begin
avoiding food (Madra & Zeltser,
2016). This change was not seen
in adult mice, and was also not
induced when mice were subjected to only one stressor and not
the other. This demonstrates that
having an at-risk genotype in itself is not sufficient for developing anorexia-like behavior, but
that disease development is the
combination of stress, dieting,
and age that work together with
a genetic predisposition. This can
help explain the increase in rates
of anorexia in non-western countries due to the introduction of
unhealthy socio-cultural standards
of weight loss and beauty which
then triggers disease development
in youths who are already genetically susceptible. Researchers hope
to use this new mouse model to
study the change and disruptions
in neuronal circuits that cause

Figure 4 fMRI of increased activity in
the left amygdala-hippocampal region,
anterior cingulate, and left insula in the
anorexic group (Ellison et al., 1998).

the metabolic, neuroendocrine,
and behavioral disease symptoms
(Madra & Zeltser, 2016). This
leads to the question, what are the
neuronal disruptions in AN?
Dysregulation of the Reward
System in AN
Many of us resolve to avoid fatty
foods and unhealthy desserts, yet
our self-control often vanishes
when tempted by a piece of cake
after a long day. This normal behavior makes sense considering the
role of hunger as our body’s cue to
seek out and approach food. In
addition, hunger actually increases
the intensity of food rewards, and
this enhanced sensitivity to reward
is a motivational cue to eat, mediated through increased activation
of reward salience circuitry in the
ventral striatum, dorsal caudate,
anterior cingulate cortex (Wierenga et al. 2015). How are patients
with anorexia able to ignore these
urges? Unlike healthy controls,
who show an increased activation
of reward circuitry when hungry,
patients with remitted AN do not
show this increased activation,
lessening their sensitivity to the
motivational drive of hunger (Figure 3).
Furthermore,
patients
with remitted AN showed increased activation in the ventrolateral prefrontal cortex (Figure 3).
This increased activity in cognitive
control circuitry perhaps allows
them to better resist the temptations of food. This can, perhaps,
explain the puzzling question of
how individuals with AN are able
to restrict food intake (Wierenga

et al. 2015). In addition, these differences in activation might possibly occur before the development
of the disorder, demonstrating
the strong biological factors that
predispose certain individuals to
developing AN. Frank (2013) proposed a model of structural and
functional alterations in the insula
and frontal cortex, areas that contribute to both reward and anxiety
processing, that can occur prior to
AN development along with additional changes in these circuits
from malnutrition that can further
hinder recovery by promoting illness behavior and relapse (Frank,
2013).
The neurotransmitter dopamine plays a vital role in regulating the reward system, and alterations in mesolimbic dopamine
levels have been shown in activity-based anorexia mouse models
(Avena & Bocarsly, 2012). Although current dopamine-targeting drug treatments have proven
ineffective in treating the disease,
there is promising research into
atypical antipsychotics that may
modulate the irregular dopamine
systems seen in anorexia (McKnight & Park, 2010).
Abnormal Amygdala
Activation
Patients with AN often display
an abnormal preoccupation with
food-related items, in addition
to a fear of eating high calories
items. Functional magnetic resonance imaging (fMRI) was used
to study the response of patients
with AN when they imagined
drinking high versus low calorie
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Figure 5 AN patients display elevated
global CB1R expression in both cortical
and subcortical regions (Monteleon et al.,
2005).

food. Increased activation in the
limbic and paralimbic network
was associated with high calorie
foods, suggesting a conditioned
fear to high calorie foods (Figure
4). In addition, abnormal activity in the limbic and paralimbic
areas has been associated with
depressive and obsessive-compulsive symptoms, perhaps further
contributing to the prevalence of
these traits in patients with AN
(Ellison et al., 1998). Even after
weight restoration, patients recovering from AN continue to choose
low calorie food over more nutrient dense, higher calorie food
that would help them maintain
a healthy body weight (Berridge,
2003). This calorie fear highlights
how a better understanding of the
neurobiological changes caused by
AN can help the development of
better-targeted strategies to improve existing treatment plans.
Anorexia is also frequently
characterized by a preoccupation
with body size and body dysmorphia, an obsessive focus on
a perceived flaw in appearance.
Concerned parents might look at
their daughter and see an alarmingly skinny body with protruding
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bones, yet the girl herself would
perceive her body as fat. fMRI was
used to study changes in the brain
when patients with AN and controls were stimulated with digital
pictures of their own body image.
In patients with AN, stimulation
with their own body image caused
activation in the right amygdala,
the right gyrus fusiformis, and the
brainstem region (Seeger, 2002).
Studies have linked activation of
the right amygdala to aversive,
anxiety-producing stimulus. Understanding this activation of the
“fear network” in response to one’s
own body can be used to help explain why, during mirror confrontation therapy, patients with AN
display fear and avoidance when
looking at their own body, especially during weight gain (Smeets,
1999). This knowledge can then
possibly be used during recovery
to learn how to combat this conditioned fear of one’s own body.
A Potential New Treatment
Site- the Endocannabinoid

System
The endocannabinoid system is a
new and relatively understudied
potential treatment site for anorexia due to increased information about the critical role it plays
in body homeostasis. CB1-receptors (CB1R) are densely located
in key brain regions involved in
appetite, food intake, and energy
expenditure (Marco et al., 2012).
Studies have shown a deregulation
of the endocannabinoid system in
anorexia. For example, fMRI research has demonstrated that AN
patients display elevated global
CB1R expression in both cortical
and subcortical regions that is believed to be a long-term compensation mechanism for hypofunctioning of the endocannabinoid
system (Figure 5) (Monteleon et
al., 2005). Meanwhile, cannabinoids have been shown to be a safe
and effective tool for treating anorexia associated with weight loss
in patients with AIDS through
activation of CB1 receptors ex-

Figure 6 Dronabinol induced increase in weight gain of AN patients (Andries, 2013)
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pressed in brain regions such as
the hypothalamus and mesocorticolimbic system that are involved
in energy modulation by promoting food intake and reinforcing
the hedonic value of food (Gross,
1983).
Women with severe and
long-lasting anorexia (AN) were
treated with dronabinol, a synthetic cannabinoid agonist, to
study its effects on body weight
and eating disorder related psychopathological personality traits
(Andries, 2013). Participants
gained a significantly greater
amount of weight during dronabinol treatment than during placebo
treatment with no change in leptin
levels. Dronabinol was believed to
facilitate weight gain through an
anabolic mechanism (Figure 6)
(Andries, 2013). This result was
supported by a study on the effects
of CB1R agonist tetrahydrocannabinol (THC) on activity-based
anorexia (ABA) modeling rats.
ABA is the most widely used rodent model used to study the underlying changes in neural circuits
behind anorexia. It models two
key symptoms of anorexia: reduction in food intake and increase
in exercise. Rats that experience
food restriction while having unrestricted access to running wheel
time exhibit hyperactivity by voluntarily spending more time on
the running wheel than those with
unrestricted access to food. These
ABA also exhibit paradoxical reductions in food intake which
leads to weight loss and even death
without experimenter intervention. THC treatment was able to
induce maintenance of a healthy

weight in ABA modeling rats due
to a decrease in energy expenditure
through decreased thermogenesis
(Verty et al., 2011). Studying the
effects of THC on the endocannabinoid system is one step closer to
a promising novel pharmacological treatment for anorexia.
Early detection and Prevention
Early detection is vital for treating
AN because the longer the duration of the disease, the greater the
harmful effects on the body, and
the greater the changes in neural
circuits. A fMRI study showed
that even when recovered from
anorexia, subjects showed irreversible grey matter volume deficits
(Katzman et al., 1997).
Policies can be made to
improve school-based health curricula starting at a younger age,
with content aimed at preventing
eating disorders. In a longitudinal
study, adolescents who engaged in
dieting and unhealthy weight-control behaviors had higher rates of
obesity and eating disorders five
years later. Dieting is a stressor
that can trigger the development
of illness, and parents and schools
should create prevention programs that shift away from drastic
weight-control measures such as
dieting in favor of measures to implement long-term healthful eating and physical activity behaviors
(Neumark et al., 2006). In addition, there needs to be better and
increased training of educators
and health providers with respect
to identifying eating disorders.
Last of all, advertising and
social media policies should be

created to counter the negative
self-image promoted by unrealistic
and unhealthy body ideals on television, print, and social media. For
example, several social media sites
have paved the way by creating
anti-anorexia promoting policies
that have had varying levels of success. It is suggested that the media
can actually be a positive influence
on young, impressionable women
through presenting a greater variety of body shapes and discouragement of dieting.
Conclusion
Overall, the etiology of anorexia is unknown, and much can be
learned from studying the neurobiological basis of the disease. Not
only can current treatment plans
be altered to better fit the needs of
patients in recovery, but promising
new pharmacological drugs may
also better target the abnormal
neural circuitry in AN. Furthermore, understanding the interplay
of genetics and environment in the
development and maintenance of
this disorder can help patients feel
less guilty and isolated when battling this terrible disease.
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All Roads Lead to
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Mental Health in Young Adults with Autism Spectrum Disorders
By Nikki Scheman

T

he rate of psychiatric disorders in young adults with
Autism Spectrum Disorders
(ASD) is extremely high.1 But,
even though mental illness can be
more common for people on the
autism spectrum than the general population, the mental health
of individuals with ASD is often
overlooked. Co-occurring mental
illness can come in the form of
depression, ADHD, bipolar disorder, and others. One of the most
common disorders co-occurring
with ASD is anxiety disorder.1 In
fact, individuals with ASD experience anxiety at rates exceeding
both the general population and
other neurodevelopmental disor-

ders.2 The common co-occurrence
of anxiety in ASD has been confirmed in over forty studies before
2014.3 Managing multiple conditions can make the transition
into young adulthood especially
difficult for youth with ASD. Being able to recognize comorbid, or
co-occurring, psychiatric disorders
may identify targets for specific intervention that could reduce
overall impairment and improve
quality of life. Recognizing that
the symptoms of mental illnesses,
like anxiety, could look different
in those with ASD than in those
without could help individualize
care for youth on the spectrum.4
When these needs are not met,

there is a social cost.
Autism advocate and
co-founder of Autism Goggles,
a website dedicated to expressing
the experience of being autistic,
Daniel Share-Strom, talks about
the anxieties that come from living
on the spectrum. Not surprisingly,
difficulties in communication can
contribute to the layers of anxiety individuals on the spectrum
experience on a daily basis. In a
blog post to his site, he writes that
“the feeling of living on edge… of
waiting to mess up… can cause
tremendous anxiety.”5 Parents and
teachers would benefit youth with
ASD if they increased awareness,
acceptance, and knowledge about
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Figure 1 Imitation/Mirror Neuron Circuit. This includes the rostral inferior
parietal lobule (IPL) and inferior parietal
cortex (PFG) as well as the posterior inferior frontal gyrus (IFG).25

autism spectrum disorders and
the common anxieties and mental health disorders that can often
co-occur. This can lead to better
strategies for support and reduce
misunderstanding of youth with
ASD both at home and in the
classroom. This has the potential
to help children with ASD become
less anxious and more likely to be
open to learning about how to improve their communication skills.
What are Autism Spectrum
Disorders?
Autism spectrum disorders are
increasingly common, with 1 in
48 children affected.6 They are
characterized by the Diagnostic
and Statistical Manual of Mental
Disorders, Fifth Edition (DSM5) as persistent deficits in social
interactions and communication
as well as restricted, repetitive patterns of behavior, interests, or activities.7 Early indications of ASD
include deficits in social skills such
as mentalizing and face processing.
Specifically, a lack of interest in the
human face and voice and a pref-
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erence for inanimate objects is an
indication of ASD.8
Individuals with ASD
sometimes struggle to connect with
others in typical ways. Specifically,
the ability to think about another
person’s perspective is essential for
meaningful connections. Studies
show that there may be atypical
development of the neural circuitry that underlies mentalizing
and self-appraisal.9 Mentalizing
is this ability to understand that
others have different desires and
perspectives than one’s own. There
is evidence for a whole system of
the brain that co-activates to the
actions, intentions, and emotions
of the self and others. This system,
called the mirror neuron system
(MNS), is comprised of regions
in the inferior frontal gyrus (IFG)
and inferior parietal lobule (IPL)
that are active during the perception and execution of actions (Figure 1).9 In a study done by Dapretto et al., children with autism
and controls both imitate facial expressions showing basic emotions.
The children with ASD showed
less MNS activation that healthy
controls, and the extent of activation in the MNS was correlated
with the severity of their autism
symptoms.10
Children with ASD also
show deficits in face processing
that are due to issues in skills like
eye gaze, face identification, and
emotional recognition. Much of
how we gather social information
is from looking at other people’s
eyes. Individuals with ASD show
significant impairment in gaze fixation to the eyes and erratic gaze
patterns (Figure 2).11 It is possible

that the difficulty remembering
faces that individuals with ASD
also experience is because of this
eye-gaze deficit. Dysfunction of
the fusiform face area (FFA) also
leads to this difficulty in people
with ASD (Figure 3).9 Individuals
with ASD also focus on other features of the face besides emotional
expressions, like accessories, suggesting that there is a difference in
the salience in emotional expressions. Studies have shown dysfunction in the amygdala, a somewhat
almond shaped structure that is a
key part of the emotional circuit,
in response to emotional faces.12
Emotions and the Amygdala
We know dysfunction has been

Figure 2 Abnormal eye-gaze patterns
in patients with ASD. Eye gaze of ASD
group shown on the left, and a control
group with a typical inverted triangle pattern of visual gaze on the right.11
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Figure 3 Results from an fMRI study presenting participants with either fearful or angry
faces. In the ASD group, there was decreased fusiform face area and increased amygdala
activation in as anxiety levels increased.9

main hormone associated with
stress and anxiety is called cortisol. More cortisol is released from
the adrenal glands in stressful situations. Researchers looked at the
effect of cortisol levels on the connectivity of the amygdala to other
face regions during emotional face
perception. More cortisol was correlated with increased connectivity
of the amygdala with many different parts of the brain, including
the cerebellum. This connectivity
has also been reported in anxiety
disorder patients.15
A Brief Look at Anxiety
Disorders

shown in the amygdala of patients with ASD, but what is the
amygdala and what role does it
play in emotion? The amygdala is
a collection of nuclei at the front
end of the hippocampus that receives sensory input in a highly
processed form from all types of
senses (Figure 4).13 While many
types of input go to the amygdala,
the most common emotion (but
not the only emotion) following amygdala activation, is fear.13
There are three main regions of
the amygdala: the basolateral nuclei, centromedial nuclei and the
peripheral nuclei. The basolateral
group in particular has been implicated in both decision-making

and social perception.14 In fact, in
one study, researchers looked at
the role of the primate amygdala
in decision-making with respect to
others. Chang et al. found that the
basolateral amygdala neuron activation seemed to mirror the value
of the reward both to themselves
and to a recipient primate. Their
findings support the idea that the
amygdala, specifically the basolateral region, is a critical area for regulating social decisions.14
However, the amygdala is
associated with more than reward
and decision-making. Interestingly, the function of the amygdala
in emotional processing can be
associated with anxiety, too. The

Before talking about the struggle
that individuals with ASD face
when they experience comorbid
psychiatric disorders, particularly
anxiety disorders, a brief description of the latter is required. Anxiety disorders are characterized by
maladaptive anxiety symptoms
that cause distress and impair
function.16 Many brain regions
appear to be involved in the recognition and regulation of negative
emotional stimuli and response to
these stimuli. The principal neural
circuits thought to be related to
anxiety are presented in Figure 5.17
While many structures seem to be

Figure 4 Location of the amygdala in the
brain attached to the hippocampus.
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Figure 5 Main neural circuits associated with anxiety. This includes the thalamus, prefrontal cortex (PFC), anterior cingulate cortex (ACC), hippocampus, hypothalamus,
brainstem, and the basolateral (BLA) and central (CeA) nuclei of the amygdala.

critical for the regulation of negative emotion in anxiety, the amygdala, in particular, appears to play
a crucial role.17
Researchers have shown
that patients with anxiety disorders exhibit hyperactivation of the
amygdala in response to faces than
controls.17 The basolateral nucleus
of the amygdala receives information on potentially negative emotional stimuli from both the senses
and the thalamus, the relay station
for sensory input. This, in turn,
activates the central nucleus of the
amygdala, its main output pathway (Figure 6). Projections from
the central nucleus send information to the hypothalamus and
brainstem via inhibitory GABAergic neurons. GABA is a neurotransmitter that silences signals
between neurons. Its levels may be
linked to these feelings of anxiety
and also to anxiety disorders.
The Amygdala in ASD and
Anxiety
While it has been shown that the
amygdala is hyperactive in indi-
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viduals with anxiety disorders, evidence of amygdala abnormality in
ASD is conflicting. Some studies
have found that the amygdala is
hypoactive and fails to process social stimuli as meaningful (Figure
7), while others say that the amygdala is hyperactive. In those cases,
the avoidance of social stimuli seen
in patients with ASD could be the
result of an aversive over-arousal.18
The abundance of inconsistent
findings in the published literature
on ASD may reflect differences
between study populations regarding age, level of symptom severity
within ASD groups, and not accounting for underlying anxiety
level in the study groups.19 Many
studies have investigated the relationship between anxiety and
ASD and the effect of their co-occurrence on the amygdala, since
the rate of comorbidity is so high.
When looking at the relationship between self-reported
anxiety and fMRI activation to
emotional faces, Kleinhans et al.
found that ASD individuals with
higher anxiety showed increased
amygdala activation (Figure 3).9

They had participants look at angry or fearful faces and match the
emotions seen to a target face. Interestingly, the area of the brain associated with face processing, the
fusiform face area, was less activated the more anxious an individual
rated themselves. This would suggest that more anxious participants
avoided the face area entirely to
avoid the negative feelings of anxiety. On the other hand, low-anxiety ASD groups have been shown
to have decreased amygdala activity compared to controls.20 So,
maybe all the conflicting data on
amygdala activity in people with
ASD comes down to their anxiety
levels. If this is the case, researchers and doctors could predict the
level of social impairment that an
individual with ASD might face.
One study looked at the relationship between social impairments
and amygdala habituation, the diminishing of a response to a stimulus after repeated exposure. They
found that in the ASD group,

Figure 6 Different nuclei of the amygdala. This primary three nuclei are the
lateral nucleus that receives input, the
basal nucleus and the central nucleus that
sends output information to other brain
regions.
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Figure 7 Decreased amygdala activation in ASD individuals with low anxiety. Amygdala activation is circled in green. (A) Control group
only. (B) ASD group only. (C) Control vs a low-anxiety ASD group, measured by the SCARED total score. (D) Controls vs ASD patients
with low anxiety, measured by the SCARED Separation Anxiety Score.20

lower amygdala habituation was
associated with more severe social
impairments.9 This supports the
idea that social impairment can be
predicted in the lab, but evidence
on the effects of anxiety could
provide insight into how to target interventions to help with the
increased ASD symptom severity
that results.
Co-occurrence of ASD and
Anxiety
Anxiety interventions would be
especially important for individuals with ASD because children
with anxiety disorders actually
experience increased ASD-like
traits.2 In a parent rating of ASD
severity, the children with the
highest levels of anxiety were rated the highest for ASD symptoms
as well.2 However, the challenge
comes in recognizing this anxiety,
because youth with ASD express it
in ways both similar and dissimilar
to DSM definitions.21 There is also
the presence of unusual fears, worries, compulsive behaviors, etc.,
that appear to be associated with
ASD-related traits that may be a

distinct manifestation of anxiety
symptoms and the increased risk
of anxiety disorders. This provides
an avenue for future research, but
in the meantime requires more
awareness from parents and teachers of youth with ASD in order to
best provide support.
Challenges of ASD During
Adolescence
While it is evident that co-occurring anxiety makes already existing
ASD symptoms worse and provides added challenges, plenty of
challenges exist already. The neural underpinnings discussed earlier, as well as other factors, have
far reaching impacts on the daily
lives of youth with ASD. These
differences in brain function can
manifest themselves in many different ways. To get a sense of what
the daily challenges are for people
with ASD, a blog post from the
writers of Autism Goggles describes what individuals with ASD
wish the people in their lives knew
about their experience. Most of
their focus was on communication. Despite this being the case,

research has shown that social involvement with peers improves
the behavioral skills essential for
everyday life in people with ASD.
However, making these social connections is tricky for a number of
reasons.
To start, individuals with
ASD can have trouble coming up
with the words they want to say in
a timely manner during interactions, despite having large vocabularies.5 This can lead to deficits in
their social interactions with people who do not understand why
this occurs. It can also be hard for
people with ASD to understand
the main point of a request or
reading topic, but they don’t always know that they have misunderstood.5 When others point out
the error, it can cause shock and
embarrassment. This was a common theme: the embarrassment
that comes from mistakes that were
completely unintentional. It can
be very anxiety producing when
you unexpectedly get negative
feedback for your actions without
always knowing why. However, individuals with ASD can also have a
hard time finding the words to de-
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fend themselves when they believe
someone is angry or disappointed
with them. Because of this, selectively going silent can be a coping
method. In fact, it is not uncommon for children with ASD to be
very quiet or even not speak at all
in the school setting. Awareness of
this is essential for teachers to be
able to provide the right kind of
support for their children on the
spectrum.
Awareness from teachers,
family, and society is not always
the reality, though. Regardless of
a diagnosis on the autism spectrum, adolescence is, in general,
a time of increased demands on
our youth. For example, adolescents are expected to begin following multistep directions, keep
their school materials organized,
begin to socialize outside of their
families, and gain independence.
However, studies show that the
cognitive abilities of youth with
ASD might not be improving fast
enough during adolescence to
keep up with these increased demands.22 The gap between expectations and the abilities of adolescents with ASD widens over time.
In particular, working memory
(the ability to hold a memory for a
short amount of time for processing), imitation, and organization
become increasingly problematic
over time.22 Data in this area emphasizes the need for continuing
intervention and support throughout later adolescence, when typically school and clinical resources
become less available.
ASD and Mental Illness:
Broader Impacts
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Individuals with ASD experience
challenges during adolescence that
make life even harder than it already is during this time of growth
and development. At the same
time, the rate of comorbid mental
health issues, like anxiety, is high.
Environmental factors seem to
play a major role in this. Daniel
Share-Strom, from Autism Goggles, believes that “people with
autism aren’t immediately born
anxious or with depression,” but
that “the world is fundamentally
not built for us, and people are always judging and trying to change
you, whether they have the best
intentions or not.”5 Because of
these added challenges, providing
support and resources for young
adults with ASD is extremely important.
However, many children
with ASD are not getting the
mental health services they need.
Compared to children with other disabilities or mental illnesses,
children with ASD have more
unmet healthcare needs and more
difficulty accessing mental health
services.6 Although inadequacies
in mental health services affect
many Americans, the problem is
more severe for individuals and
families affected by ASD. At least
15% of children with ASD who
needed mental health services did
not have access.23 This is especially
problematic when mental illness
brings its own challenges and also
exacerbates the already present
challenges associated with ASD.
Consequently, improving access
to quality mental health services
and other health care is necessary.

However, this will require both
insurance reform and improved
training in medical school and
healthcare systems.
Mental illness can inadvertently go untreated if it is believed
to be just another characteristic of
ASD. But it is, in fact, a misconception that some symptoms cannot be from other mental health
disorders. In reality, mental health
symptoms can still be treated or
helped in individuals with ASD.
This can come in the form of both
medication, which can improve
mood and reduce impulsivity and
Cognitive Behavioral Therapy.
This therapy involves changing the
young adults’ patterns of behaving and thinking by making them
aware of why their patterns are not
productive.
In addition, further training on working with youth with
ASD should be required for teachers. This would help teachers to
provide the kind of in-class environment that would support
rather than add to the already existing anxieties and struggles that
people with ASD face on a daily
basis. However, training should
focus on both ASD symptoms as
well as signs of co-occurring mental illness. This way, the people
who need extra help can get the
support they should be receiving
for mental illness disorders such
as depression, anxiety disorders,
ADHD, and others.
The occurrence of autism
spectrum disorders has only grown
over the years. Now, approximately 1 in 48 children are diagnosed
with ASD.6 This is an incredibly
high statistic that is continuing to
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rise. Within this population, the
prevalence of co-occurring anxiety
disorders and other mental illnesses is widespread but also widely
overlooked. Parents, teachers, and
communities all need to be more
aware of the specific challenges individuals with ASD face, and the
possibility for other mental health
issues that could be occurring at
the same time. But, while awareness is a great step, that awareness
must turn to both acceptance and
changes in the way teachers and
health practitioners are trained
with regard to people with ASD in
order to really improve their quality of life.
References

Simonoff, E., Pickles, A., Charman, T.,
Chandler, S., Loucas, T., & Baird, G.
(2008). Psychiatric Disorders in Children With Autism Spectrum Disorders:
Prevalence, Comorbidity, and Associated
Factors in a Population-Derived Sample.
Journal of the American Academy of
Child & Adolescent Psychiatry, 47,
921-929.
Hallett, V., Lecavalier, L., Sukhodolsky,
D.G., Cipriano, N, Aman, M.G., McCracken, J.T., McDougle, C.J., Tierney
E., King, B.H., Hollander, E., Sikich, L.,
Bregman, J., Anagnostou, E., Donnelly,
C., Katsovich, L., Dukes, K., Vitiello,
B., Gadow, K., & Scahill, L. (2017).
Exploring the Manifestations of Anxiety
in Children with Autism Spectrum Disorders. Journal of autism and developmental disorders, 43(10), 2341–2352.
Galvan, A. (2017). The Neuroscience
of Adolescence. Cambridge: University
Printing House.
Haelle, T. (2017, October 1). Young
adults with autism also have mental
health issues. Message posted to http://
www.npr.org.
D Share-Strom. (2017). Parenting and
ASD: You CAN do this. You ARE doing
it! [web log comment]. Retrieved from
http://www.autismgoggles.com
Dawson, G. (2013, January 29). Autism

Speaks Advocates for Mental Health.
Message posted to http://www.autismspeaks.org.
American Psychiatric Association.
(2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.
Pelphrey, K., Sasson, N., Reznick, J.,
Paul, G., Goldman, B., & Piven, J.
(2002). Visual scanning of faces in
autism. Journal of Autism and Developmental Disorders, 32, 249-644.
Kleinhans, N., Richards, T., Weaver, K.,
Johnson, L.C., Greenson, J., Dawson,
G., & Aylward, E. (2010). Association
between amygdala response to emotional
faces and social anxiety in autism spectrum disorders. Neuropsychologia, 12,
3665-3670.
Dapretto, M., Davies, M., Pfeifer, J.,
Scott, A., Singman, M., Bookheimer,
S., & Iacoboni, M. (2006). Understanding emotions in others: mirror neuron
dysfunction in children with autism
spectrum disorder. Nature Neuroscience,
9, 28-30.
Papagiannopoulou, E., Chitty, K.,
Hermens, D., Hickie, I., & Lagopoulos, J. (2014). A systematic review and
meta-analysis of eye-tracking studies in
children with autism spectrum disorders.
Social Neuroscience, 9, 610-632.
Ashwin, C., Baron-Cohen, S., Wheelwright, S., O’Riordan, M., & Bullmore,
E.T. (2006). Differential activation
of the amygdala and the ‘social brain’
during fearful face-processing in Asperger Syndrome. Neuropsychologia, 45,
2-14.
Baron-Cohen, S., Ring, H.A., Bullmore,
E.T., Wheelwright, S., Ashwin, C., &
Williams, S.C.R. (2000). The amygdala theory of autism. Neuroscience &
Biobehavioral Reviews, 24, 355-364.
Chang, S.W.C., Fagan, N.A., Toda, K.,
Utevsky, A.V., Pearson, J.M., & Platt,
M.L. (2015). Neural mechanisms of
social decision-making in the primate
amygdala. PNAS, 112, 16012–16017.
Hakamata, Y., Komi, S., Moriguchi, Y.,
Izawa, S., Motomura, Y., Sato, E., Mizukami, S., Kim, Y., Hanakawa, T., Inoue,
Y., & Tagaya, H. (2017). Amygdala-centred functional connectivity affects daily
cortisol concentrations: a putative link
with anxiety. Scientific Reports, 7, 8313.

Rauch, S.L., Shin, L.M., & Wright,
C.I. (2003). Neuroimaging studies of
amygdala function in anxiety disorders.
Annals of the New York Academy of
Sciences, 985, 389-410.
Nuss, P. (2015). Anxiety disorders and
GABA neurotransmission: a disturbance
of modulation. Neuropsychiatric Disease
and Treatment, 11, 165-175.
Corden, B., Chilvers, R., & Skuse,
D. (2008). Avoidance of emotionally
arousing stimuli predicts social–perceptual impairment in Asperger’s syndrome.
Neuropsychologia, 46, 137–147.
Juranek, J., Filipek, P.A., Berenji, G.R.,
Modahl, C., Osann, K., & Spence, M.A.
(2006). Association Between Amygdala
Volume and Anxiety Level: Magnetic
Resonance Imaging (MRI) Study in
Autistic Children. Journal of Child Neurology, 21(12), 1051–1058.
Harrington, J.D., Miller, J.S., Pandey,
J., & Schultz, R.T. (2016). Anxiety and
social deficits have distinct relationships with amygdala function in autism
spectrum disorder. Social Cognitive and
Affective Neuroscience, 11, 907-914.
Kerns, C.M., Kendall, B.C., Berry, L.,
Souders, M.C., Franklin, M.E., Schultz,
R.T., Miller, J., & Herrington, J. (2014).
Traditional and atypical presentations of
anxiety in youth with autism spectrum
disorder. Journal of Autism Developmental Disorders, 44, 2851-2861.
Rosenthal, M., Lawson, R., Dixon, E.,
Kenworthy, L., Wallace, G.L., Wills,
M.C., & Yerys, B.E. (2013). Impairments in real-world function increase
from childhood to adolescence in autism
spectrum disorders. Neuropsychology,
27, 13-18.
Darer, J. D., Hwang, W., Pham, H. H.,
et al. (2004). More training needed in
chronic care: A survey of US Physicians.
Academic Medicine, 79, 541–548.
Iacoboni, M. & Dapretto, M. (2006).
The mirror neuron system and the
consequences of its dysfunction. Nature
Reviews Neuroscience, 7, 942-951.
Title Image: “Road” by Larisa Koshkina
is licensed by CC0.

153

SCIENTIFIC KENYON

Mushroom
For
Improvement:
The Case for Psilocybin-Assisted Therapy
By Harry Justus

“I had a clear mind, it lifted the fog of depression. I could see my life, like a light in the tunnel.”
“I was lucid and alert, the depression had evaporated. It puts your head above the fog.”1

T

hese are quotes from individuals who underwent a
decidedly unconventional treatment for their depression: psychedelic-assisted psychotherapy.
Psychotherapy itself is a commonly-used treatment for depression,
with about 45% of Americans
diagnosed with major depression
receiving psychotherapy as a primary treatment method.2 However, the traditional combination of
psychotherapy and antidepressant
medication does not work for everyone, and certain patients have
depression that does not respond
to these forms of treatment. This
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is referred to as treatment-resistant
depression, which for this article
will be defined as a consistent,
professionally-diagnosed
score
of 17 or higher on the Hamilton
Depression Rating Scale (indicating at least moderate-to-severe
depression), and at least two failed
attempts at treating their depression with antidepressant medications during the current period
of depression.1 This article aims
to discuss the ways in which psychedelics affect the brain, the potential ways in which psychedelics
could be implemented as an aid in
psychotherapy, reasons why this

is a potentially beneficial research
area, and finally some potential
future steps toward a better understanding of the ways in which psychedelics could be a valuable tool
for the treatment of some mental
health disorders.
Wait— what’s a psychedelic?
Throughout history, humans have
used naturally-occurring chemical
compounds in a number of capacities, whether spiritual, therapeutic, or otherwise.3 Psychedelics
(meaning soul-revealing, from the
Greek words psyche— soul and
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deloun — to reveal) are a somewhat loosely-defined category of
consciousness-altering chemicals
which includes lysergic acid diethylamide (LSD, pictured above)
psilocybin, which is the active-ingredient in so-called “magic mushrooms,” (pictured below) and others.4 Psychedelics are chemically

similar to the neurotransmitter
serotonin, and have a strong effect on serotonin-2A receptors.
In other words, that means that
these chemicals affect various parts
of the brain in order to produce
profound shifts in our sensory
perceptions and in the ways we
think.5 However, in the past it was

difficult to research these chemicals much beyond their subjective
psychological effects— little was
known about the effects of psychedelics on the brain itself, only
the behavioral effects that could
be observed in people or animals
to whom these compounds were
administered.4 By the mid-1960s,
there had been a large number of
studies that showed a great deal of
potential for using psychedelics
as a therapeutic intervention for
mental health issues ranging from
depression to addiction, and even
end-of-life anxiety.5 These older
studies, while not up to the same
rigorous standards as modern ones,
provided a foundation of promising data upon which the modern
renaissance of psychedelic research
is based. Psychedelic research in
the United States was stalled when
psychedelics, increasingly associated with the counterculture movements of the 1950s and 1960s,

Some Other Controlled Substances:6
Schedule 1 (High risk of abuse and
addiction, no accepted medical uses):
Heroin, Cannabis (marijuana), peyote,
MDMA (Ecstasy).

Schedule III (Lower potential for
addiction than Schedule II, but still
potentially harmful): Ketamine, anabolic steroids, testosterone.

Schedule II (High risk of abuse,
some accepted medical uses): Vicodin,
Methamphetamine, Adderall, Ritalin,
fentanyl, cocaine.

Schedule IV (Lower potential for
addiction than schedule III): Xanax,
Ativan, Ambien, Valium, Tramadol.

were stigmatized and eventually
made illegal under the Controlled
Substances Act of 1970. The Controlled Substances Act designated
LSD and psilocybin as Schedule I
substances, which means that, according to the law, they have no
accepted medical use and a high
potential for addiction.6
In the past twenty years or
so, there has been a revitalization
of research into the psychotherapeutic potential of psychedelics.
This is due in large part to more advanced technology and techniques
that allow us to see with increasing clarity how exactly psychedelics affect our minds. For example,
many studies are now using modA brief history of psychedelics in
the 20th Century:4
1943 Albert Hofmann first discovers the conciousness-altering effects of
LSD
1947 Werner Stoll publishes first paper on these effects
1950 First English-language paper on
LSD published
1956 Term “psychedelic” first coined
1957 Term “magic mushrooms” first
coined
1958 Hofmann discovers the presence
of psilocybin as the main psychedelic
chemical in “magic mushrooms.”
1965 Sandoz, then the main manufacturer of psychedelic chemicals for
research in the US, stops synthesizing
LSD and psilocybin.
1966 Use of and research on psychedelics in the US begins to be suppressed.
1970 US President Richard Nixon
signs the Controlled Substances Act
into law, which designates LSD and
psilocybin as Schedule I substances.
This marks the end of research into
psychedelics in the US for the foreseeable future.
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ern brain imaging technologies
to see in real-time which parts of
the brain are being activated when
someone is under the influence of
a psychedelic chemical.8,9 This has
allowed for an entire new era of research that can begin to match the
intense subjective effects of psychedelics with the regions of the
brain that they appear to affect in
order to better understand exactly

!

What could psilocybin-assisted
psychotherapy look like?
Studies have been done to determine the most effective ways in which
psilocybin would be integrated into a psychotherapeutic setting. The
most common procedures involve two acute doses of psilocybin at two
separate testing times, usually about a week apart. Here is a timeline of
a potential treatment plan, compiled from recent studies whose results
show promise for the efficacy of psilocybin-assisted psychotherapy:1, 6 10

Before the First Dose

1

Participants undergo a battery of screenings in order to determine
mental and physical fitness for the study.

For

clarification purposes in the rest of this
article, unless otherwise
indicated, the term psychedelic will be used to refer to
both LSD and psilocybin, as
these have been the psychedelic
compounds that have received
the most attention for research.
However, this article is primarily about psilocybin and the case
for further research into its use
as a therapeutic tool to help
people with treatment-resistant
depression.

The aim of this article is not
to push for total legalization
of psychedelics. Far from it in
fact— these are chemicals that
have a powerful effect on the
brain, and thus should not be
taken lightly. Rather, this article
aims to encourage a reevaluation of the current scheduling
of psilocybin such that it could
be researched further as a potentially revolutionary tool for
helping individuals with treatment-resistant depression.
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The Dosing Sessions
9:00am Participants arrive at the testing facility and are tested for
alcohol, marijuana, and other drugs. This is followed by a quick
psychological testing session to ensure that there are no major deviations from the previously-gathered scores. Following successful
completion of these tests, participants are then brought into the
therapy room, where they are familiarized with the dosing environment and meet with the psychiatrists who will be supporting
them before, during, and after the dosing sessions.

Every half hour until 4:30pm Participants’ blood pressure and
heart rate are taken; psychiatrists make note of the apparent intensity of the participant’s experience. Psychiatrists also perform
check-ins with the participant to determine the current subjective
experience of the psilocybin— usually simply asking how they are
feeling.
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2

Participants meet with the psychiatrists running the study and undergo a brain
scan using an fMRI (functional magnetic resonance imaging), which will provide baseline levels of brain activity to which post-psilocybin brain activity can
be compared.

3
Participants undergo a lengthy preparation session with their assigned psychiatrist. This includes a long conversation with the psychiatrist wherein
the participant is encouraged to speak candidly about their life experiences,
including their own thoughts on how and why their depression originated.
Additionally, patients are exposed to some of the parts of the psilocybin-assisted psychotherapy session in order to familiarize themselves with the procedure, such as listening to selections of specially-chosen music with eye
shades on.

Throughout the dosing sessions: Supervising psychiatrists do not direct the
participant, instead allowing them to direct their own session, giving them the
freedom to immerse themselves in the experience without self-consciousness or
inhibition.

10:30am Patients receive their dose of psilocybin. In the first
session, they are given a low dose of 10 milligrams (mg) of psilocybin, which is meant to both familiarize the patient with the
subjective effects of psilocybin and also to assess how well the patient can tolerate the effects of the psilocybin. The second session
is the same, but the dosage of psilocybin is increased to 25mg.

Approx. 11:30am Subjective effects of psilocybin begin to manifest in the participants.
Approx. 12:30-1:30pm Participants experience peak psychedelic effects of psilocybin.

After the Dosing Sessions
6-7 hours post-dosing session Participants fill out a test that measures
their subjective experience of an altered state of consciousness.

One day post-25mg dose Participants are invited back to the testing facility to take the same battery
of tests that they underwent before
the first dosing session, including an
fMRI brain scan. Participants are
given the opportunity to debrief their
experience with the assisting psychiatrists.

One, two, three, and five weeks;
three months post-25mg dose
Participants take a follow-up test
that determines their current level
of depressive symptoms in order to
determine the extent to which (if
any) the psilocybin-assisted therapy
has affected their mental health.
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how and why these effects manifest.

Source (9)

The Case for Psilocybin-Assisted
Psychotherapy
How does it work?
As previously mentioned, psilocybin (and psychedelics in general)
have a very strong effect on serotonin receptors in the brain. Serotonin is involved in vision, hearing, and a variety of other cognitive
processes, meaning that psychedelics (as serotonin-like chemicals)
have pronounced effects on these
particular processes. To highlight
this, brain-imaging studies found
that LSD and psilocybin have a
significant effect on brain activity
in regions that are associated with
vision, hearing, and organized
thought. For a graphical representation of these changes in perception, see the above figure from
Carhart-Harris and colleagues9,
which provides a comparison of
the changes in perception and
thought between individuals who
had taken psilocybin compared to
a non-drug placebo. Clearly, psilocybin facilitates profound changes
in the way people experience the
world around them. It has been
proposed that this is one of the
main mechanisms by which psychedelics could help with treatment-resistant depression— many
patients with treatment-resistant
depression note that they often
get stuck in negative, circular
thought patterns. That is, they become bogged down in depressive
thoughts and cannot break free of
them. Since psilocybin so totally
alters the perception of thoughts
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and feelings, researchers think that
it can help the depressed patients
to break out of these oppressive
thought patterns and help them
see the world in a new way.1 To
quote one participant from a psilocybin-assisted
psychotherapy
study,

“my mind works differently
[now]. I ruminate much less,
and my thoughts feel ordered,
contextualized. Rumination was
like thoughts out of context, out
of time; now my thoughts feel
like they make sense, with context and logical flow.”1
Another study evaluated a group of
mentally healthy individuals who
were given varying doses of psilocybin, from a very low dose (almost
negligible) to a higher dose that is
around the same as the dose that
would be given in the second session of therapy as laid out above.11
These participants were then asked
to complete a series of tasks that
measured, among other things,
the experience of an altered state

of consciousness. The researchers
found that there were several shifts
in the participants’ perception of
their consciousness, notably in the
feeling of “oceanic boundlessness,”
which indicates a feeling of being
connected to everything around
oneself— as though they were one
with the world around them.11
This corroborates the subjective
accounts of the psilocybin experience in another study, which notes
a major shift in its participants’
attitudes from feelings of disconnection with the world around
them to feeling more connected
to themselves, their emotions, and
the world around them.1 Another way in which it has been proposed that psychedelics in general
change brain function to combat
depression is through increasing
what is called cortical entropy.
Essentially, cortical entropy is an
increase in random activity in the
brain, allowing for communication between brain regions that
are normally not associated.12 Increased cortical entropy has been
linked with the personality trait of
openness to experience, which is
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in line with the idea that psychedelics may help combat depression
by aiding the individual in acquiring a new interpretation of the
world around them and their own
thoughts.1,12
Hold on, is this even safe?
Remember, this article is not written in support of recreational psychedelic use. The aim of this article is to provide support for the
stance that psychedelics have the
potential to be an effective tool in
treating depression. Research has
shown that psychedelics are actually quite safe physically, as they
do not build tolerance easily and
doses that could cause any lasting
physiological harms are substantially higher than any dose that
would be administered in a clinical setting.11 Psychedelics also have
not been shown to cause mutations
in cells, which are a precursor for
many negative health outcomes.13
Moreover, psychedelics have less of
a permanent effect than MDMA
(which has been considered for
treating some psychiatric disorders) on the brain’s ability to use
the serotonin that it produces naturally, which means that psychedelics may be less harmful for use
in the long-term than other proposed drug therapies.14 One study
of a large sample of the US population found that people who had
used psychedelics at some point
in their lives experienced lower
rates of psychological distress and
suicidal behavior.15 It is, however,
important to note that psilocybin
and other psychedelics can have
some potential adverse effects. In

fact, psychedelics have been used
in some studies to model psychotic states; hence the importance of
screening out patients in danger of
having a psychotic episode as a result of their use.16 One study found
that some patients experience
fleeting anxiety while undergoing
the psychedelic experience.11 That
said, research shows that as long
as the participants are adequately
screened, prepared, and taken care
of during the treatment sessions,
none of these negative effects last
beyond the dosing sessions. Moreover, it appears that the physical effects of psychedelics do not
cause any lasting physical health
issues in well-prepared users.11 Additionally, in the unanimous opinion of the twenty participants in
one study, the psilocybin-assisted
treatment was preferable to any
previous form of therapy for their
depression.
Moving Forward
Current Limitations
Psychedelics are still not well-understood compared to other drugs,
and have received an unsavory image in many countries due to their
legal status and portrayals in popular media as being used mainly
by less-than-reputable individuals.
As such, there are many misconceptions about psychedelics that
must be dispelled if they are to be
legalized and publicly accepted for
research in the US (or anywhere
else in the world). The key to
this will be education about these
chemicals. It is important to note
that any proposed psychedelic-assisted therapies do not call for sim-

ply handing the patient a powerful
mind-altering substance and simply hoping for the best; remember,
the patients are monitored closely and work with highly-trained
mental health professionals at every step of the process, especially during the period where the
patient is experiencing the acute
physiological and psychological effects of these substances.1
Possible Future Steps
The first institutional step towards
the implementation of psychedelic-assisted therapies is lifting
restrictions that keep these chemicals from being researched in a way
that could produce more powerful
results than previous studies. The
current group of studies, while important and vital to the furthering
of this research area, all have very
small sample sizes— usually fewer
than twenty people, and often fewer than ten. Recent studies indicate
that psychedelics (at the very least
LSD and psilocybin) are safe to administer in well-controlled clinical
environments, which for now are
the only environments in which
these studies should be taking
place to begin with. Additionally,
psychedelics have been considered
for use as a way to better understand the neurological bases of
other mental illnesses like schizophrenia, as some of the effects of
psychedelics (such as hallucinations) are similar to those observed
in patients with these illnesses.17
In the future, with more data and
less limiting laws on research, psilocybin-assisted therapies have the
potential to be used in a variety
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of clinical settings. These include
therapies to treat end-of-life anxiety, alcohol and tobacco addiction, and obsessive-compulsive
disorder, among others.18,19 Additionally, new studies are beginning
to look at other illegal or highly
restricted substances like MDMA
(ecstasy) and ketamine for use in
treating depression, post-traumatic stress disorder, addiction, and
others.20, 21
In sum, I believe the most
important point to take away from
this article is that psychedelics
(especially psilocybin) are worth
researching, because they could
provide new and effective ways
to treat otherwise treatment-resistant mental health disorders. They
have already shown a great deal of
promise— if psychedelics could
be the way for a chronically-depressed person to finally get above
that fog of incessant rumination
and despair, then they are absolutely worth researching.
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Tasting the Rainbow:
Perception, Hallucination, Act
of God, or Just Plain Crazy?
By Olivia DePalo

S

ight. Hearing. Taste. Smell.
Touch. Everything that we
know and understand about the
world is perceived through our
senses. We rely on them every
minute of the day and trust without question that our perceptions
are accurate and tell us truths
about reality. But what does it
mean when individuals report
hearing colors, tasting sounds, or
smelling music? Are they crazy?
Do these experiences represent
some kind of divine intellect? Or
is it possible that various brain
mechanisms are leading to these
experiences? Synesthesia is the experience in which the stimulation
of one sensory or cognitive stream
reliably leads to an automatic and
involuntary stimulation of an unrelated cognitive stream. The experience of synesthesia has been
recorded by individuals in various
ways throughout the course of history. It has been reported that as
many as 4.3% of the population
has some form of these experiences. However, the ways in which the
phenomenon of synesthesia has
been perceived throughout history
is extremely variable and can tell
us a lot about the inherent nature
of this phenomenon.

Brief History of Synesthesia
The book of Exodus in the Bible
includes a passage in which the
people who gathered with Moses
on Mount Sinai hear visions and
see the voice of God. Rather than
being diagnosed with a medical
condition or being called crazy,
Moses was praised and believed
to be a messenger sent from God
because of the experience that the
people on Mount Sinai were able
to have through him.
Hildegard Von Bingen, a
Christian Visionary of the 11th
century, was believed to receive
messages from God through the
five senses: sight, hearing, taste,
smell, and touch. Throughout her
recording of these visions, she extensively uses the term “veriditas”
(translated as “greenness”) which
she uses to describe the lusciousness and fertility of the divine nature of God.
Around the time of classical philosophers such as Plato and
Aristotle was when synesthesia
moved away from its association
with mystical or spiritual intervention from God and became
solidified as an established sensory
phenomenon. In his On Sense and
The Sensible, Aristotle writes that
the harmony of colors is equiva-

lent to the harmony of sounds and
went on to relate specific light and
sound frequencies (Aristotle, 350
B.C).
By the 20th century, synesthesia begins to make more of
an appearance in literature as a romantic ideal: Nabokov writes, “If
I had some paints handy, I would
mix burnt sienna and sepia for
you as to match the color of a ‘ch’
sound..and you would appreciate
my radiant ‘s’ if I could pour into
your cupped hands some of those
luminous sapphires that I touched
as a child.” (Nabokov, 1935). In
this case, it seems that the purpose
of the author’s choice to incorporate these synesthetic experiences
was not to imply any type of mysticism of the narrator but simply
to celebrate this experience as
something beautiful to be appreciated.
Most recently, the experience of synesthesia in literature
has been depicted as a symbol of
health and balance. In her novel A
Mango Shaped Space, Wendy Mass
presents a young teenager named
Mia who’s synesthesia disappears
when her beloved cat dies but returns once she has grieved and
worked through the trauma of the
experience (Brown 2010). It’s clear
that the perception of individuals
who experience the phenomenon
of cross activation of the senses has
been extremely variable throughout the course of history. But as
synesthesia became more normalized in our society, researchers became more and more invested in
looking into the scientific pathways and brain mechanisms underlying the phenomenon, which
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Figure 1 Visual Word Form area is located directly adjacent to V4 color area.
Green = graphemes, Red= colors.

led to its medicalization.
Proposed Neurological
Mechanisms of Synesthesia
Because the experience of synesthesia includes so many different
subtypes and relies on individual experiences, a cohesive, working-theory of the neurological
mechanisms of synesthesia has not
yet been developed. However, Dr.
V.S. Ramachandran, a leader in
the field of synesthesia research,
has come up with three main hypotheses as to the neurological
underpinnings of synesthesia that
have been widely recognized by
the scientific community.
Local Cross-Activation Model
The first of these theories is the
local cross-activation model (Ramachandran, 2005). This theory is
largely based off of grapheme-color synesthesia, which is a form
of synesthesia where individuals
associate specific graphemes with
specific colors. Dr. Ramachandran
was interested in the fact that the
“Visual Word Form Area” (the
area of your brain that recognizes
written graphemes) is anatomically adjacent to the “V4 color area”
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(the main region of your brain
that recognizes colors) (Figure
1). Because this synesthesia is the
most commonly reported subtype
and because these brain regions
also happen to be right next to
each other, Dr. Ramachandran
postulated that this form of synesthesia may be due to cross-activation of these two brain regions
that are normally unconnected in
non-synesthetic individuals. This
theory built off of previous studies about “phantom-limb sensation”, the experience in which an
individual is still able to feel sensation and pain in a limb that has
previously been amputated. These
studies demonstrated that phantom-limb sensation derives from
a cortical reorganization of brain
connections and this model uses
this same explanation of cross-activation in order to explain the
sensory experiences of synesthesia.
This theory also takes into account
the fact that as brains develop,
connections are cut or “pruned”
over time. This makes sense with
the cross-activation model because
synesthesia is much more common amongst young children and
decreases over time. This theory
also hypothesizes that the cross-activation of brain areas involved in
synesthesia is due to a failure of
pruning of these connections over
the course of development.

“sensory nexus” within the brain
that is typically inhibiting connections between various senses
in non-synesthetic individuals.
This model hypothesizes that in
synesthetes, people with synesthesia, this sensory nexus might
be dis-inhibited (meaning connections between brain-regions
would be enhanced!) The specific
region of the brain that Dr. Ramachandran proposes might be this
sensory nexus is called the “temporo-parietal-occipital junction”
(figure 2). One piece of evidence
for this theory is the fact that
non-synesthetic individuals under
the influence of psychedelics often
report having synesthesia-like experiences. This suggests a sensory
nexus by indicating that a specific brain area could be involved in
all types of synesthesia. Another
piece of evidence for the longrange disinhibited feedback model comes from the case study of a
patient who developed a type of
blindness at age 40 due to a condition called retinitis pigmentosa
(Armel, 1999). While the patient
was non-synesthetic before the onset of the disease, after 2 years of
blindness he reported that tactile
stimuli invoked the experience of

Disinhibited Feedback Model
The next theory of synesthesia
that Dr. Ramachandran proposes
is the “long-range, disinhibited
feedback model”. This model proposes that there may be a specific

Figure 2 The temporo-parietal-occipital junction is proposed to be a “sensory
nexus” that inhibits connections between
senses in non-synesthetic individuals.
(Image: TheBrainWashBlog)
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Figure 3 Re-entrant processing model. Not only does the form of a word influence its
color, but the meaning of word can also influence its color in synesthetic individials .
(Smilek, 2002)

seeing visual movement. What’s
more is that these synesthetic experiences were enhanced if he
placed his hand directly in front
of his face which once again indicates that some type of multisensory structure could be involved in
the neural mechanism underlying
synesthesia.
Re-Entrant Model
The third hypothesis as to the
neural mechanisms of synesthesia
is somewhat of a combination of
the local cross-activation model
and the long-range disinhibited
feedback model (Smilek, 2002).
This model is referred to as the
“re-entrant” model and suggests
that sensory information transmitted in grapheme-color synesthesia
flows not only from the visual
word form area to the color area
but also from the color area back
to the visual word form area. This
hypothesis is largely based on the
fact that the meaning of the word
can often affect its color for syn-

esthetes but also that the shape of
a word can have influence on its
color.
While each of the proposed theories as to the neurological mechanisms underlying synesthesia seems to make sense for
various subtypes, there is not one
unifying theory that explains all
facets of synesthesia. Because each
of the senses are processed by different areas of the brain, it is quite
possible that different brain mechanisms are responsible for different
subtypes of synesthesia. Another
piece of evidence for the idea that
different brain mechanisms might
be responsible for different facets
of synesthesia is the fact that the
subjective experience of this phenomenon differs even within the
same type of synesthesia. For example, in grapheme- color synesthesia, there are thought to be two
different sub-groups of synesthetes
: projector and associators synesthetes (Dixon, 2004). Associator
synesthetes experience their synesthesia as an association between a

color and a grapheme. They don’t
see letters any differently than anyone else but just inherently know
that the letter n is purple for example. Projector synesthetes, however, physically project the color
of each letter onto the page and
visual areas of the brain light up
accordingly.
There are also many ways
in which the outside environment
can influence the experience of
synesthesia. For example, a case
study done in 2008 examined the
synesthetic experiences of a grapheme-color synesthete (Dixon,
2008). They first had her record
the colors that she associated with
each letter of the alphabet and
then had her do this same thing
21 days later in order to show that
her perceptions were consistent
over time, which is typically considered a criteria of synesthesia.
They then compared these colors
to a set of refrigerator magnets
that she had as a child and found
some remarkable similarities indicating that sensory experiences
and memories that you have as a
child can significantly effect your
synesthesia throughout your life.
Another study found that music-color synesthesia is mediated
by emotion (Palmer, 2013). In this
study, participants chose colors
most similar to those seen when
listening to specific classical pieces
such as Bach, Mozart and Brahms.
The general trend was that faster
music in a major key produced
colors that were brighter, lighter
and yellower while slower, minor
music produced colors that were
desaturated, darker and bluer. This
demonstrates that emotions can

163

SCIENTIFIC KENYON

RECAP TIME!!!!
So people who
experience synesthesia
went from being called “prophets” and “messengers of God” to
medical patients and scientific subjects??
significantly impact the experience
of music-color synesthesia and
suggests that other types of synesthesia may also be mediated by
emotion.
Medicalization
The Medical Dictionary describes
“medicalization” as the process by
which life problems become articulated as health or mental health
conditions. Around the 1950’s,
the notion of illness as a deviant
behavior began to develop and
with it came the categorization
of illness in the form of medicalization. One reason for the medicalization of mental illness is that
it is a way to give social membership to “deviant” individuals who
would otherwise be alienated
from society. Rogers and Pilgrim
state, “To maintain our credibility in a social group, there has to
be a consensus about what our
senses detect around us. In most
contexts, if a person sees or hears
something that others do not,
then their credibility, and therefore, their social group membership, is jeopardized.” (Rodgers and
Pilgrim, 2014) People bond with
each other over the fact that they
experience the world in the same
way. When it is clear that someone
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What caused this
drastic shift in our
explanation of synesthesia
from something mystical to
something scientific?
experiences things in a different
way, they are quickly isolated from
society. However, the attempt to
define synesthesia as a medical
condition is an attempt to group
synesthetes together and give them
an explanation for their experiences. These scientific explanations
tend to calm people down, whether or not they are proven to be the
definitive cause of the experience.
The medicalization of
mental disorders and of synesthesia in particular also results
from our Western desire to rationalize and categorize the world.
In The Order of Things, sociologist Michael Foucault coins the
term “heterotopia”, which he describes as those nuanced instances
in which things have more than
one meaning simultaneously and
therefore cannot be explicitly defined or distilled into a singular explanation. He says, “Heterotopias
are disturbing, probably because
they secretly undermine language,
because they make it impossible to
name this and that, because they
shatter or tangle common names,
because they destroy ‘syntax’ in
advance, and not only the syntax with which we construct sentences but also that less apparent
syntax which causes words and
things (next to and also opposite

one another) to ‘hold together’”
(Foucault, 1966). Stated more
simply, we theorize and categorize
the world in order to avoid these
heterotopias and get closer to a
place where the world is completely understood, where there is no
ambiguity. The fact that a small
portion of the population seemed
to be having synesthetic experiences without any type of explanation other than that it was the
“will of God” must have become
increasingly distressing. The medicalization of synesthesia makes
sense according to Foucault’s idea
of categorization in order to avoid
the ambiguous nature of these experiences and group these people
together by providing a scientific
explanation for what they were experiencing.
So what do you think
about synesthetic experiences??
Act of God? Neurological diagnosis? Should time and money be put
into researching the neurological
mechanisms underlying this phenomenon?
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How to Read: A

Written Guide

By Ben Tauber

“D

ylan, like many other
dyslexic children, went
to great lengths to disguise his
challenges. He employed his excellent oral vocabulary, sophisticated
humor and emotional intelligence
to keep us all distracted from the
thing that privately shamed and
haunted him: Dylan thought
he was stupid.” Kyle Redford, a
teacher and a mother of a dyslexic son, retells her son’s experience
with dyslexia. “Too many educators still whisper the word, too few
students get identified early, and
many don’t get identified at all...
Dylan had to wait until fourth
grade to learn to read.” Lack of
awareness around dyslexia is confounded by the many questions
science still has about dyslexia.
It is common for people to
associate dyslexia with flipping letters such as “b” and “d” and poor
spelling. Although not all people
with dyslexia have the same experiences, some common behavioral
characteristics are poor spelling,
poor reading speed, and poor
reading accuracy. Given the dynamics of a classroom these factors
can compound and cause other
issues. Students who struggle with
reading and are required to do so
in front of a group will become
experts in evading this uncomfortable situation. Deirdre Griffin, a registered educational psychologist, writes “Some respond
by ‘acting out’ or becoming upset
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about going to school or completing homework, others choose to
give up – deciding it’s better to not
bother than to try and fail, while
others opt to become the class
clown.” Aside from reading and
writing, Griffin describes many
other tasks that may be especially
difficult for those with dyslexia.
These include: poor planning, organization, and difficulty remembering dates including the current
one. All of these factors can have
deleterious effects on a student’s
self-esteem. To understand how
differences in reading abilities
arise, it is important to understand
how humans’ ability to read
evolved in the first place.
The human brain has
evolved to recognize faces because
there is an evolutionary benefit to
recognizing friend and foe quickly.
Similarly, color vision was selected for as this gave us advantages
such as determining the quality of
food. These energetically expensive systems evolved due to the
immense evolutionary pressure
to be efficient at these behaviors.
Many of our ancestors, stretching
deep into the vertebrates, share
these abilities. This demonstrates
how far back in time these traits
developed. The time scale for the
evolution of these traits is on the
order of hundreds of thousands of
years. Our ability to read, on the
other hand has only been around
for approximately 5,400 years, as

this is when the first written language formed. There are color-vision and face recognition regions
to the brain because evolution has
selected for it. However, there has
not been time nor significant evolutionary pressure to create a reading center of the brain. Yet, as evidenced by your understanding of
this text so far, many people have
little difficulty reading. How can
we accomplish such a feat if we did
not evolve to have a reading center
in our brains?
Stanislas Dehaene, a
French neuroscientist working at
Institut national de la santé et de la
recherche médicale and a professor
at the College of Paris, proposed
the theory of neural recycling. “We
can learn to read because we have
a region which we inherit from
evolution,” Dehaene says; “[this
region’s] function is sufficiently
close to reading and we can recycle [it] for this function.” An area
in the left posterior temporal lobe
is highly tuned to respond to detailed images such as faces, objects,
lines, and shapes. Dehaene proposes “We recycle areas that have to
do with object recognition, shape
recognition because our brain did
not evolve for reading.” This area
of the brain has been termed the
visual word form area. Multiple
studies give strong evidence that
this area is the site of grapheme
interpretation and was recycled
from other responsibilities. A
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study compared the activity of the
visual word form area in Israeli
and American participants. When
the known language was shown to
the participants, functional MRI
showed increased activity. However, when Hebrew was shown
to the American participants and
vice versa no increase in activity
was noted. This indicates that the
visual word form area is especially
tuned to respond to letters we are
familiar with. Evidence that the
visual word form area evolved for
purposes other than reading comes
from an interesting observation.
When first learning to write, children will often write their letters
in a mirrored fashion, as depicted
in Figure 1. It is unlikely that children have seen mirrored letters or
that anyone is teaching children
to write mirrored letters. Dehaene
proposes it is likely that mirrored
writing is a remnant from the visual word form area’s previous responsibility as a face and object
recognition center. When you see
a picture and the mirror image
of that picture, your eyes receive
completely different sets of data.
However, your brain is able to
determine that the content is the
same. This phenomenon is known
as symmetry generalization and
is very useful for objects and faces. However, letters require more
specificity so this generalization
must be unlearned, demonstrating neural recycling. Given the
evidence for neural recycling and
brain imaging, the visual word
form area has been shown to be
key in grapheme analysis. Grapheme analysis is one large component to the comprehension of the

Figure 1 It is common for all children to write letters backwards. This may be evidence
of neural recycling and not necessarily dyslexia. Image Courtesy of understood.org.

written word however; a word
must be represented phonologically in the brain as well. This phonological representation occurs in
Wernicke’s area.
In 1993 Monica Strauss
Hough, a researcher at East Carolina University, detailed the experience of Patient R.C.

“R.C. was a sixty six-yearold female who suffered to left
hemisphere strokes verified by CT
scan and neurological examination. After the first stroke, the
CT revealed a lesion involving
the posterior portion of the first
temporal gyrus.”
R.C. had her stroke in Wernicke’s
area resulting in death of the brain
tissue and loss of function of that
brain region. Her deficits included
many phonological abnormalities
including: inability to complete
animal naming, inability to read,
and poor auditory comprehension. This and earlier case studies
lead researchers to hypothesis that
Wernicke’s area is heavily involved
with phonological processing. In
August of 2017, Kamel El Salek
et al. used functional magnetic
resonance imaging to look at participants’ brains when completing
reading tasks. Their aim was to
more accurately and consistently

identify Wernicke’s area for brain
mapping prior to brain surgery. El
Salek writes “As a reading comprehension task, [incomplete sentences for which participants had to fill
in a blank] can activate areas in the
posterior temporal cortex that pertain to language processing.” This
technique allows for the highly
precise identification of a brain
structure needed for surgery. The
authors reported that this specific
type of reading test more precisely and consistently activated Wernicke’s area as compared to word
generation from a single letter
prompt or word generation from
a category prompt. Salek proposes the success of this test, as compared to the other tests, is due to
participants simultaneously reading and semantically representing
phonemes. Semantic representation of phonemes or phonological representation is the ability to
cognitive relate the sound combinations that comprise a word.
This experiment provides further
evidence for the phonological importance of Wernicke’s area.
Given the need for proper phonological representation in
reading it was previously thought
that this was the area in which
dyslexic people struggled. French
cognitive scientist Frank Ramus
describes his work with this theory: “ [we] initiated a series of ex-
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periments tapping the phonological deficit in dyslexia and, against
our expectations, none of them
was consistent with the hypothesis
of degraded representations. It also
appeared that to us that the published literature was not as supportive as it seemed.” Ramus and
others proposed a new theory for
dyslexia. Instead of an issue with
the representation of phonemes,
they proposed dyslexia is caused
by an inefficiency with accessing these phonological representations. Although seemingly
a subtle difference between the
representation of phonemes its
self and the access of the representation of phonemes it implies
a completely different anatomical
structure. Boets et al. (2013) published important findings in support of this theory. Boets showed
pseudo-words to neuro-typical
and dyslexic participants during
MRI testing. Phonologic similarities of letters in pseudo-words
and the degree of activation for
specific brain areas was analyzed.
To the surprise of the researchers, no difference in phonological
representation was observed between dyslexic and neuro-typical
participants. This became a large
detractor of the prevailing theory
that dyslexia is due to poor phonological representation. While
studies have shown that phonological representation is not a source
of dyslexia, poor access theory has
received more support. Further
support for the poor access theory,
known as the connectivity theory
of dyslexia, came with Boets’ next
experiment. As part of this study
Boets et al. conducted functional
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connectivity analysis. This group
looked at the relative residual signal intensity across 13 anatomical
structures active during reading
tests. They found that dyslexic
participants had weaker connectivity in the area of Wernicke’s
area. Further evidence for the connectivity theory of dyslexia came
with structural analysis of the collection of nerve fibers stretching
from the visual word form area
and Wernicke’s area onto the frontal cortex in dyslexic populations.
This tract of fibers is called the
arcuate fasciculus. Jason Yeatman
and his colleagues demonstrated
that the arcuate fasiculus has structural differences in dyslexic people
that contribute to inefficiency.
This inefficiency is thought to be
the base for the connectivity issue
that causes poor access to phonological representation in dyslexic
brains. Fortunately, the brain is
highly plastic which allows it to
be taught and grow. This means
that although people with dyslexia
will always have certain difficulties with reading and writing, it is
possible for them to practice and
improve these skills with proper

education.
In our educational system
there are two primary methodologies: the Whole Word approach
and a phonics based approach. As
the name would imply the Whole
Word approach to reading education relies on gaining meaning
from the entire word. This is in
contrast to the phonics approach
which breaks up a word into parts
to ascertain its meaning.
The phonics based system, sometimes referred to as the
sub-lexical approach, emphases
decoding of words. Decoding involves breaking a word up into individual sounds. The word “food”
would be broken down to the “f ”
sound, double “oo” sound, and
“d” sound. The smallest part of a
word that makes a single sound is
referred to as a grapheme and the
sound is a phoneme. Students can
either be taught the connections
between phonemes and graphemes
explicitly or embedded in text.
Explicit education often involves
flash cards or other memory aid
devices to help students’ learning.
Embedded instruction has students read as a group and as exam-

“Dislexia,”licensed by CC0.
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ples of complex phoneme-grapheme pairings present themselves
in the text the teacher discusses
them. A method that uses a combination of these two variations is
the Orton-Gilligham method. Dr.
Samuel Orton and others invented Orton-Gilligham or OG in the
1920s. In addition to a large phonics component OG relies heavily on multi-sensory education. In
addition to seeing and hearing the
phoneme, students would write
out phonemes in sand, shaving
cream, or on carpet remnants. Students may take shots with a foam
ball on an indoor basketball hoop
while reciting grapheme-phoneme
combinations. This type of education is best practice for those with
learning differences (LD) such as
dyslexia or attention difficulties.
The Whole Word approach relies on the assumption
that children acquire reading skills
at the word level, rather than from
individual letters. David Ingram, a
researcher at Arizona State University, wrote, “First, children acquire
words, not individual consonants
and vowels, and show little awareness of segments...children are
word-oriented, not segment-oriented.” These assumptions stem
from a philosophical theory that
a whole is more than the sum of
its parts. In the classroom this approach includes sight memorization techniques, reading aloud in
a group, and prioritizing finding
texts that interest the student. Especially in English language education, where a large percentage
of words cannot be decoded using
phonics given the lack of phonetic
spelling, sight word memorization

becomes necessary.
Although there is overlap
between the two methodologies,
the emphasis is different. Phonics
relies on decoding of words where
as the Whole Word approach relies
on gaining meaning from a word
as a whole. The Whole Word approach often supplements phonics
which has become the predominate method of education in The
United States of America. There is
support in the literature for the
benefits of phonics over the Whole
Word reading method. Melissa
Schmidgall, a researcher at The
Ohio State University, and her
team conducted a comparative
analysis of several Whole Word
reading protocols and a phonics
based protocol. They found that
there was no difference in efficiency or efficacy between Whole
Word reading methods. They
students cumulative word-reading performance was better when
phonics instruction was used. It is
important to note that this study
was completed on neuro-typical
students.
Just as brain structure affects learning, learning changes
the structure of the brain. Michel
Thiebaut de Schotten, a researcher at King’s College, conducted a
study that looked at the microstructure of illiterate people, literate people, and people who had
learned to read as adults (ex-illiterate). The results of the study
demonstrated structural difference
between illiterate and literate people. The micro structural differences this team noted may be due to
the diameter of the neuron’s axon,
the density of the axons in the ar-

cuate fascicles, or the quality of
the myelination or insulating covering. The compelling component
of the study was that the results
from ex-illiterate and literate participants were indistinguishable.
This Demonstrates that learning
changes the way the brain is structured at the cellular level. In 2014
Alicia Che, a researcher at the University of Connecticut, conducted
a genetics study that looked these
micro-structural components. The
gene DCDC2 has been linked to
dyslexia and is believed to causes differences in receptor density
and cortical development. Specifically Che found that neurons in
a mouse model with this dyslexia
genetic variation had reduced temporal precision in action potentials
firing. As the timing of action potentials is key to neuronal communication, such a finding may
further support the connectivity
theory of dyslexia. Several other
genes have been linked to dyslexia as well. The relation between
these genes, epigenetics, and environmental factors in the cause of
dyslexia is still under investigation.
Reading is a highly complicated behavior that requires the
seamless integration of many cognitive functions. Using advanced
brain imaging, scientists have
started to unravel the mystery of
how humans who did not evolve
to read gained such a remarkable
function. Through this research a
neural explanation for dyslexia has
started to come to light. Having
this neural base bolsters the idea
that dyslexic people are not merely
stupid or lazy, but in fact have cognitive differences. Changes in ped-
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agogy have produced great results
not only for students with learning
difference such as dyslexia but for
students in general. Redford explains this progress. “Dylan came
of age during an educational renaissance. Over the last two decades, educators have learned that
there are effective interventions
for learning problems like dyslexia that used to merely carry scary
names. We have also learned that
dyslexia can be identified early, and
there are effective evidence-based
reading methods to ensure that
children with dyslexia CAN learn
to read.” Despite the difficulties
dyslexia causes, many people with
dyslexia learn to successfully navigate their difference and achieve in
their own ways.
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